VAERS Reports 065K21A

VAERS 2643204

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge 065K21A

kritisch

Staat: CA
Alter: 69,0
Geschlecht: F
Eingang: 31.10.2023
Impfdatum: 15.01.2021
Beginn: 20.01.2021
Tage bis Beginn: 5,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Angina pectoris Asthenia Blood pressure decreased Dizziness Heart rate decreased Blood pressure fluctuation Breast cancer female Breast operation Cardiac failure congestive Cardiac function test normal Cardiac perfusion defect Cardiomyopathy acute Catheterisation cardiac abnormal Chest pain Ejection fraction decreased Fatigue Feeling abnormal Hypertrophy

Symptomtext

After day 6 through day 20 of first dose (and for second dose, day 6 though day 16): extreme pulsating pain in heart muscle that lasted 10-15 seconds each episode. Episodes repeated several times an hour; lessening to every few hours. Extreme weakness developed, close to passing out. Heart rate dropped to 48- 58 beats a minute. Blood pressure dropped to 50 -60 Systolic/Diastolic.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: -
Labordaten: Occurred during height of Covid cases; ERs were over-flowing. Current family Doctor closed office. Unable to get medical care. Kept monitoring self in case husband needed to call 911. Eventually recovered. Repeated after second dosage. Doctor later assumed it might have been pericarditis or myocarditis. Please NOTE: In late December 2022, experienced severe heart failure with severe Ejection fraction reduction 27%; now 30 % with medications. No heart blockages found; arteries completely clear of plaque. Cause undetermined.
Aktuelle Erkrankungen: None
Vorgeschichte: Treated for triglycerides
Andere Medikamente: Fenofibrate 90 mg
Allergien: None
Vorherige Impfungen: -

VAERS 2661254

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: TN
Alter: 78,0
Geschlecht: M
Eingang: 26.07.2023
Impfdatum: 18.04.2022
Beginn: 10.06.2023
Tage bis Beginn: 418,0
Dosis: 3
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Vaccine breakthrough infection

Symptomtext

COVID related death; breakthrough case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN, Arthritis, GERD, Hodgkins disease, malignant neoplasm
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2660635

JANSSEN · COVID19 (COVID19 (JANSSEN)) · Charge 065K21A

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 25.07.2023
Impfdatum: 31.03.2022
Beginn: 26.01.2023
Tage bis Beginn: 301,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient Deceased

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: HTN, Depression
Andere Medikamente: Tylenol, Fentanyl, Magnesium, Narcan, Protonix, Potassium, Escitalopram, minoxidil, Metoprolol
Allergien: HCTZ, PCN
Vorherige Impfungen: -

VAERS 2634925

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: FL
Alter: 60,0
Geschlecht: M
Eingang: 22.05.2023
Impfdatum: 04.01.2021
Beginn: 04.06.2022
Tage bis Beginn: 516,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Anticoagulant therapy Arrhythmia COVID-19 COVID-19 pneumonia Cough Obstructive sleep apnoea syndrome Pneumonia Pneumonia bacterial Pneumonia viral Pyrexia Respiratory failure SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

BREAKTHROUGH COVID: PT FULLY VACCINATED. Pt reported spouse tested positive,reported having a fever and cough. It's noted that the patient uses a BiPAP when he sleeps at night. He denies any chills, SOB, chest pain, abdominal pain, nausea, vomiting, diarrhea, headache and dizziness. Pt diagnosed acute on chronic, hypoxic respiratory failure, COVID-19 viral pneumonia, community-acquired bacterial pneumonia ,obstructive sleep apnea, Cardiac dysrhythmia, Possible zoster exacerbation and Acute kidney injury. Pt treated with Decadron, azithromycin: 500 mg, cefTRIAXone: 1 gm,IV Solu-Medrol, amd heparin t.i.d.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: MOBID OBSESITY, HYPERTENSION, DM
Andere Medikamente: UNKNOWN
Allergien: bananas, kiwi, augmentin, latex, codeine.
Vorherige Impfungen: -

VAERS 2607853

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge 065K21A

kritisch

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 31.03.2023
Impfdatum: 12.04.2022
Beginn: 04.03.2023
Tage bis Beginn: 326,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Arrhythmia Asthenia Atrial flutter Bladder catheter removal Bladder catheterisation COVID-19 COVID-19 pneumonia Cardiac telemetry abnormal Chest X-ray abnormal Confusional state Cough Echocardiogram normal Ejection fraction normal Electrocardiogram abnormal Fall Haematuria Hypoxia

Symptomtext

Patient is a 87 y.o. male who presented from home on 3/4/2023 after a fall. He was found to have COVID-19 infection. Was hypoxemic, initially requiring 5 L of oxygen. Treated with remdesivir and Decadron. Oxygen weaned off. All symptoms of COVID have resolved. Discharged home. Assessment and Plan Pneumonia due to COVID-19 -Presented with: cough, sore throat, generalized weakness, confusion -His symptoms started on 3/2/2023 with -He tested positive for COVID-19 on admission on 3/4/2023 -He has been vaccinated and boosted x2 -Initially needed to be placed on 5 L oxygen and then slowly weaned off oxygen. He has been off oxygen since 3/6 -He was treated with Decadron and remdesivir while in the hospital. Since he has been off oxygen and doing well, medication stopped on discharge Acute hypoxemic respiratory failure -Suspect more related to covid -Initially required 5L NC to maintain sats above 90%, now weaned off oxygen -CXR show moderate bilateral lower lung linear opacities of unclear etiology. Fall Generalized Weakness -no head trauma or LOC -diffusely weak, likely from above -Seen by PT/OT. Rehab was recommended but patient wanted to go home. He refused home health since he says he has helpers who comes every day at home to help. Arrhythmia -Suspect exac by pneumonia (initial ekg show ?"aflutter", repeat ekg show "sinus rhythm w/PAC's" -He was monitored on telemetry metric which showed PACs. No evidence of A-fib -EKG repeated again on 3/6 with sinus rhythm and PACs -Has history of SVT status post ablation 1997 -Echo with normal EF -Continue beta-blocker BPH Urinary retention -BPH noted on outpatient chart review, not on medications -Initially needed placement of Foley catheter which was removed. Voiding well Hematuria -Suspect due to traumatic foley placement in ER -Now resolved

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2593877

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: TN
Alter: 77,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 08.04.2022
Beginn: 03.03.2023
Tage bis Beginn: 329,0
Dosis: 4
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Electrocardiogram Vaccine breakthrough infection X-ray

Symptomtext

COVID-RELATED DEATH/ BREAKTHRPOUGH CASE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 48,0
Labordaten: XRAY, EKG, PULMONARY EXAMS
Aktuelle Erkrankungen: HCAP (HEALTHARE-ASSOCIATED PNEUMONIA), ACUTE ON CHRONIC HEART FAILURE, AKI (ACUTE KIDNY INJURY) PULMONARY VASCULAR CONGESTION, ACUTE METABOLIC ENCEPHALOPATHY
Vorgeschichte: HTN, CVA, T2DM
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568677

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: MN
Alter: 88,0
Geschlecht: M
Eingang: 26.01.2023
Impfdatum: 27.09.2022
Beginn: 19.11.2022
Tage bis Beginn: 53,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Chronic obstructive pulmonary disease Cough Decreased appetite Dyspnoea Feeling abnormal Influenza Influenza virus test negative Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

Patient seen in the ED on 11/19/22 after feeling poorly approximately a week ago with shortness of breath, sore throat, cough, and decreased appetite. He had been seen at urgent care 2x prior to being seen in the ED. The day prior to coming to the ED (11/18), the patient was seen in clinic and diagnosed with influenza and COVID. Retest in the ED was positive for COVID-19 by PCR and negative for Influenza. Ultimately patient admitted 11/19/22 - 11/21/22 with acute hypoxic respiratory failure secondary to influenza and COVID-19, COPD with possible exacerbation. Supplemental O2 up to 2L NC during admission, however patient was weaned to room air.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2604567

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: -
Alter: 63,0
Geschlecht: F
Eingang: 24.01.2023
Impfdatum: 04.04.2022
Beginn: 21.12.2022
Tage bis Beginn: 261,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Alanine aminotransferase normal Angiogram pulmonary normal Anion gap Aspartate aminotransferase normal Asthenia Band neutrophil percentage Basophil count decreased Basophil percentage decreased Bilirubin urine Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium normal Blood chloride normal Blood creatinine normal Blood glucose normal Blood potassium normal

Symptomtext

Narrative: 12/21/22 - Pt sent to ED from community residential care facility for hypotension, generalized body weakness (GBW), body aches x 1 day. Pt reported chills and muscle pain. In ED, Pt tested COVID +. Pt given 1L NS IVF considering tachycardia / likely dehydration, rectal Tylenol, cefepime IV. Pt will be admitted to hospital 12/21 d/t COVID-19, GBW, body aches and abnormal chest x-ray (possible pneumonia). Pt admitted 12/21/22 through 1/20/23. PRINCIPAL DIAGNOSIS (Reason for admission after study): Acute hypoxic respiratory failure secondary to COVID and possibly aspiration pneumonia. ADDITIONAL DIAGNOSES: Acute on chronic dysphagia due to cervical osteophyte complex COVID viral pneumonia Schizoaffective disorder Syncope Hypothyroidism Hospital Course: 1. Acute COVID 19 infection/pneumonia - clinically resolved. Completed course of remdesivir and decadron. 2. Acute hypoxic respiratory failure due to COVID 19 and possible bacterial pneumonia - resolved. No evidence of PE on Chest CTA. S/P cefepime x 7 days 3. Dysphagia - Failed MBSS badly, per both SLP and radiologist there is little change of recovery short of potential surgery. Osteophyte complex. Community provider has accepted for transfer, but no beds right now. Pt will be transferred to facility for evaluation of osteophytes once bed is available. 4. Hypothyroidism - TSH high nl range cont levoxyl repeat TSH in 4- 6 weeks 5. Syncope, resolved - likely related to hypotension. No further evaluation. 6. Schizoaffective ds, PTSD - Stable, at baseline. Cont Haldol 150mg q4weeks (last dose 12/8/22) Given mentation/sensorium concerns and low plts MH recommended to d/c Valproate (mood instability hx). Can be reconsidered in future as an outpatient, with close monitoring of labs 7. DVT ppx- hep sc

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Pt tested COVID + on 12/21/22. Vital Signs * Temperature 99.6 F (37.6 C) Pulse 136 Respirations 27 Blood Pressure 97/47 Pain scale recorded: 99 Pulse Oximetry 96 Room Air General: awake/alert/oriented, well-appearing, nontoxic, no distress, resting in well lit room ENT: nl phonation Eyes: anicteric, no apparent photophobia Neck: supple, CV: Rapid rate, normal rhythm, distal pulses 2+ Pulmonary: No increased work of breathing, no wheezes appreciated, occasional cough observed Abdomen: soft, NTTP, no guarding, non-acute abdomen Back: no CVA TTP appreciated Extremities: baseline range of motion, no increased warm or redness appreciated Neuro: speech clear, mostly single word answers, moving all extremities, gait not tested, follows directions Skin: warm/dry Psych: blunted mood/affect PERTINENT LABS independently reviewed if resulted: TROP-I iSTAT: 0.04 APPEARANCE: Clear UR COLOR: Light-Yellow SPECIFIC GRAVITY: 1.015 UROBILINOGEN: 3 UR KETONES: 10 UR GLUCOSE: Normal UR PROTEIN: NEGATIVE UR PH: 8.0 WBC/HPF: 5 RBC/HPF: 22 H NITRITE, URINE: NEGATIVE LEUKOCYTE ESTERASE, URINE: Negative SQAUMEPITHELIALHPF: 1 URINE BLD: 2+ URINE BILI: NEGATIVE VALPROIC ACID: 102.7 TOTAL BILIRUBIN: 0.4 ASAT: 34 ALKALINE PHOSPHATASE: 50 TOTAL PROTEIN: 7.3 ALBUMIN: 3.3 L SODIUM: 138 POTASSIUM: 4.4 CHLORIDE: 104 CO2: 24 ANION GAP (CALCULATED): 10 GLUCOSE: 93 CREATININE: 0.8 CALCIUM: 9.8 ALT: 8 EGFR: 83 UREA, BUN: 17 WBC: 12.1 H RBC: 3.20 L HGB: 10.4 l HCT: 30.6 L MCV: 95.6 H MCH: 32.6 MCHC: 34.0 RDW: 13.6 PLT: 113 L MPV: 8.5 SEGS: 55.2 BANDS: 23.8 H LYMPHS: 1.9 L MONOCYTES: 8.6 META: 10.5 H PLT. (SMEAR EST.): Low POLYCHROMASIA: FEW OVALOCYTES: MOD EOSINO, ABSOLUTE: 0.0 BASO, ABSOLUTE: 0.0 GRAN % (SS): 86.6 H LYMPH % (SS): 1.7 l MONO % (SS): 11.4 EOS% (SS): 0.0 BASO% (SS): 0.3 GRAN# (SS): 10.5 H LYMPH# (SS): 0.2 L MONO# (SS): 1.4 H STOMATOCYTES: MOD MDW: 25.66 H* COVID-19 PCR (FLUVID)(CEPHEID): POSITIVE H* FLU A PCR (FLUVID)(CEPHEID): NEGATIVE FLU B PCR (FLUVID)(CEPHEID): NEGATIVE RSV PCR (FLUVID)(CEPHEID): NEGATIVE IMAGING chest xray independently reviewed, no ptx or pleural effusions, patchy opacity L base and radiology report reviewed as below: Radiology Impression (2Days) Date Procedure CPT Status Case # 12/21/2022 CHEST 1 VIEW Verified There are patchy focal infiltrates or consolidations seen in the left lung base. A new finding since prior study. EKG independently reviewed showing: sinus tach 123, nonspec t wave changes noted
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2526829

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: SD
Alter: 98,0
Geschlecht: M
Eingang: 08.12.2022
Impfdatum: 11.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 9,0
Dosis: 3
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 01/28/2021, 02/25/2021, and 07/12/2022. They also received the Pfizer Bivalent product on 10/11/2022. They tested positive for COVID-19 on 09/15/2022. They received home care from a hospital system from 10/14/2022 until their death on 10/20/2022. Also note this person received their last booster about 8 days before their death. COVID-19 disease is on the death certificate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hyperthyroidism, Hypertension, Hyperlipidemia, coronary artery disease. Recent deterioration in overall health, with increased confusion and falls.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2520484

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: WA
Alter: 72,0
Geschlecht: F
Eingang: 30.11.2022
Impfdatum: 07.04.2022
Beginn: 26.11.2022
Tage bis Beginn: 233,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Ankle fracture Atrial fibrillation COVID-19 pneumonia Cardiac failure Condition aggravated Fall Metabolic encephalopathy SARS-CoV-2 test positive Syncope

Symptomtext

Patient received Moderna COVID vaccine on 7/28/21 (lot # 033C21A), 9/10/21 (lot # 034C21A), and 4/7/22 (lot # 065K21A). On 11/25/22, patient had a mechanical fall with syncopal episode. On 11/26/22, patient admitted to our inpatient facility (med/surg unit) s/p mechanical fall with acute hypoxic respiratory failure secondary COVID pneumonia and HFrEF, acute metabolic encephalopathy, afib with RVR, and left ankle fracture s/p mechanical fall 11/25. As of today (11/30/22), patient is still admitted in the med/surg unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: COVID status positive 11/26/22.
Aktuelle Erkrankungen: -
Vorgeschichte: history of CKD, HFrEF (mildly reduced per 2/2020 TTE, unable to quantify), T2DM, HTN, pAF and h/o DVT/PE on warfarin
Andere Medikamente: acetaminophen, bumetanide, diltiazem, vitamin d, escitalopram, gabapentin, hydrochlorothiazide, insulin glargine, insulin lispro, melatonin, potassium chloride, simvastatin, preservision areds-2, warfarin
Allergien: penicillin, amoxicillin, rosuvastatin, duloxetine, oxycodone, metformin
Vorherige Impfungen: -

VAERS 2506687

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: -
Alter: 72,0
Geschlecht: F
Eingang: 12.11.2022
Impfdatum: 11.04.2022
Beginn: 05.10.2022
Tage bis Beginn: 177,0
Dosis: 5
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Angiogram pulmonary abnormal COVID-19 COVID-19 pneumonia Condition aggravated Dyspnoea Hypercalcaemia Hypophagia Hypoxia Interstitial lung disease Lung opacity Malnutrition Oesophagitis Oral candidiasis Peripheral arterial occlusive disease Peripheral ischaemia Respiratory failure SARS-CoV-2 test positive

Symptomtext

Clinical Summary A 73 y.o. female with a history of ILD on chronic steroids, Sjogren's syndrome, iatrogenic Cushing's disease, anxiety and depression who presented to hospital 10/5/2022 with dyspnea and hypoxia SAT level 79% RA, CTPA showed multilobar ground glass opacities consistent with inflammatory or infectious process. COVID-19 negative initially then repeat 10/08/22 positive. Patient received empiric antibiotics, IV steroids, and Remdesivir with minimal improvement in hypoxia. She developed severe esophagitis with poor PO intake on chronic malnutrition. She also experienced acute RLE limb ischemia. Pulmonology, GI, peripheral cardiology, and palliative care followed. She was eventual changed to a DNRCC and was discharged. 1. Acute on chronic hypoxic respiratory failure: Suspect ILD exacerbation, complicated by COVID-19 infection, less likely bacterial process. CTPA showed multilobar ground glass opacities consistent with inflammatory or infectious process, RA sat 79%. Worsened clinically 10/07/22 and progressed from NC to HHF. Completed 5 day course of empiric Rocephin/Azithromycin 10/10/22. S/p IV solumedrol, switched to PO prednisone 10/12/22. Failed attempt at nasal oxymizer 10/12/22, successful on second attempt 10/14/22. Transitioned to DNRCC 10/15/22 given additional co-morbidities below. Symptom management per hospice. 2. Esophagitis: Concern for candida esophagitis given thrush and high dose steroids, possibly erosive given high dose steroids. GI consulted, recommended IV PPI BID and IV Pepcid. Symptom management per hospice. 3. Acute RLE limb ischemia: Patient noted pain and discoloration of RLE toes. ABIs with severe PAD. Peripheral cardiology evaluated, suspected embolic, poor candidate for intervention. Symptom management per hospice. 4. Hypercalcemia: Secondary to TUMS use. Initiated TUMS for above, patient/family requesting more, discussed risks of hypercalcemia. Notified that husband was also giving TUMS from home. Discontinued TUMS order and re-educated patient/husband. iCal improved with IVF. No further lab draws given goals of care. 5. COVID-19 pneumonia: COVID-19 initially negative but repeat 10/07/22 positive. Steroids as above. Completed Remdesivir 10/12/22. Pulmonology followed. 6. ILD: diagnosed 2019, follows with Dr. has been on chronic Prednisone 10 mg daily, was started on Dapson for prophylaxis 2020 but not taking now. Continued high dose steroids per pulmonology. 7. Sjogren's syndrome: mild, no specific organ involvement. 8. Anxiety and depression: continued home meds. 9. Thrush: Oral nystatin started 10/10/2022 10. Underweight/Severe malnutrition present on admission: BMI 16.19, patient denies anorexia. PO diet as tolerated, doesn't like any of the available protein supplements. Dietician followed. Patient and family decline artificial nutrition given goals of care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2505658

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: MI
Alter: 82,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 20.04.2022
Beginn: 04.11.2022
Tage bis Beginn: 198,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory distress syndrome Acute respiratory failure Angiogram pulmonary abnormal Barium swallow Blood electrolytes Blood lactic acid normal Bronchial secretion retention Bronchial wall thickening COVID-19 Chronic obstructive pulmonary disease Condition aggravated Cough Dysphagia Dyspnoea Electrolyte depletion Electrolyte substitution therapy Escherichia urinary tract infection Laboratory test normal

Symptomtext

COVID+ 11/4/22 - Vaccination status - moderna x4 Discharge Physician: MD, Primary Care Physician: DO Date of Admission: 11/4/2022 Discharge Date: 11/10/2022 Room Number: BRIEF OVERVIEW: Active Hospital Problems Diagnosis Date Noted POA ? COVID-19 11/04/2022 Yes ? Pneumonia LUL 11/04/2022 Yes ? Toxic metabolic encephalopathy 11/04/2022 Yes ? PAD (peripheral artery disease) (HCC) 05/20/2022 Yes ? Chronic obstructive pulmonary disease with acute exacerbation (HCC) 05/14/2021 Yes ? Paroxysmal atrial fibrillation with RVR 05/14/2021 Yes ? Essential hypertension DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COPD exacerbation (HCC) [J44.1] Pneumonia of left lung due to infectious organism, unspecified part of lung [J18.9] HOSPITAL COURSE: 82 y.o. caucasian male patient with past medical history chronic obstructive pulmonary disease, dementia, dysphagia, paroxysmal atrial fibrillation, hypertension, PAD. presents from his care facility via EMS with increased dyspnea, severe wheezing, shortness of breath Laboratory data reviewed showing WBC 12K initial lactate normal via point of care in ER, patient's heart rate 110's to 130s, without significant tachypnea but noted some lethargy and ineffective cough with upper airway wheezing. He received duo nebulized bronchodilators as well as 125 mg IV Solu-Medrol in the ER. CT angiogram thorax obtained for further evaluation to rule out PE. Noted negative for pulmonary embolism, left upper lobe pneumonia, small left pleural effusion, bronchial thickening and mucous plugging which may be indicative bronchitis. Patient tested positive for COVID-19, patient was noted to be in acute respiratory distress, acute hypoxic hypercapnic respiratory failure secondary to viral pneumonia. Patient was treated with IV dexamethasone and started on IV remdesivir completed 5 day course. Patient was gradually weaned off oxygen transition to hear. Patient was initially started on Rocephin and azithromycin however after a procalcitonin was negative antibiotic was discontinued. Patient was noted to have E coli urinary tract infection for which he was treated with IV Rocephin and transition to oral Ceftin and completed course of antibiotic during the hospitalization. Patient does have history of dementia with progressive deterioration of his mentation. Home medications were continued acute encephalopathy was noted at the time of admission which progressively improved and patient was back to baseline. He was also noted to have dysphagia for which speech therapy was consulted and video fluoroscopic study was completed speech adjusted as dysphagia diet PT/OT recommended return to SNF. MSW/CM consulted for discharge planning. Patient able to return to mission point which was arranged. Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge. CONSULTANTS: SLP PT/OT MSW/CM INPATIENT PROCEDURES: VFSS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Dysphagia Chronic obstructive pulmonary disease with acute exacerbation (HCC) Dementia (HCC) Essential hypertension Paroxysmal atrial fibrillation with RVR Tobacco dependence Recurrent major depressive disorder, in full remission (HCC) Psoriasis Slow transit constipation Primary insomnia Lethargy PAD (peripheral artery disease) (HCC)
Andere Medikamente: Acetaminophen 1,000 mg Oral Every 8 hours PRN Albuterol Sulfate 108 (90 Base) MCG/ACT 2 puffs Inhalation Every 6 hours PRN Aspirin 1 tablet Oral Daily with lunch Citalopram Hydrobromide 20 mg Oral Daily with lunch Donepezil HCl 10 mg Oral N
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2501399

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: WA
Alter: 71,0
Geschlecht: F
Eingang: 07.11.2022
Impfdatum: 27.04.2022
Beginn: 29.10.2022
Tage bis Beginn: 185,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 pneumonia

Symptomtext

Patient received Moderna COVID vaccine on 3/5/21 (lot # 029A21A), 4/5/21 (lot # 026B21A), 11/17/21 (lot # 066F21A), and 4/27/22 (lot # 065K21A). On 10/29/22, patient admitted to our inpatient facility (med/surg unit) with acute hypoxic respiratory failure secondary to COVID-19 pneumonia and generalized weakness. On 11/3/22, patient discharged back to ALF.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: ALF resident with history of osteoporosis with recurrent pathological fracture, T12 fracture, mild cognitive impairment with memory loss (last MOCA 19/30 11/2022)DM2, CKD stage 2, h/o brain tumor, HTN, HLD, GERD, recurrent UTI and emphysema/chronic respiratory failure has been off her oxygen for the past 4 months from 10/29/22
Andere Medikamente: acetaminophen, atorvastatin, calcium/vitamin d3, cetirizine, fluticasone/salmeterol inh, fluticasone nasal sp, insulin glargine pen, levothyroxine, lidocaine patch, montelukast, oxycodone, pregabalin, sertraline, sitagliptin
Allergien: bee, iodine, peanut
Vorherige Impfungen: -

VAERS 2492760

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: SD
Alter: 90,0
Geschlecht: F
Eingang: 28.10.2022
Impfdatum: 21.04.2022
Beginn: 13.07.2022
Tage bis Beginn: 83,0
Dosis: 4
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated 4 times, having received the Moderna product on 01/21/2021, 02/19/2021, 09/28/2021, and 04/21/2022. They tested positive for COVID-19 via antigen test on 07/13/2022 at the nursing home at which they were a resident. They died on 07/17/2022. I see no indication they were hospitalized for this illness. They may have died at the nursing home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Pancreatic Cancer, Long Term use of Anticoagulants (Warfarin), Hypothyroidism, Hypertension, Stage 3 Chronic Renal Impairment, Past History of A-Fib, Pre-diabetes, Hyperlipidemia The individual was a resident of the nursing home indicated in the Address portion of this form.
Andere Medikamente: Long-term use of Warfarin
Allergien: -
Vorherige Impfungen: -

VAERS 2426427

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: KY
Alter: 70,0
Geschlecht: F
Eingang: 01.09.2022
Impfdatum: 12.05.2022
Beginn: 17.07.2022
Tage bis Beginn: 66,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Abdominal pain Acute kidney injury Acute myocardial infarction Anaemia Asthenia Asymptomatic COVID-19 Blood creatinine increased Blood loss anaemia Cardiac stress test abnormal Clostridium difficile colitis Colonoscopy Computerised tomogram abdomen Echocardiogram Ejection fraction Haemoglobin decreased Intensive care Oesophagogastroduodenoscopy SARS-CoV-2 test positive

Symptomtext

Patient ID: 70 y.o. Admit Date: 7/18/2022 Discharge Date: 8/9/2022 Discharge Diagnosis: Principal Problem: Septic shock Active Problems: NSTEMI (non-ST elevated myocardial infarction) Acute renal failure with acute tubular necrosis superimposed on stage 4 chronic kidney disease Atonic bladder Severe protein-calorie malnutrition UTI (urinary tract infection) due to urinary indwelling Foley catheter COVID-19 virus infection Acute blood loss anemia C. difficile colitis Retained ureteral stent Type 2 diabetes mellitus, without long-term current use of insulin Essential hypertension Hospital Course: 70 year old female with atonic bladder was admitted initially for acute on chronic renal failure with Cr 3.4. She was initially treated with antibiotics. She was transferred to ICU for developing septic shock. She required vasopressors. Due to anemia nad shock, ASA and Plavix were stopped. Foley was maintained. She had NSTEMI. She became very weak from this. She finally improved and was transferred to the floor but later developed C diff colitis and was treated for that with oral Vancomycin, She was started on PT and OT. Stress test on 8/6 show LVEF 65%. TTE on 7/19 showed it to be 30-35%. Dr. reviewed the films and decided she does not require Life Vest for now. Hgb is stable at 8.6. Renal function stable with Cr 2 today. She has been accepted at a HCF for rehab and the family agreed. She will be transferred there today. She initially tested (+) for Covid-19 on admission and is still testing (+) today even though she is asymptomatic. She will be transferred today. Total discharge time >30 minutes. Patient educated on appropriate level of care post-discharge. Follow up with nephrology and cardiology. Physical Exam on the day of discharge: Last Recorded Vital Signs: Temp: 97.6 ?F (36.4 ?C) Heart Rate (Monitor): 100 Pulse: 104 BP: 134/65 Respirations: 15 SpO2: 99 % O2 Flow Rate (l/min): 3 l/min General Appearance: no distress Eyes: PERRLA ENT: moist mucus membranes, no adenopathy Lungs: clear to auscultation bilaterally Heart: regular rate and rhythm Abdomen: soft, non-tender Skin: No rashes or lesions Extremities: no edema Neuro: alert Consults: IP CONSULT TO UROLOGY IP CONSULT TO NEPHROLOGY IP CONSULT TO SOCIAL WORK IP CONSULT TO WOUND CARE IP CONSULT TO INFECTIOUS DISEASES IP CONSULT TO INFECTIOUS DISEASES IP CONSULT TO CARDIOLOGY IP CONSULT TO VASCULAR SURGERY IP CONSULT TO GASTROENTEROLOGY IP CONSULT TO WOUND CARE IP CONSULT TO WOUND CARE IP CONSULT TO DIETARY IP CONSULT TO SUPPORTIVE CARE SERVICES IP CONSULT TO SOCIAL WORK IP CONSULT TO GASTROENTEROLOGY IP CONSULT TO SUPPORTIVE CARE SERVICES IP CONSULT TO PASTORAL CARE Significant Diagnostic Studies: CT abdomen and pelvis, VQ scan, TTE, stress teat Operations: EGD, colonoscopy Disposition: SNF Discharge Condition: Fair Discharge Medications: Current Discharge Medication List START taking these medications Details midodrine (PROAMATINE) 5 mg tablet 3 Tabs by Per Tube route Three times a day. Refills: 0 Associated Diagnoses: Acute blood loss anemia torsemide (DEMADEX) 10 mg tablet Take 1 Tablet by mouth Once Daily. Refills: 0 Associated Diagnoses: Acute blood loss anemia CONTINUE these medications which have NOT CHANGED Details simvastatin (ZOCOR) 40 mg tablet Take 1 Tablet by mouth At bedtime. Qty: 30 Tablet, Refills: 5 Associated Diagnoses: Hyperlipidemia, unspecified hyperlipidemia type sertraline (ZOLOFT) 50 mg tablet Take 50 mg by mouth Once Daily. clopidogreL (PLAVIX) 75 mg tablet Take 1 Tablet by mouth Once Daily. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: NSTEMI (non-ST elevated myocardial infarction) folic acid (FOLVITE) 1 mg tablet Take 1 Tablet by mouth Once Daily. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: Chronic generalized abdominal pain; Folic acid deficiency magnesium chloride (SLOW-MAG) 64 mg DR tablet Take 1 Tablet by mouth Twice a day. Qty: 60 Tablet, Refills: 2 Associated Diagnoses: Hypomagnesemia famotidine (PEPCID) 20 mg tablet Take 1 Tablet by mouth At bedtime. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: Gastroesophageal reflux disease without esophagitis iron polysaccharides (NIFEREX) 150 mg capsule Take 1 Capsule by mouth Once Daily. Qty: 30 Capsule, Refills: 3 Associated Diagnoses: Other iron deficiency anemia sodium bicarbonate 650 mg tablet Take 1 Tablet by mouth Twice a day for 90 days. Qty: 270 Tablet, Refills: 3 Associated Diagnoses: Metabolic acidosis levothyroxine (SYNTHROID) 150 mcg tablet Take 1 Tablet by mouth Once Daily for 30 days. Qty: 90 Tablet, Refills: 3 Associated Diagnoses: Acquired hypothyroidism pantoprazole (PROTONIX) 40 mg DR tablet Take 1 Tablet by mouth Twice a day. Qty: 180 Tablet, Refills: 3 Associated Diagnoses: Gastroesophageal reflux disease with esophagitis without hemorrhage dicyclomine (BENTYL) 20 mg tablet Take 1 Tablet by mouth Before meals. Qty: 270 Tablet, Refills: 3 Associated Diagnoses: Chronic generalized abdominal pain isosorbide mononitrate (IMDUR) 30 mg CR tablet Take 1 Tablet by mouth Once Daily. Qty: 90 Tablet, Refills: 1 Associated Diagnoses: NSTEMI (non-ST elevated myocardial infarction); Hypotension due to drugs insulin aspart U-100 (NOVOLOG) 100 unit/mL injection Administer 0.02 mL subcutaneously As directed. Refills: 0 Associated Diagnoses: Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin nitroglycerin (NITROSTAT) 0.4 mg SL tablet Take 1 Tablet sublingually Every 5 minutes as needed for Chest pain. Qty: 25 Tablet, Refills: 5 Associated Diagnoses: Stable angina pectoris; Coronary artery disease involving native coronary artery of native heart without angina pectoris insulin glargine (LANTUS) 100 unit/mL injection Administer 10 Units subcutaneously At bedtime. QAM & QHS !! Miscellaneous Medical Supply Misc 1 Each Daily. Nocturnal hallucinations Check Nocturnal pulse ox.x 8 hours. Med assist ( please fax to them) Qty: 1 Each, Refills: 0 Associated Diagnoses: Substance or medication-induced psychotic disorder, with hallucinations Insulin Needles, Disposable, (BD ULTRA-FINE MINI PEN NEEDLE) 31 gauge x 3/16" Ndle 1 Each Four times a day as needed. Qty: 140 Each, Refills: 11 Associated Diagnoses: Uncontrolled type 2 diabetes mellitus with hyperglycemia; DM type 2, goal HbA1c < 7% Lancets Misc 1 Each Before meals and at bedtime. Qty: 150 Each, Refills: 11 Associated Diagnoses: Uncontrolled type 2 diabetes mellitus with hyperglycemia; DM type 2, goal HbA1c < 7% !! Miscellaneous Medical Supply Misc 1 Each Daily. Hospital bed, automatic with HOB at 30 degrees at all times, due to risk GERD aspiration Qty: 1 Each, Refills: 0 Associated Diagnoses: Gastroesophageal reflux disease with esophagitis without hemorrhage; Debilitated; Decreased mobility; Orthopnea; CRF (chronic renal failure), stage 4 (severe); Other osteoarthritis involving multiple joints; History of non-ST elevation myocardial infarction (NSTEMI); Coronary artery disease involving native coronary artery of native heart, angina presence unspecified Blood Sugar Diagnostic Strp After meals & at bedtime. One touch vera strips Qty: 150 Strip, Refills: 11 Associated Diagnoses: Uncontrolled type 2 diabetes mellitus with hyperglycemia !! Miscellaneous Medical Supply Misc 1 Each Daily. Wheelchair For Decrease mobility Qty: 1 Each, Refills: 0 Associated Diagnoses: Decreased mobility blood-glucose meter (ONETOUCH VERIO FLEX START) Kit 1 Kit Before meals and at bedtime. Has coupon Qty: 1 Each, Refills: 0 Associated Diagnoses: Uncontrolled type 2 diabetes mellitus with hyperglycemia !! - Potential duplicate medications found. Please discuss with provider. STOP taking these medications nitrofurantoin, macrocrystal-mono, (MACROBID) 100 mg capsule Comments: Reason for Stopping: hydrOXYzine pamoate (VISTARIL) 25 mg capsule Comments: Reason for Stopping: Cholecalciferol, Vitamin D3, (VITAMIN D3) 1,000 unit Cap Comments: Reason for Stopping: carbamide peroxide (DEBROX) 6.5 % otic solution Comments: Reason for Stopping: furosemide (LASIX) 40 mg tablet Comments: Reason for Stopping: metoprolol (TOPROL-XL) 100 mg XL tablet Comments: Reason for Stopping: ipratropium-albuteroL (DUO-NEB) 0.5 mg-3 mg(2.5 mg base)/3 mL nebulizer solution Comments: Reason for Stopping: cyanocobalamin (VITAMIN B-12) 1,000 mcg/mL injection Comments: Reason for Stopping: aspirin 81 mg tablet Comments: Reason for Stopping:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2420883

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: TN
Alter: 73,0
Geschlecht: M
Eingang: 26.08.2022
Impfdatum: 29.03.2022
Beginn: 07.07.2022
Tage bis Beginn: 100,0
Dosis: 3
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Covid Vaccine x 3. Tested positive for Covid on 7/7/22. Admitted to Medical Center on 7/21/2022 and expired on 8/24/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2411140

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: CT
Alter: 74,0
Geschlecht: F
Eingang: 15.08.2022
Impfdatum: 07.04.2022
Beginn: 12.04.2022
Tage bis Beginn: 5,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Abdominal pain Anticoagulant therapy Blood test Catheter directed thrombolysis Computerised tomogram abnormal Dyspnoea Intensive care Intra-abdominal haematoma Mobility decreased Pain Pulmonary embolism Thrombosis Ultrasound Doppler abnormal

Symptomtext

Starting 04/12/2022, I became short of breath. It was so severe that I was having a hard time catching my breath. I was taken to the doctor and they referred me to the emergency room. When I got there, they did a CAT scan and numerous blood tests. I was taken up to ICU and had the EKOS procedure the next day for a PE. I would remain in the hospital until 04/17/2022 when I was discharged after the catheter was removed. I was given blood thinner injections that I would need to inject myself. On 04/19/2022, I would be in so much pain in my abdomen that I ended up calling the ambulance to return to the ER. They did a CAT scan and more blood work and determined I had numerous large hematomas in my abdomen due to the removal of the catheter. They were so painful that it was hard to move or do anything. I would remain in PCU until 04/25/2022. They thought I might have a blood clotting disorder but ruled it out. They are unsure why I had this problem. Also, they did an ultrasound in the hospital of my legs and found numerous blood clots. They recommended that I have an IVC filter put in my chest to prevent the blood clots from moving into my heart. I had an identical Massive Saddle Pulmonary Embolism back in 01/2020 after having a severe cold with shortness of breath which is atypical for me. I have never had shortness of breath in my life until then. I would be discharged in 02/2020. In hindsight, I think I may have had COVID-19 but it was not talked about at that time and it wouldn't be until a month later they started having the COVID-19 lockdowns.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 5,0
Labordaten: CAT scan (04/12/2022): Pulmonary Embolism; Numerous blood tests; CAT scan (04/19/2022): Numerous abdominal hematomas; Ultrasound of the legs (04/19/2022): numerous blood clots of the legs
Aktuelle Erkrankungen: None
Vorgeschichte: PCOS; High Blood Pressure; High Cholesterol; Hypothyroidism
Andere Medikamente: Fluoxetine; Carvedilol; Levothyroxine; Losartan; Zetia; Metformin; Ibuprofen as needed; Claritin as needed
Allergien: Sulfa; Prednisone; Penicillin; Adhesives
Vorherige Impfungen: -

VAERS 2310783

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

kritisch

Staat: WA
Alter: 90,0
Geschlecht: F
Eingang: 06.06.2022
Impfdatum: 11.04.2022
Beginn: 02.06.2022
Tage bis Beginn: 52,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac failure acute Ejection fraction decreased Pleural effusion SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 1/20/21 (lot # EL3302), 2/8/21 (lot # EL9262), 9/29/21 (lot # 30145BA), and Moderna COVID vaccine on 4/11/22 (lot # 065K21A). On 6/2/22, patient admitted to our inpatient facility (med/surg unit) with acute on chronic heart failure with moderately reduced EF-45-50%, COVID19 pneumonia, acute hypoxemic respiratory failure, and moderate right pleural effusion. As of today (6/6/22), patient is still admitted in our med/surg unit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: COVID status positive 6/2/22.
Aktuelle Erkrankungen: -
Vorgeschichte: past medical history significant for atrial fibrillation, heart failure with preserved EF, hypertension, diabetes, hypothyroidism
Andere Medikamente: acetaminophen, allopurinol, alpha lipoic acid, amlodipine, benzonatate, calcium carbonate/vitamin d3, vitamin d3, vitamin b12, darbepoetin alfa, Centrum Silver, furosemide, gabapentin, labetalol, levothyroxine, magnesium oxide, pantoprazole
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2341886

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

schwer

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 29.06.2022
Impfdatum: 29.03.2022
Beginn: 24.06.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature increased COVID-19 Chills Headache Mobility decreased Oropharyngeal pain Oxygen saturation decreased Pain SARS-CoV-2 test positive Syncope

Symptomtext

06/24/2022 When I woke up that morning, I had a viscous headache, terrible sore throat, aches, chills and could not get out of bed. I had a modest temperature, slightly elevated and low blood oxygen level. I used a rapid home test for COVID, and it was negative. 0n 6/25/2022 I took a PCR test and a home test. The home test was negative. On 6/26/2022 the PCR test came back positive, and the rapid home test was positive. On 6/26/2022 I fainted. I called my doctor and she prescribed Paxlovid. I started taking Paxlovid on 6/26/2022 in the afternoon. I have continued to take it through today with one and a half days left for the course. Today is the first day I have felt better. My temperature is normal and my blood oxygen is normal. I still continue to test positive for COVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: COVID rapid home tests, negative and positive COVID PCR, positive
Aktuelle Erkrankungen: None
Vorgeschichte: Breast Cancer in remission; Osteoporosis
Andere Medikamente: Tamoxifen; Allegra; Calcium; Vitamin D3; Fludrocortisone
Allergien: Erythromycin; Tetracycline
Vorherige Impfungen: -

VAERS 2277850

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

schwer

Staat: WY
Alter: 52,0
Geschlecht: F
Eingang: 15.05.2022
Impfdatum: 28.03.2022
Beginn: 01.04.2022
Tage bis Beginn: 4,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Aphasia Brain scan normal Laboratory test normal Loss of consciousness Transient ischaemic attack

Symptomtext

The patient stated she had what she called a "mini stroke" while at the hospital with her daughter, who was having a baby. She passed out and when she came around she had a hard time talking. The doctor ran test on her for a stroke but nothing showed up the the tests. This was approximately a week after having the covid shot

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: She stated that they did a brain scan.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2266944

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

schwer

Staat: CA
Alter: 60,0
Geschlecht: F
Eingang: 07.05.2022
Impfdatum: 05.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Back pain Fall Presyncope Pyrexia SARS-CoV-2 test Vomiting

Symptomtext

Fever on days 2 and 3 with painful joints and back pain. Fell on day 2 after vomiting and almost blacked out

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Covid rapid test and PCR
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Ibuprofen
Allergien: Chlorhexadine
Vorherige Impfungen: Pfizer

VAERS 2263301

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

schwer

Staat: NJ
Alter: 40,0
Geschlecht: F
Eingang: 04.05.2022
Impfdatum: 28.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Back pain Chest pain Formication Muscle spasms Nausea Pyrexia Restless legs syndrome Seizure like phenomena

Symptomtext

At 2am I felt like I was crawling out of my skin. I had muscle spasms almost seizure like reaction. I has a fever chills and chest and back pain. These events repeated around 6am and 10 am. Tylenol helped but it was a horrific experience much like torture. Also nausea. It was like extreme restless leg or something I can't even explaine properly. Has taken a week to fully recover.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Long covid Jan 2021-july 2021, covid Dec 2021: monoclonal antibody treatment Dec 22 2021.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2245866

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

schwer

Staat: AL
Alter: 51,0
Geschlecht: F
Eingang: 21.04.2022
Impfdatum: 18.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Computerised tomogram head Dyspnoea Gait disturbance Laboratory test Posturing Seizure like phenomena Speech disorder

Symptomtext

Posturing, seizure-like activity. I was unable to breath during each event, unable to ambulate as normal, difficulty with speech. I was in the EMERGENCY ROOM for 9 hours. Given medication, head CT, labs drawn, and IV. Have to continue to monitor myself for further adverse reactions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: Medication, lab work, head CT, IV....all on 4/19/22 in the early morning.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Premarin, Klonopin
Allergien: None
Vorherige Impfungen: -

VAERS 2240792

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

schwer

Staat: CO
Alter: 18,0
Geschlecht: M
Eingang: 19.04.2022
Impfdatum: 12.04.2022
Beginn: 15.04.2022
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatine phosphokinase increased Cardiac monitoring Chest pain Drug use disorder Echocardiogram abnormal Ejection fraction decreased Electrocardiogram ST segment elevation Haemophilus test positive Imprisonment Intensive care Malaise Myocarditis N-terminal prohormone brain natriuretic peptide increased Respiratory viral panel Respirovirus test positive Substance use Parainfluenzae virus infection Pericarditis

Symptomtext

Patient received first dose of covid vaccine on 4/12/22 in Detention Center. ATTENDING NOTE 04/18/22 I personally reviewed all the data, examined the patient myself, talked with the family. I agree with resident note with some remarks. 18 year old that has dropped school, uses meth daily when at home that got covid shot while in jail last Tuesday and by the end of the week was sick, weekend had some chest pain, not getting better and came to Hospital . EKG with ST changes , CK and troponin elevated, echo with mild dysfunction. Also found to be paraflu 3 positive

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: Patient is a previously healthy 18 year old presenting with 3 days of intermittent left chest pain with acute worsening today (4/18) with EKG findings consistent with myocarditis vs pericarditis, increasing troponins (9,000 to 11,000), elevated proBNP (583). This in the setting of recent Covid vaccination (4/12), recent meth ingestion (4/16), and being parainfluzena+ raises concern for myocarditis vs pericarditis 2/2 to covid vaccination, drug ingestion, or viral process. Important to consider other causes of mycarditis such as other infectious causes (bacterial, fungal, protozoal), other cardiotoxin (cocaine, alcohol, specific medications), or systemic disorders (sarcoidosis, thyrotoxicosis) though all less likely given history and physical exam. Admitted for close cardiac monitoring and further work up by cardiology. CV: Troponin I of 11,539. proBNP 583. CK 684. EKG showing global ST elevations c/f myocarditis vs pericarditis. Fluids/Electrolytes: CK elevated to 684.
Aktuelle Erkrankungen: Positive for paraflu
Vorgeschichte: Meth use
Andere Medikamente: Meth user, Chloraseptic, melatonin, nicotine patch
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2240792

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

schwer

Staat: CO
Alter: 18,0
Geschlecht: M
Eingang: 19.04.2022
Impfdatum: 12.04.2022
Beginn: 15.04.2022
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatine phosphokinase increased Cardiac monitoring Chest pain Drug use disorder Echocardiogram abnormal Ejection fraction decreased Electrocardiogram ST segment elevation Haemophilus test positive Imprisonment Intensive care Malaise Myocarditis N-terminal prohormone brain natriuretic peptide increased Respiratory viral panel Respirovirus test positive Substance use Parainfluenzae virus infection Pericarditis

Symptomtext

Patient received first dose of covid vaccine on 4/12/22 in Detention Center. ATTENDING NOTE 04/18/22 I personally reviewed all the data, examined the patient myself, talked with the family. I agree with resident note with some remarks. 18 year old that has dropped school, uses meth daily when at home that got covid shot while in jail last Tuesday and by the end of the week was sick, weekend had some chest pain, not getting better and came to Hospital . EKG with ST changes , CK and troponin elevated, echo with mild dysfunction. Also found to be paraflu 3 positive

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: Patient is a previously healthy 18 year old presenting with 3 days of intermittent left chest pain with acute worsening today (4/18) with EKG findings consistent with myocarditis vs pericarditis, increasing troponins (9,000 to 11,000), elevated proBNP (583). This in the setting of recent Covid vaccination (4/12), recent meth ingestion (4/16), and being parainfluzena+ raises concern for myocarditis vs pericarditis 2/2 to covid vaccination, drug ingestion, or viral process. Important to consider other causes of mycarditis such as other infectious causes (bacterial, fungal, protozoal), other cardiotoxin (cocaine, alcohol, specific medications), or systemic disorders (sarcoidosis, thyrotoxicosis) though all less likely given history and physical exam. Admitted for close cardiac monitoring and further work up by cardiology. CV: Troponin I of 11,539. proBNP 583. CK 684. EKG showing global ST elevations c/f myocarditis vs pericarditis. Fluids/Electrolytes: CK elevated to 684.
Aktuelle Erkrankungen: Positive for paraflu
Vorgeschichte: Meth use
Andere Medikamente: Meth user, Chloraseptic, melatonin, nicotine patch
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2223004

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

schwer

Staat: MA
Alter: 21,0
Geschlecht: M
Eingang: 08.04.2022
Impfdatum: 31.03.2022
Beginn: 01.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Chest pain Electrocardiogram abnormal Inappropriate schedule of product administration Interchange of vaccine products Pain in extremity Pericarditis

Symptomtext

The pt had Pfizer #2 vaccines on 5/30/2021 and 6/23/2021 Had Moderna booster" on 3/31/2022, developed left arm and left chest pain on the next day , progressively worse EKG findings c/w with pericarditis , started on Naproxen

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: EKG BW results are pending
Aktuelle Erkrankungen: URI, COVID negative
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2685603

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

moderat

Staat: CA
Alter: 35,0
Geschlecht: F
Eingang: 24.09.2023
Impfdatum: 14.04.2022
Beginn: 15.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Alopecia Amnesia Arrhythmia Ataxia Blood test normal Cardiac monitoring normal Chest pain Dizziness Dyspnoea Exercise tolerance decreased Fatigue Headache Oral pain Temperature intolerance Transient ischaemic attack Tremor Vision blurred

Symptomtext

Within 48 hours: - Severe chest pain - Shortness of breath - Blurred vision - Extreme fatigue - Hair loss - Memory loss - Uncontrolled trembling - Pain above soft palate - Arrhythmia - Heat intolerance - Exercise intolerance - Dizziness - Loss of muscle control - Headaches One year later (April 2023) - Transient Ischemic Attack

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arrhythmia
Hospital-Tage: -
Labordaten: Basic blood panels run: results "normal" Sio patch worn: results "normal"
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: None.
Allergien: None.
Vorherige Impfungen: -

VAERS 2634130

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: FL
Alter: -
Geschlecht: M
Eingang: 19.05.2023
Impfdatum: 25.08.2021
Beginn: 21.09.2022
Tage bis Beginn: 392,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatinine increased Breakthrough COVID-19 Dehydration Diarrhoea Respiratory symptom SARS-CoV-2 test positive Vomiting

Symptomtext

BREAKTHROUGTH COVID: 62 yo M FULLY VACCINATED AND BOOSTED3 TIMES, admitted to the ED with upper respiratory symptoms, vomiting, and diarrhea. Patient tested positive for COVID. Symptoms improved somewhat after 2L IV fluids, Zofran, Reglan, Benadryl, Fentanyl, and a breathing treatment. Creatinine slightly elevated. Patient likely dehydrated from N/V/D. Pt prescribed Nirmatrelvir & Ritonavir .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: recurrent sinus infections, HLD, HTN, morbid obesity and anemia DIABETES
Andere Medikamente: UNKNOWN
Allergien: UNKNOWN
Vorherige Impfungen: -

VAERS 2610893

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: CO
Alter: 59,0
Geschlecht: M
Eingang: 06.04.2023
Impfdatum: 03.04.2022
Beginn: 08.03.2023
Tage bis Beginn: 339,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dyspnoea Eye pain Headache Heart rate increased Palpitations

Symptomtext

I started to have headaches behind the eye, increased heart of 114, it would pound for hours, then go away., shortness of breath. Then I would not experience again for a day or two, then it would happen again. There were no other stress inducing factors in my life that may have caused this. I went to the doctor for a regular visit and mentioned what was going on. He could not tell by vitals as they were all normal that anything had damaged any organs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes Type II; Hypertension; High Cholesterol
Andere Medikamente: Lisinopril; Atorvastatin; Amlodipine; Ozempic; Farxiga; Baslagar
Allergien: No
Vorherige Impfungen: -

VAERS 2579588

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 10.02.2023
Impfdatum: 13.04.2022
Beginn: 28.01.2023
Tage bis Beginn: 290,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Biopsy oesophagus abnormal COVID-19 Condition aggravated Cystitis Discoloured vomit Gastritis haemorrhagic HIV test negative Haematuria Herpes simplex oesophagitis Herpes simplex test positive Oesophagogastroduodenoscopy abnormal Tremor Urinary tract infection Vomiting

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/28/2023 Discharge Date: Feb 9, 2023 PRESENTING PROBLEM: UTI (urinary tract infection) [N39.0] Acute cystitis with hematuria [N30.01] Complicated UTI (urinary tract infection) [N39.0] HOSPITAL COURSE: Patient is a 76 y.o. female with a past medical history of dementia, CKD, essential hypertension, among other comorbid conditions who presented to the Hospital Emergency Department on 01/28/2023 from a local long-term care facility via EMS with complaints of vomiting and tremors onset 1 day prior to presentation. The patient was diagnosed with an acute urinary tract and COVID-19 infection and admitted to the hospitalist service for ongoing management and coordination. She was started on Rocephin for urinary tract infection medication. COVID was treated with prophylactic remdesivir to prevent progression for 3 days. Given the patient's vomiting and a brownish color to the emesis the gastroenterology team was asked to evaluate the patient for potential upper gastrointestinal bleed. EGD showed hemorrhagic gastritis, likely from PO iron. IV Iron supplementation was started instead. Her biopsy from EGD was positive for HSV esophagitis and she was started on treatment with acyclovir. HIV testing was negative. ID was consulted who agreed with management and recommended 10 days of therapy. Patient clinically improved with no further concerns. Discussed with patient and DPOA to obtain outpatient labs in 1 week. She was prescribed Acyclovir to complete a total of 10 days of therapy and Protonix twice daily for her Esophagitis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Dysphagia Type 2 diabetes mellitus, with long-term current use of insulin GERD (gastroesophageal reflux disease) Tobacco use disorder Anemia, unspecified type Essential hypertension Arterial disease Stage 4 chronic kidney disease Dementia without behavioral disturbance Chronic diastolic congestive heart failure Gait abnormality COPD (chronic obstructive pulmonary disease) Vitamin D deficiency Peripheral vascular disease Hyponatremia Dry eyes, bilateral Edema Localized swelling on left hand Emesis Complicated UTI (urinary tract infection) Esophagitis on biopsy Statin started by Vascular Surgery with Rx to be taken over by patient's PCP
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet acyclovir (ZOVIRAX) 40 MG/ML suspension albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler bisacodyl (DULCOLAX) 10 MG suppository cloNIDine (CATAPRES) 0.3 MG tablet fu
Allergien: Aspirin
Vorherige Impfungen: -

VAERS 2558685

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: CA
Alter: 49,0
Geschlecht: F
Eingang: 12.01.2023
Impfdatum: 04.04.2022
Beginn: 19.07.2022
Tage bis Beginn: 106,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Aphasia Arthralgia COVID-19 Condition aggravated Cough Dry skin Dyspnoea Fatigue Feeling abnormal Oropharyngeal pain Pain Psoriasis Pyrexia Respiratory tract congestion Rheumatoid arthritis SARS-CoV-2 test positive Skin exfoliation Sneezing

Symptomtext

I received the Moderna COVID-19 booster on 4/4/2022. On 7/19/2022, I took a home antigen test and got a positive result. I then decided to also have a PCR test done at a local pharmacy. The PCR test also yielded a positive result. During this time, I was asymptomatic, but on 7/21/2022, I had a fever, body aches, cough, and sore throat. I took the ADVIL multisymptom cold and flu medicine, which reduced the coughing, sneezing, sore throat, and fever. However, I still felt bad despite this. I also had extreme fatigue during this time. I contacted my doctor, and I was prescribed an albuterol inhaler, TESSALON PERLES, and PAXLOVID. A couple of days after I started the PAXLOVID, I began to feel better. The albuterol inhaler and TESSALON PERLES also helped me breathe better. As I continued to take the meds, I just gradually got better. I underwent another PCR test on 7/29/2022 and got another positive result. On 8/2/2022, I contacted HR at my workplace to ask them what the best course of action would be. I explained that I felt better, though I still had cough, congestion, and fatigue. They told me that I could return to work since it had been over 5 days since I had first tested positive. I was also told that I would have to wear a mask, though. I returned to my workplace on 8/5/2022. At that point, I still had extreme fatigue, cough, and congestion. I was then given the option to telecommute, so I just worked from home for a week afterwards. It took a couple of weeks for the cough and congestion to subside, but the fatigue lingered for another 2 months. During my bout of COVID-19, my rheumatoid arthritis also flared up, and I also developed psoriasis. At the time of this writing, I still have residual psoriasis on my hands and legs; it's much milder now than it was when I first got COVID-19, and presently it just takes the form of dry, peeling patches of skin. Before I got COVID-19, I had never had psoriasis before. Also, I still have some residual issues with the rheumatoid arthritis flare up. I still have joint pain and brain fog (mainly in the form of aphasia).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Home antigen test 7/19/2022 positive result; PCR tests 7/19/2022, 7/29/2022 positive results.
Aktuelle Erkrankungen: None.
Vorgeschichte: Rheumatoid Arthritis; Type II Diabetes; Fibromyalgia.
Andere Medikamente: Metformin; FARXIGA; SIMPONI ARIA; methotrexate; vitamin D; folate; gabapentin.
Allergien: Lisinopril; DARVOCET; PERCOCET; PERCODAN; OTEZLA.
Vorherige Impfungen: -

VAERS 2496659

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: -
Alter: 65,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 11.04.2022
Beginn: 29.09.2022
Tage bis Beginn: 171,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Appetite disorder Chest pain Cough Dyspnoea Hypoaesthesia Oropharyngeal pain

Symptomtext

appetite change, sore throat, cough, SOB, chest pain, numbness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2492526

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: MI
Alter: 88,0
Geschlecht: M
Eingang: 28.10.2022
Impfdatum: 04.04.2022
Beginn: 19.10.2022
Tage bis Beginn: 198,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary normal Asthenia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Dizziness postural Exposure to SARS-CoV-2 Hypoalbuminaemia Hypoxia Laboratory test abnormal Lethargy Lung disorder Malaise Metabolic function test abnormal Nausea Normocytic anaemia Oropharyngeal pain

Symptomtext

Admission Date: 10/19/2022 Discharge Date: 10/21/2022 PRESENTING PROBLEM: Hypoxia Pneumonia due to COVID-19 virus COVID-19 HOSPITAL COURSE: The patient is a 89 y.o. male with PMHx of metastatic prostate cancer and HTN who presents today with malaise. Patient is accompanied by his wife and son at bedside. He has been vaccinated and boosted for COVID, last in 4/4/2022. He spent time with family over the weekend and two of them tested positive for COVID on 10/18. He took a home COVID test and was negative. He had a sore throat but otherwise felt fine. On the morning of presentation, he spiked a fever 102.5F and was feeling very weak, lethargic and became nauseated and dizzy with movement. He developed coughing but no shortness of breath. No diarrhea, myalgias, rashes or poor appetite. He took his regularly prescribed medications but nothing else. His wife initially called his PCP office to arrange for Paxlovid but was advised to call an ambulance. She called EMS and patient was brought to ED. In the ED he was febrile, tachypneic with normal O2sats on room air but he became hypoxemic with activity 88 percent. Labs with normocytic anemia, normal WBC count and platelets, CMP with hypoalbuminemia. UA negative for infection, COVID-19 PCR positive. CXR with moderate left greater than right patchy airspace densities concerning for multifocal PNA and mild bilateral pleural effusions. He was given tylenol, ibuprofen and a liter of normal saline and was admitted for further evaluation. He was continued on IV remdesivir. He was started on Decadron due to episodes of hypoxia was sleeping. CT angiogram thorax was negative for PE. He felt improved enough to go home. He was evaluated by pulmonary rehab and did not require supplemental oxygen. He was range of home care. He was enrolled in a transition to home program. He was instructed to hold home prednisone until completion of Decadron then resume taking prednisone. He should follow up with his PCP as an outpatient. He was discharged home in stable condition on 10/21/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Wet age-related macular degeneration of left eye with active choroidal neovascularization Myopia of right eye with astigmatism Dermatochalasis of both upper eyelids Diabetes mellitus type 2 without retinopathy Myopia of both eyes Metastatic adenocarcinoma to prostate Allergic rhinitis Benign essential HTN Benign prostatic hyperplasia with nocturia Hearing loss Aortic stenosis Adjustment disorder Pure hypercholesterolemia Carotid arterial disease Aortic regurgitation Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia
Andere Medikamente: abiraterone (ZYTIGA) 250 MG tablet amoxicillin-clavulanate (AUGMENTIN) 875-125 MG per tablet aspirin EC 81 MG enteric coated tablet benzonatate (TESSALON) 100 MG capsule dexamethasone (DECADRON) 6 MG tablet doxazosin (CARDURA) 4 MG tablet g
Allergien: Bicalutamide Environmental Procardia [Nifedipine]
Vorherige Impfungen: -

VAERS 2491245

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: MI
Alter: 82,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: 12.02.2021
Beginn: 04.09.2022
Tage bis Beginn: 569,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Dyspnoea SARS-CoV-2 test positive

Symptomtext

09/04/22 presents to ED for "shortness of breath". PMHx of "A. Fib on AC, PE, DVT, asthma"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 09/04/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2484200

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: WA
Alter: 78,0
Geschlecht: M
Eingang: 20.10.2022
Impfdatum: 14.04.2022
Beginn: 23.08.2022
Tage bis Beginn: 131,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 Chills Cold sweat Decreased appetite Mobility decreased Pain Poor quality sleep SARS-CoV-2 test positive Weight decreased

Symptomtext

On 8/23/2022, I had chills symptoms. I took the COVID-19 home test on 8/24/2022 and the result was positive. I had chills and aches, cold sweats, I lost all my energy. I had no appetite. I lost 10 pounds. I spent 4 days in bed. I did not sleep well. I took an anti-congestion. No sore throat. I never lost my sense of smell or taste. On 8/24/2022 I called my doctor and was prescribed the Paxlovid. I started taking it on 8/26/2022. On 8/31/2022, I tested negative. On 9/1/2022 is when I started feeling a little better. 10/20/2022. I have a lot of my energy back. I am trying to put the weight back on. I am on the road to recovery.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: 8/24/2022 - COVID-19 home test - positive 8/31/2022 - COVID-19 home test- negative.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Multivitamin; Pravastatin
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2484082

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: WA
Alter: 64,0
Geschlecht: F
Eingang: 20.10.2022
Impfdatum: 01.04.2022
Beginn: 18.07.2022
Tage bis Beginn: 108,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Fatigue Head discomfort Malaise Nasopharyngitis Pneumonia Productive cough Pulmonary congestion Pyrexia SARS-CoV-2 test negative Tremor

Symptomtext

Severe symptoms began 07/18-07/19 included a severe fever, with quivering and shaking, my head felt like it would explode. I took four Advil PMs and it knocked me out for the rest of the evening. The following day I was able to shower and then went back to sleep. I took more Advil PMs and then I slept through the night. My fever broke by that evening and I took another shower and then felt good enough to get up and get dressed and go about my day. I was not feeling well but I was mobile. I was still suffering from head and chest congestion and total exhaustion. These symptoms lasted until about 07/24 to 07/25. I did not get up to normal daily function until about the second week of August. On the 27thth of September started to come down with symptoms of a head and chest cold and congestion began. On the 9th of October, congestion began to loosen up and I was able to clear the phlegm from my lungs. I went to my physician on the 12th of October and was given medication for Pneumonia. I am now feeling better and improving with the medication.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: -
Labordaten: OCT122022 - COVID-19 Test- Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Obesity; Asthma
Andere Medikamente: Armor Thyroid; Probiotics; Vitamin D3
Allergien: Penicillin; Vitamin B-12; Codeine
Vorherige Impfungen: -

VAERS 2433594

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: MI
Alter: 55,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 04.02.2021
Beginn: 23.08.2022
Tage bis Beginn: 565,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Dyspnoea SARS-CoV-2 test positive

Symptomtext

08/23/22 presents to ED for "shortness of breath". PMHx of "hypertension"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 08/23/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2298629

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: NY
Alter: 76,0
Geschlecht: F
Eingang: 17.08.2022
Impfdatum: 12.04.2022
Beginn: 01.04.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Balance disorder COVID-19 immunisation Headache Heart rate Cardiac monitoring abnormal Tachycardia Interchange of vaccine products Myalgia Palpitations Pyrexia Supraventricular extrasystoles Vaccination site pain

Symptomtext

Interchange of vaccine products; Revaccination with different Covid-19 vaccine; About 12 hours after, she had a racing heart; Body aches; Fever; Headaches; Pain in her upper left arm when pressed around the inoculation area.; Felt weak; Off-balance/off-centered; PAC (premature atrial contractions) benign; This spontaneous case was reported by a patient and describes the occurrence of SUPRAVENTRICULAR EXTRASYSTOLES (PAC (premature atrial contractions) benign), PALPITATIONS (About 12 hours after, she had a racing heart), ASTHENIA (Felt weak), BALANCE DISORDER (Off-balance/off-centered) and MYALGIA (Body aches) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for Product used for unknown indication: Pfizer (Dose number: 1, Lot number: EL9266 and dose was unknown) on 18-Feb-2021, Pfizer (Dose Number: 2, Lot number: EN6205 and dose was unknown) on 11-Mar-2021, Pfizer (Dose Number: 1st booster and Lot number: FD0810 and dose was unknown) on 20-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 12-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced PALPITATIONS (About 12 hours after, she had a racing heart). In April 2022, the patient experienced MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headaches). In 2022, the patient experienced SUPRAVENTRICULAR EXTRASYSTOLES (PAC (premature atrial contractions) benign), ASTHENIA (Felt weak), BALANCE DISORDER (Off-balance/off-centered) and VACCINATION SITE PAIN (Pain in her upper left arm when pressed around the inoculation area.). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different Covid-19 vaccine). The patient was treated with METOPROLOL SUCCINATE at a dose of taking half pills and METOPROLOL SUCCINATE at a dose of 25 milligram. In April 2022, PYREXIA (Fever) and HEADACHE (Headaches) had resolved. At the time of the report, SUPRAVENTRICULAR EXTRASYSTOLES (PAC (premature atrial contractions) benign) and PALPITATIONS (About 12 hours after, she had a racing heart) was resolving and ASTHENIA (Felt weak), BALANCE DISORDER (Off-balance/off-centered), MYALGIA (Body aches), VACCINATION SITE PAIN (Pain in her upper left arm when pressed around the inoculation area.), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different Covid-19 vaccine) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2022, Heart rate: About 105 all night long. On 13-Apr-2022, Heart rate: Regular (Normal). On an unknown date, Heart rate: High as 165. and Went from 120 to 160s. No concomitant product use was reported. The patient never had COVID positive test or not diagnosed. The patient received 2nd booster of Moderna COVID19 Vaccine. The night that she had her booster, about 12 hours after, she had a racing heart, about 105 all night long. She had fever, body aches, headaches, felt like crap. The following day, her heart was at a regular heart rate (it was normal) but extremely irregular. The headaches and fever lasted at least 24 hours. She was not felt like herself for about a week. At night she had the tachycardia. She contacted cardiology, who ordered a monitor. She wore it for 17 days, just under 3 weeks. The monitored started at 5 PM on 06-May-2022 and ended on 23-May-2022. They found PAC (premature atrial contractions), which they said were benign. She felt weak and off balance. She was not falling down, but off centered. She had many bouts during the day, and they lasted a number of minutes. She was less disturbed by them by the time the monitor was wrapping up. The irregularity continued at a much lesser rate. She had to go to the emergency room for tachycardia at rest. It was as high as 165. It went anywhere from 120 to 160s for approximately 4 hours. They put her on a beta blocker. Her heart rate was pretty much regular, and she was weaning off the medication. For the past month, she had pain in her upper left arm when pressed around the inoculation area. She was most aware when getting in and out of the car, when she pushes it on that side. It was not aching or hurting with regular activities. The patient not experienced a similar event in the past. When the patient was in the emergency room on 16-Jul-2022, they gave her a beta blocker and IV. She was at the time of report taking a 30-day course of the beta blocker (metoprolol succ ER 25 mg). She was taking half pills for the last 10 days because she can't stop taking it abruptly. Company comment: This spontaneous case concerns a 76 years old female, with no relevant medical history, who experienced the unexpected non serious AESI event supraventricular extrasystole, which occurred unspecified days after third dose (reported as booster dose) of mRNA-1273 vaccine. Additionally non serious event palpitation is also reported. The patient was noted to have received three doses with Comirnaty (Interchange of vaccine products) approximately 5 months Prior to mRNA-1273. Patient experienced racing heart after 12 hours vaccination booster vaccination, she also had fever, body aches, headaches, felt like crap. The following day, her heart was at a regular heart rate (it was normal) but extremely irregular. The headaches and fever lasted at least 24 hours. Patient didn't feel like herself for about a week. At night, patient had the tachycardia. Patient had contacted cardiologist advised to wear monitor patient wore it for 17 days. They found premature atrial contractions, which they said were benign, patient felt weak and off balance. Patient not falling down, but off-centered. patient went to emergency for tachycardia It was as high as 165. It went anywhere from 120 to160s for approximately 4 hours. They put her on a beta blocker. Her heart rate is pretty much regular and she is weaning off the medication. For the past month, she has pain in her upper left arm when pressed around the inoculation area. She is most aware when getting in and out of the car, when she pushes it on that side. It doesn't ache or hurt with regular activities. At the time of report event was resolving. The benefit-risk relationship of mRNA-1273 is not affected by this report; Sender's Comments: This spontaneous case concerns a 76 years old female, with no relevant medical history, who experienced the unexpected non serious AESI event supraventricular extrasystole, which occurred unspecified days after third dose (reported as booster dose) of mRNA-1273 vaccine. Additionally non serious event palpitation is also reported. The patient was noted to have received three doses with Comirnaty (Interchange of vaccine products) approximately 5 months Prior to mRNA-1273. Patient experienced racing heart after 12 hours vaccination booster vaccination, she also had fever, body aches, headaches, felt like crap. The following day, her heart was at a regular heart rate (it was normal) but extremely irregular. The headaches and fever lasted at least 24 hours. Patient didn't feel like herself for about a week. At night, patient had the tachycardia. Patient had contacted cardiologist advised to wear monitor patient wore it for 17 days. They found premature atrial contractions, which they said were benign, patient felt weak and off balance. Patient not falling down, but off-centered. patient went to emergency for tachycardia It was as high as 165. It went anywhere from 120 to160s for approximately 4 hours. They put her on a beta blocker. Her heart rate is pretty much regular and she is weaning off the medication. For the past month, she has pain in her upper left arm when pressed around the inoculation area. She is most aware when getting in and out of the car, when she pushes it on that side. It doesn't ache or hurt with regular activities. At the time of report event was resolving. The benefit-risk relationship of mRNA-1273 is not affected by this report

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: -
Labordaten: Test Name: Heart rate; Result Unstructured Data: High as 165.; Test Name: Heart rate; Result Unstructured Data: Went from 120 to 160s; Test Date: 20220412; Test Name: Heart rate; Result Unstructured Data: About 105 all night long; Test Date: 20220413; Test Name: Heart rate; Result Unstructured Data: Regular (Normal)
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2298629

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: NY
Alter: 76,0
Geschlecht: F
Eingang: 17.08.2022
Impfdatum: 12.04.2022
Beginn: 01.04.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Balance disorder COVID-19 immunisation Headache Heart rate Cardiac monitoring abnormal Tachycardia Interchange of vaccine products Myalgia Palpitations Pyrexia Supraventricular extrasystoles Vaccination site pain

Symptomtext

Interchange of vaccine products; Revaccination with different Covid-19 vaccine; About 12 hours after, she had a racing heart; Body aches; Fever; Headaches; Pain in her upper left arm when pressed around the inoculation area.; Felt weak; Off-balance/off-centered; PAC (premature atrial contractions) benign; This spontaneous case was reported by a patient and describes the occurrence of SUPRAVENTRICULAR EXTRASYSTOLES (PAC (premature atrial contractions) benign), PALPITATIONS (About 12 hours after, she had a racing heart), ASTHENIA (Felt weak), BALANCE DISORDER (Off-balance/off-centered) and MYALGIA (Body aches) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for Product used for unknown indication: Pfizer (Dose number: 1, Lot number: EL9266 and dose was unknown) on 18-Feb-2021, Pfizer (Dose Number: 2, Lot number: EN6205 and dose was unknown) on 11-Mar-2021, Pfizer (Dose Number: 1st booster and Lot number: FD0810 and dose was unknown) on 20-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 12-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced PALPITATIONS (About 12 hours after, she had a racing heart). In April 2022, the patient experienced MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headaches). In 2022, the patient experienced SUPRAVENTRICULAR EXTRASYSTOLES (PAC (premature atrial contractions) benign), ASTHENIA (Felt weak), BALANCE DISORDER (Off-balance/off-centered) and VACCINATION SITE PAIN (Pain in her upper left arm when pressed around the inoculation area.). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different Covid-19 vaccine). The patient was treated with METOPROLOL SUCCINATE at a dose of taking half pills and METOPROLOL SUCCINATE at a dose of 25 milligram. In April 2022, PYREXIA (Fever) and HEADACHE (Headaches) had resolved. At the time of the report, SUPRAVENTRICULAR EXTRASYSTOLES (PAC (premature atrial contractions) benign) and PALPITATIONS (About 12 hours after, she had a racing heart) was resolving and ASTHENIA (Felt weak), BALANCE DISORDER (Off-balance/off-centered), MYALGIA (Body aches), VACCINATION SITE PAIN (Pain in her upper left arm when pressed around the inoculation area.), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different Covid-19 vaccine) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2022, Heart rate: About 105 all night long. On 13-Apr-2022, Heart rate: Regular (Normal). On an unknown date, Heart rate: High as 165. and Went from 120 to 160s. No concomitant product use was reported. The patient never had COVID positive test or not diagnosed. The patient received 2nd booster of Moderna COVID19 Vaccine. The night that she had her booster, about 12 hours after, she had a racing heart, about 105 all night long. She had fever, body aches, headaches, felt like crap. The following day, her heart was at a regular heart rate (it was normal) but extremely irregular. The headaches and fever lasted at least 24 hours. She was not felt like herself for about a week. At night she had the tachycardia. She contacted cardiology, who ordered a monitor. She wore it for 17 days, just under 3 weeks. The monitored started at 5 PM on 06-May-2022 and ended on 23-May-2022. They found PAC (premature atrial contractions), which they said were benign. She felt weak and off balance. She was not falling down, but off centered. She had many bouts during the day, and they lasted a number of minutes. She was less disturbed by them by the time the monitor was wrapping up. The irregularity continued at a much lesser rate. She had to go to the emergency room for tachycardia at rest. It was as high as 165. It went anywhere from 120 to 160s for approximately 4 hours. They put her on a beta blocker. Her heart rate was pretty much regular, and she was weaning off the medication. For the past month, she had pain in her upper left arm when pressed around the inoculation area. She was most aware when getting in and out of the car, when she pushes it on that side. It was not aching or hurting with regular activities. The patient not experienced a similar event in the past. When the patient was in the emergency room on 16-Jul-2022, they gave her a beta blocker and IV. She was at the time of report taking a 30-day course of the beta blocker (metoprolol succ ER 25 mg). She was taking half pills for the last 10 days because she can't stop taking it abruptly. Company comment: This spontaneous case concerns a 76 years old female, with no relevant medical history, who experienced the unexpected non serious AESI event supraventricular extrasystole, which occurred unspecified days after third dose (reported as booster dose) of mRNA-1273 vaccine. Additionally non serious event palpitation is also reported. The patient was noted to have received three doses with Comirnaty (Interchange of vaccine products) approximately 5 months Prior to mRNA-1273. Patient experienced racing heart after 12 hours vaccination booster vaccination, she also had fever, body aches, headaches, felt like crap. The following day, her heart was at a regular heart rate (it was normal) but extremely irregular. The headaches and fever lasted at least 24 hours. Patient didn't feel like herself for about a week. At night, patient had the tachycardia. Patient had contacted cardiologist advised to wear monitor patient wore it for 17 days. They found premature atrial contractions, which they said were benign, patient felt weak and off balance. Patient not falling down, but off-centered. patient went to emergency for tachycardia It was as high as 165. It went anywhere from 120 to160s for approximately 4 hours. They put her on a beta blocker. Her heart rate is pretty much regular and she is weaning off the medication. For the past month, she has pain in her upper left arm when pressed around the inoculation area. She is most aware when getting in and out of the car, when she pushes it on that side. It doesn't ache or hurt with regular activities. At the time of report event was resolving. The benefit-risk relationship of mRNA-1273 is not affected by this report; Sender's Comments: This spontaneous case concerns a 76 years old female, with no relevant medical history, who experienced the unexpected non serious AESI event supraventricular extrasystole, which occurred unspecified days after third dose (reported as booster dose) of mRNA-1273 vaccine. Additionally non serious event palpitation is also reported. The patient was noted to have received three doses with Comirnaty (Interchange of vaccine products) approximately 5 months Prior to mRNA-1273. Patient experienced racing heart after 12 hours vaccination booster vaccination, she also had fever, body aches, headaches, felt like crap. The following day, her heart was at a regular heart rate (it was normal) but extremely irregular. The headaches and fever lasted at least 24 hours. Patient didn't feel like herself for about a week. At night, patient had the tachycardia. Patient had contacted cardiologist advised to wear monitor patient wore it for 17 days. They found premature atrial contractions, which they said were benign, patient felt weak and off balance. Patient not falling down, but off-centered. patient went to emergency for tachycardia It was as high as 165. It went anywhere from 120 to160s for approximately 4 hours. They put her on a beta blocker. Her heart rate is pretty much regular and she is weaning off the medication. For the past month, she has pain in her upper left arm when pressed around the inoculation area. She is most aware when getting in and out of the car, when she pushes it on that side. It doesn't ache or hurt with regular activities. At the time of report event was resolving. The benefit-risk relationship of mRNA-1273 is not affected by this report

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: -
Labordaten: Test Name: Heart rate; Result Unstructured Data: High as 165.; Test Name: Heart rate; Result Unstructured Data: Went from 120 to 160s; Test Date: 20220412; Test Name: Heart rate; Result Unstructured Data: About 105 all night long; Test Date: 20220413; Test Name: Heart rate; Result Unstructured Data: Regular (Normal)
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2391071

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: WA
Alter: 68,0
Geschlecht: F
Eingang: 26.07.2022
Impfdatum: 12.04.2022
Beginn: 07.07.2022
Tage bis Beginn: 86,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Diarrhoea Fatigue Feeling abnormal Impaired work ability Loss of personal independence in daily activities Mobility decreased Nasopharyngitis Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Tremor Vomiting

Symptomtext

On July 7, 2022, I was fine when I woke up but at noon I felt like someone hit me. I realized I had a fever and I was shaking with chills. I had 103 temperature. I began to have diarrhea and cough with congestion and sore throat. The next morning when I woke I was unable to keep fluids down. I took the home COVID-19 test and it was immediately positive. I called urgent care and received script for PAXLOVID. I continued to have fever. The next day I woke up and still felt like I had a very bad cold and diarrhea continued, but I no longer had fever. Each day that I took PAXLOVID, I began to feel better except for the diarrhea. I was also so very fatigued and could not keep liquids down. I was unable to do anything but lay down for days 2, 3, and 4. Day 5 the fatigue was easing up and I was able to function. After the 5 days of PAXLOVID. The following Friday I had congestion again and just treated it as a cold and just tired. I took the entire next week off from work because I was just tired and wasn't able to think as normal. I was just unable to process. On the 22nd I felt better and was able to think again and was not as tired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: Home COVID-19 test, positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Type 2 Diabetic; High Blood Pressure; Auto Immune Pernicious Anemia, Chronic Pancreatitis; Chronic Anemia; Fibromyalgia
Andere Medikamente: Vitamin D; CLARITIN; TYLENOL; HCTZ; bupropion; SYNTHROID; protonic; FARXIGA; pravastatin; meloxicam; gabapentin; irbesartan; L-methyl folate; aspirin; CREON
Allergien: Sulfa; tetracycline; iodine; penicillin; SOMA; ZANTAC; amlodipine; lisinopril
Vorherige Impfungen: -

VAERS 2368868

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: GA
Alter: 75,0
Geschlecht: F
Eingang: 14.07.2022
Impfdatum: 07.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 24,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac disorder Cardiac stress test Cerebral disorder Dizziness Dyspnoea Echocardiogram Electrocardiogram Electroencephalogram Laboratory test Magnetic resonance imaging heart

Symptomtext

All of this started in April and I started getting light headed like I wanted to pass out, that is why I went to the Cardiologist which is why we started the testing. After he did all the testing, he wanted me to go see a neurologist who did an EEG of my head in May, After all the testing they have done they found out electrical activity in the frontal lobe on on the left side. This was done in June, and I received medications June for Sparks because people in their 70's get this. The lightheadedness started after the 4th dose and that is why I am now on medication for both my heart and my brain. It seems to be under control now, but now I am having trouble breathing. I do not know if this came about because of the booster vaccine but this is what has happened afterwards.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: EEG; Echo; Stress Test; EKG; MRI of the Heart and Blood Pressure Test as well.
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma; Bronchitis; Bronthiectasis
Andere Medikamente: Levothyroxine; Multi Vitamin; Vitamin B 12; Vitamin D; Cu-Zyme; Vitamin C; Zinc; Ezetimide; Breo Ellipta; Singulair; Famotidine; Hydroeye.
Allergien: Penicillin
Vorherige Impfungen: Flu shot, pain in my arm and my neck after the shot, Lot number 312832.

VAERS 2363108

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: WA
Alter: 80,0
Geschlecht: F
Eingang: 08.07.2022
Impfdatum: 07.04.2022
Beginn: 09.05.2022
Tage bis Beginn: 32,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autoscopy Chest X-ray Computerised tomogram Exposure to SARS-CoV-2 Feeling cold Oxygen saturation abnormal Pneumonia Pyrexia Taste disorder

Symptomtext

I had been exposed by a friend after singing with them on May 11th. I had a minor change in taste, low grade fever of 99, chills that lasted a couple of days. I then developed a cough and had oxygen saturation issues. After two weeks, I started feeling a little better and went to see my primary doctor. He wasn't concerned about my oxygen levels. It continued to get worse. About a week ago I scheduled another appointment with a different doctor who did a chest x-ray and a CT scan because they were scared I could have a blood clot in my lungs. I did not. I had pneumonia. They put me on a 5 day antibiotic. I am not on a 12 day Prednisone protocol and Albuterol.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: -
Labordaten: Chest Xray; CT scan;
Aktuelle Erkrankungen: N/A
Vorgeschichte: Reactive airways; autoimmune issues; asthma
Andere Medikamente: Daily antibiotic for UTI
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2327077

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: CA
Alter: 65,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Asthenia Bone pain C-reactive protein increased Fatigue Feeling abnormal Gait disturbance Mobility decreased Musculoskeletal stiffness Pain Polymyalgia rheumatica Red blood cell sedimentation rate increased

Symptomtext

approx. 4 hours after vaccine pt started stumbling around and felt weird. Bones hurt with body aches and felt tired ever since s/p vaccination booster dose. DX with polymyalgia rheumatica developed after her last booster per provider.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: meets criteria: shoulder pain bilat with decreased ROM , + HIP GIRDLE WEAKNESS , + AM STIFFNESS, > 2 WEEKS FATIGUE , ELEVATED ESR AND CRP
Aktuelle Erkrankungen: -
Vorgeschichte: HTN, HYPOTHYROIDISM PER PT.
Andere Medikamente: VIT.D 3 125 MCG QD, CA. CITRATE 1000 MG QID, B 12 GUMMY VITAMINS, SYNTHROID 25 MCG QD,LISINOPRIL 40 MG , TOPIRAMATE 100 MG , ESCITALOPRAM 10 MG
Allergien: SULFA DRUGS,PCN,CODEINE
Vorherige Impfungen: -

VAERS 2323269

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 17.06.2022
Impfdatum: 22.04.2022
Beginn: 31.05.2022
Tage bis Beginn: 39,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Ageusia Blood test COVID-19 COVID-19 pneumonia Computerised tomogram normal Cough Decreased appetite Dehydration Pain Productive cough Respiration abnormal SARS-CoV-2 test positive Secretion discharge Throat irritation X-ray abnormal

Symptomtext

Around June 1, 2022I finish cutting my grass and was breathing funny. My throat was raspy and I started coughing. My body got sore. My legs and back were very sore. I was spitting up a lot of mucus. I had no appetitive and when I did eat I did not get the flavor. I finally called the doctor and was seen. The lower part of my lung and pneumonia and the doctor informed me it was Covid related. I was prescribed medication but am unsure of what they were. I was given a Covid test at the doctor but do not know the results. My at home government Covid test came back positive. I was dehydrated and ended up in a local hospital and was given 2 bags of saline solution and a shot of morphine to ease my pain on Wednesday 6/15/2022. I was kept in the emergency room for about 6 hours and then was sent home. Today I still have a cough, bringing up phlegm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: -
Labordaten: CT scan- proper organ function, X-ray showed Covid related pneumonia, blood draws.
Aktuelle Erkrankungen: None
Vorgeschichte: Colitis
Andere Medikamente: CoQ10; phenyl fibrate; olmesartan; baby aspirin; pravastatin; valsartan; garlic pill; multivitamin; potassium; magnesium
Allergien: Statin
Vorherige Impfungen: -

VAERS 2310186

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: SD
Alter: 64,0
Geschlecht: F
Eingang: 06.06.2022
Impfdatum: 14.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 17,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Chest X-ray abnormal Chronic obstructive pulmonary disease Condition aggravated Cough Dyspnoea Pulmonary fibrosis

Symptomtext

The doctor said it was an acute COPD flare up. I was having a hard time coughing and breathing. The symptoms are still ongoing and started about the 1st of may. I went to the doctor, they did a chest xray and gave me prednisone, nebulizer. I still have lingering cough that was worse before covid and still don't have my sense of taste, I can't taste anything that's spicy everything else has come back except that one. I had COVID Nov 29, 2020

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: chest xray - showed there was some scarring and doctor thinks it's from covid
Aktuelle Erkrankungen: no
Vorgeschichte: copd
Andere Medikamente: multivitamin, fish oil, vitamin D
Allergien: no
Vorherige Impfungen: -

VAERS 2302164

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: LA
Alter: 34,0
Geschlecht: M
Eingang: 30.05.2022
Impfdatum: 30.03.2022
Beginn: 30.05.2022
Tage bis Beginn: 61,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea

Symptomtext

PATIENT STATES ITS HARD TO BREATH WHEN HE LAYS DOWN TO SLEEP

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2284756

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: MS
Alter: 64,0
Geschlecht: F
Eingang: 19.05.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypoaesthesia Hypoaesthesia oral Paraesthesia oral

Symptomtext

Right upper lip numbness and tingling beginning within an hour of injection. Right side of face numb within 6 hours but facial numbness and tingling resolved the next day. Right upper lip mild numbness and tingling remains and is current.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: -
Vorgeschichte: Pulmonary MAI
Andere Medikamente: Pyridoxine 100mg, estradiol 1mg, rosuvastatin 5mg, VitD,
Allergien: PCN, Keflex, Suprax, Bactrim, Cipro, Lorazepam,
Vorherige Impfungen: -

VAERS 2282971

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: OH
Alter: 69,0
Geschlecht: F
Eingang: 18.05.2022
Impfdatum: 10.04.2022
Beginn: 10.05.2022
Tage bis Beginn: 30,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Head discomfort Mobility decreased Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID breakthrough case. I received my 2nd booster shot on 04/10/2022, my adverse event started on 05/10/2022. In the morning I had cough, sore throat, low grade fever most evening 99-100 and 2 nights it went to 102. I also body aches. I felt like my head was stuffed up. It was hard for me to go up the steps. I took a COVID home test yesterday on 05/17/2022 which was positive. Then I called my doc she prescribed Paxlovid for 5 days. Am still on the medications. I took 3 pills yesterday and few today. I guess it will take few more days to get better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: COVID home test.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Regular meds gabapentin; cholesterol med; Claritin; omeprazole
Allergien: None
Vorherige Impfungen: -

VAERS 2278336

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: NY
Alter: 65,0
Geschlecht: F
Eingang: 16.05.2022
Impfdatum: 16.04.2022
Beginn: 09.05.2022
Tage bis Beginn: 23,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Condition aggravated Cough Dysgeusia Dysphonia Fatigue Oropharyngeal discomfort Oropharyngeal pain Productive cough Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough Case of COVID beginning 05:05/09/2022. SX began with mild cough and phlegm. It got worse I had a fever on 05/10/2022 or 05/11/2022 of about 100.5 for two days. I tested on 05/12/2022 and saw the APRN on 05/13/2022 and got PAXLOVID and I took my first doses that day. I was still pretty horrible, hoarse and sore throat and felt better almost immediately. Now I am better but still coughing and tired. My mouth tastes like I've been sucking on a rusty penny. I am going to take the week off of work because I can.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Home test - positive on 05/12/2022
Aktuelle Erkrankungen: No
Vorgeschichte: Osteoarthritis in hips
Andere Medikamente: Calcium; low dose aspirin 81mg; 4 TYLENOL per day; COLACE; CLARITIN
Allergien: Penicillin; sulfa
Vorherige Impfungen: -

VAERS 2278252

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: WI
Alter: 79,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 12.02.2021
Beginn: 20.03.2021
Tage bis Beginn: 36,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Heart rate increased Sleep disorder Tinnitus

Symptomtext

Rapid heart beat when going to sleep, and changes in my Tinnitus . After second Covid shot my heart rate would increase dramatically when trying to go to sleep. Too fast to even try to count for one second. Dr. ordered a heart monitor for three day recording period. Supposed to mark time on cell phone type unit. I worked as a Locomotive Engineer for twenty four years following a previous nine years as a Brakeman. My system is still attuned to going to a wide awake state anytime I'm awakened. In Lew of being, I included a note as to the times this rapid beat was happening. Their report was nonsense. I'm quite sure a rapid beat before a resting sleep rate would be quite noticeable. They did list one episode of 172 beats. Corporation $$$$$, too much of a hurry. I'm blind in my right eye and need glasses to operate their cell phone unit, plus I would have had to turn on brighter lights to see what I was doing. I also have trouble with my hands, arthritis from the years operating the locomotives. I also have to contend with the over five inches in height I've lost from railroading. I loath loss of sleep. I had a appointment Jan 6, 2022 CLINIC CARDIOLOGY. Dr. changed my prescription for METOPROLOL TARTRATE 25MG twice a day to METOPROLOL ER 50MG - 1 TAB AM and 1/2 TAB PM. The fast heart rate has slowed considerably, but the beat are really strong. The heart rate is still faster than it should be. I have had some nights without the fast heart rate, and nights with the slowed heart rate. A couple of nights of no fast heart rate to be awakened after falling asleep with faster than normal strong heart beat rate some of which really pulse. My dad, his brother and sister, and a cousin (dad's brother daughter) all died of cerebral aneurysms. Strong beats do concern me. Today up at 04:30am regular beat, 09am sleepy sitting in Morris Chair , 09:10am beat speeding up, 09:20am beat faster and stronger as close to sleep; 09:30am, more awake; 09:40am normal, up walking around. It's not unusual having this sleepy events happen in mornings and afternoons. I had kidney failure in the eighty's. I was sick and had multiple appointment with my general practitioner. He order a glucose test and the tech found blood cells in the urine. Sent for ivp x-rays. They were unable to see kidney, Ordered blood tests. Creatine was 15.3 and Bunn was 122. Dialysis Nurse told me "I've seen your blood work. You should be in bed puking, not up walking around". Nine dialysis treatments and they had my kidneys restarted, Had 70% then, last test in 2020 was 37%.. Failure was attributed to viral infection and Dyazide shut them down. I had a new physician after that. I do a lot reading on the net, but careful where. On computers if something goes in, something comes out! Never, never self help groups. Everything placed on the dinner table was homemade, vegatables were either fresh or frozen. That's why I felt that I wasn't in bed puking. Tinnitus - I've had Tinnitus for years. It's been a high pitched monotone. Quite loud at times. After the second Covid shot the monotone changed to a jet engine roar. After acouplke of months it would switch back and forth between the monotone and jet engine roar. After the fourth Covid shot, same as above but now I've had instances of what sounds like a radio talk show is on, except the talk is muffled and not understandable. Weird! I'd be amused if I could understand it. Today 05/15/22 tone is monotone again. 05/16/2022 up at 4:30am - monotone, 07am - jet sound; 08am - monotone. Personal history. Was married to my wife for fifty-five years. She expired in 2018 of stage four Parkinson's Disease. We have five children, three girls and two boys who have provided fourteen grand, great-grand children. My primary occupation was a Brakeman for nine years and then a Locomotive Engineer for twenty four years. My promotion exam to Locomotive Engineer was seven hours of verbal examination by the toughest examiner the company ever had. As a side note I never missed giving a complete correct answer. To keep my mind active on long road trips on the Company I would keep my station times in binary and, or hexadecimal form calculated enentirely in my mind. Raising five children meant I did a lot of side jobs including autobody work, engine work, all the building trades, welding landscaping, many others. Hobby's were Morris Style woodworking, stained glass, computers and gunsmithing. Even at eighty I make my own meals, wash my own clothes and drive a car (I avoid night time driving if possible). With this rapid heart beat I imagine a question would be - Why I have had the additional booster shots. My answer would be my current health status. On the railroad I was subjected to ultrafine silica sand dust from the locomotive wheel sanding. I have a mass in my lower left lung. It's in the lower left lung from all the hours leaning left to see towards the backward direction while switching cars. They want a ct scan but I have declined account I can no longer hold my arms over my head to preforn their scan. There is a design flaw with the diesel exhaut stacks and a attached spark arrester that forces the exhaust to enter the car body that then is then drawn into the cab by traction motor blowers located below the cab. Another design flaw with the train brake valve in most of their GP9's and GP&7's. When ever using the train brakes the train line air is exhausted directely into the cab of the locomotive. Trian line air is high pressure, 75-90 psi. The exhaust would be full of fine oil mist. My breathing is degrated from the above. I'm sixteen lustrums. I am diabetic. I have kidney disease. My BMI is high. (Loss of five inches doesn't help). One of the early studies of Covid deaths said a high percentage (70% ?) of those deaths of over 65 were of blood type A +. Wan'na guess my blood type. It's not just surving Covid, it's what your goning to have left. I started sheltering in 02 of 2020. I find it had the amount of people that believed the POTUS retoric he was putting out. I guess it reinforced what I've seen with people that are smart, or those especially proclaiming to be smart, that a good percentage are seriously short of common sense. I haven't had Covid. I'm alone 95% of the time, that doesn't bother me as on the RR I was alone a lot. I do miss the banter the wife and I had, though. One of the many favorite was when we were sitting under the eve of the garage. It was L shaped and offered protection from the cold Lake wind. This particular day was heavy overcast (fog) just above the tree tops. A group of geese from the rail yards, where a lot of grain was spilled from leaking grain cars, would fly to the Bay area. We could hear a group coming as they were honking excessively. They flew over us right at tree top level account of the heavy overcast. It was down right irratating all the noise. A few minutes later another group followed. This group was not honking and when they went overhead you could hear the wind flowing over their wing as they flapped, and the heavy breathing from keeping those heavy bodies in the air. After they passed my wife asked "Was that second group a different kind of goose?". I ansewered dryly "NO, Those were all Males". I instantely received a back hand slap on the shoulder. I miss those days. Ya, some of you are probably thinking right now, but in our house there wasn't any male or female jobs, and the worst thing any of those kids could say was "I don't know how". My energy was spent on the mechanical side of things, so if you would excuse my grammer and spelling I would appreciate it, and of the length of this, because standing is now limited, I sit a lot more for things like this. Even with hearing aids I have trouble with higher pitched voices (some females). As an Engineer I blew the whistle a lot. During the time I was a Brakeman a nineteen year old girl later subcumed follow a grade crossing collision. What was really chilling was, forty-five minutes after hitting the car, a baby started crying. The baby was up under the dashboard and the driver and passenger were not in a condition to tell us. As having been a Locomotive Engineer I'LL gladily admit to being whistle happy. I rarely talk about this part of my RR career.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Type 2 diabetes, Diabetic peripheral neuropathy, chronic renal
Vorgeschichte: Lumbosacral spondylosis without myelopathy with hx of right sided sciatica Lumbar post-laminectomy syndrom: History of bilateral knee arthroplasty both knees Mixed hyperlipidemia: Postate cance Essentialhypertension; Type 2 diabetes mellitus treated with insulin- hammertoes and peripheral neuropathy uses diabetic shoes; Diabetic peripheral neuropathy; Primary osteoarthritis of both knees; Non-proliferative diabetic retinopathy mild, without macular edema - right eye , mostly blind right eye. VitreoRetinal surgery - checks bs 4 x per; CRD (chronic renal disease), stage III stable, has seen nephrology
Andere Medikamente: METOPROLOL ER 50MG 1-AM, 1/2-PM; FAMOTIDINE TWICE DAILY; HYDROCODINE/ACETAM 7.5-325MG i use one in am, occasionally a second 2 or 3 times a month, prescribed every eight hours; PRAVASTATIN 80MG-BEDTIME; OTC- CETIIRIZINE HYDROCHLORIDE 10MG
Allergien: Milk Protein Extract, Metformin, Triamterene-Hctz, asprin
Vorherige Impfungen: -

VAERS 2266505

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: CO
Alter: 46,0
Geschlecht: M
Eingang: 06.05.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest discomfort Dizziness Dyspnoea Dyspnoea exertional Throat tightness Urticaria Wheezing

Symptomtext

46 year old male - PMH of Asthma and recently being tx for a sore throat and flu like sx and was taking mucinex since May 2nd. Pt declared an emergency, pt reports chest tightening, throat closing, + dizziness after covid vaccine this afternoon.+ hives on abd and back, pt reports sx began right away and progressively got worse. pt was feeling sob on presentation to the clinic. Lungs diminshed throughout received 50mg IM of benadryl x 1 and an albuterol neb tx and oxygen applied at 2L-NC. pt reports improved hives and breathing at this time. DOE, resp slightly labored lungs with wheezing throughout.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: FLU LIKE SYMPTOMS 4 DAYS PRIOR SORE THROAT
Vorgeschichte: ASTHMA, ELEVATED LIVER FUNCTION TESTS
Andere Medikamente: ALBUTEROL INHALER AS NEEDED, ALUTEROL 0.083% INHALE 1 AMPULE BY NEBULIZER TWICE AS NEEDED ALVESCO 160MG 2 PUFF TWICE DAILY AS NEEDED TYLENOL AS NEEDED TESSALON PERLES 2 CAPS TWICE DAILY
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2260456

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: NY
Alter: 50,0
Geschlecht: M
Eingang: 02.05.2022
Impfdatum: 20.04.2022
Beginn: 25.04.2022
Tage bis Beginn: 5,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia COVID-19 Dysgeusia Dyspnoea Fatigue Headache Nasal congestion Oropharyngeal pain Pain Pain in extremity Peripheral swelling Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Throat irritation

Symptomtext

I did get a sore and swollen arm when I got the vaccine. I started getting symptoms of sore throat. The next day my throat was sore and scratchy. The third day I had headaches, low grade fever, soreness, tiredness, and nasal congestion. I had a COVID-19 test done on 4/27/2022 which was positive. I did a telehealth visit and received a prescription for Paxlovid. After I started taking Paxlovid, I lost sense of taste except for a bitter taste. I now feel like I have shortness of breath, headache, and congestion. My headaches are worse in the evening time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: COVID-19 test
Aktuelle Erkrankungen: None
Vorgeschichte: HTN controlled
Andere Medikamente: Metformin, Pantoprazole, Atorvastatin, Bupropion, Escitalopram
Allergien: Sulfa
Vorherige Impfungen: Moderna - 1st dose flu like symptoms

VAERS 2259957

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

moderat

Staat: VA
Alter: 57,0
Geschlecht: F
Eingang: 01.05.2022
Impfdatum: 18.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Erythema Pruritus Rash Urticaria

Symptomtext

Skin on back and arms sensitive red and itch next day after shot. Took Benadryl . Itching and redness worsened throughout the day. On April 20 woke up with raised hives on legs stomach and neck in addition to back and arms. Continued to take Benadryl. Called PAs office at a local HCF- they prescribed multi day pack of prednisone. Started prednisone at 3pm on April 20. By 8pm itching had subsided. April 21 swelling and redness diminished. By April 23 most redness dissipated . Healing continued until rash was completely resolved

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Nope
Vorgeschichte: None
Andere Medikamente: Fosamax Wellbutrin allegra
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2250200

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: ID
Alter: 59,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 22.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Feeling of despair Headache Ligament pain Myalgia Palpitations Pyrexia

Symptomtext

Profound despair/hopelessness 4/23/22 9:00 am-1:00 pm Extreme Headache - 48 hours Fever/Chills - 24 hrs Heart Palpitations-12 hrs Extreme muscle/ligament pain-48 hrs

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma
Andere Medikamente: Oral/vaginal estrogen Trazadone Probiotic
Allergien: Penicillin
Vorherige Impfungen: Both full dose and both half-dose booster Covid vaccines-3/7/21 to 4/22/22. Moderna arm injection

VAERS 2248181

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: MS
Alter: 45,0
Geschlecht: F
Eingang: 22.04.2022
Impfdatum: 18.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Diarrhoea Nausea Pain Palpitations Pyrexia Tachycardia

Symptomtext

fever, chills, body aches, diarrhea, nausea x 4 days and still ongoing. temp 101-102 F Side effects worse that after dose 1 and longer lasting. palpitations/tachycardia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no
Vorgeschichte: diabetes hypertension
Andere Medikamente: metformin lisinopril tylenol advil
Allergien: influenza vaccine
Vorherige Impfungen: anaphylaxis after influenza vaccine approximately 6 years ago

VAERS 2247879

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

moderat

Staat: NC
Alter: 73,0
Geschlecht: M
Eingang: 22.04.2022
Impfdatum: 21.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Confusional state Diarrhoea Dyskinesia Tremor

Symptomtext

tremors, involuntary jerking, generalized weakness, confusion, had diarrhea 2 days prior. Provider stopped Bumex, and spironolactone and encouraged fluids. evaluation continuing

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: hx of end stage heart failure, Acute kidney injury, chronic kidney disease stage 3,
Vorgeschichte: -
Andere Medikamente: albuterol sulfate, Trazadone, tamsulosin, nitroglycerine, gabapentin , famotidine, aspirin, amiodarone, duloxetine, metformin, spironolactone, glipizide, ferrous sulfate, miralax, bumetanide, metoprorlol, entresto, tramadol, cetirizine, lop
Allergien: codeine, morphine, latex, oxycodone
Vorherige Impfungen: -

VAERS 2241158

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: GA
Alter: 60,0
Geschlecht: M
Eingang: 19.04.2022
Impfdatum: 12.04.2022
Beginn: 16.04.2022
Tage bis Beginn: 4,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypogeusia Paraesthesia oral

Symptomtext

Since receiving my 4th dose of my Moderna vaccine, my taste has been affected. I can still taste things but everything tastes bland. On my tongue and around the inside of my lips I have noticed a tingling sensation as well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma; Diabetes; H.I.V.; Hypertension; Osteoporosis; Major Depressive Disorder (recurrent); Generalized Anxiety Disorder; Mild Neuro Cognitive disorder; Cov 2 Long Haul Syndrome; Arthritis involving multiple joints; Cyst Spondyloarthropathy; Neuropathy; COPD; ADHD; Lipoatrophy; Renal Insufficiency; Vitamin D Deficiency; Hyperlipidemia; Hypogonadism; Horse shoe kidney; Hematuria
Andere Medikamente: Tivicay Descovy Edurant Dronabinol Triamcinolone Tamsulosin hcl Gabapentin Xanax Clonazepam Lexapro Adderall Montelukast Trelegy-Ellipta Albuterol Sulfate Proventil Inhaler Allegra D Xolair Lisinopril Lipitor Metformin Testosterone Gel Vit
Allergien: Shellfish; ritonavir; VIRAMUNE; magnesium salicylate
Vorherige Impfungen: -

VAERS 2238142

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

moderat

Staat: MA
Alter: 67,0
Geschlecht: M
Eingang: 17.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Dizziness Fatigue Headache Lethargy Mobility decreased Pain

Symptomtext

Systemic: Body Aches Generalized-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Headache-Severe, Systemic: Weakness-Severe, Additional Details: pt says they cant get up out of bed day after booster dose, dizzy,headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2238058

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

moderat

Staat: OH
Alter: 64,0
Geschlecht: F
Eingang: 16.04.2022
Impfdatum: 12.04.2022
Beginn: 12.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest discomfort Chest pain Extra dose administered Injection site pruritus Tachycardia

Symptomtext

Site: Itching at Injection Site-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Tachycardia-Mild, Additional Details: EMS was called and patient stated to feel a little better. First responders recommended patient be seen at hospital and she left premises under their care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2235895

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

moderat

Staat: MD
Alter: 64,0
Geschlecht: F
Eingang: 15.04.2022
Impfdatum: 02.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Injection site bruising Injection site erythema Joint injury Limb injury Paraesthesia Skin discolouration

Symptomtext

Site: Bruising at Injection Site-Medium, Site: Redness at Injection Site-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-, Additional Details: Pt states vaccination was administered in scar tissue and has had some discoloration of her arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2225850

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: OH
Alter: 64,0
Geschlecht: F
Eingang: 11.04.2022
Impfdatum: 07.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Ataxia Condition aggravated Dysstasia Fall Fatigue Feeling abnormal

Symptomtext

Severe ataxia resulting in fall with weakness - unable to get up for approximately 15 minutes; brain fog, fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: none
Vorherige Impfungen: Severe fatigue, low grade headache.

VAERS 2225469

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

moderat

Staat: MI
Alter: 80,0
Geschlecht: F
Eingang: 10.04.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dyspnoea Wheezing

Symptomtext

Systemic: Allergic: Difficulty Breathing-Medium, Additional Details: patient did not have any issues with first two doses nor first booster. After second booster she said she felt wheezy. she took her albuterol and 2 benadryl. ems came and told her

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2223187

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: NJ
Alter: 50,0
Geschlecht: F
Eingang: 08.04.2022
Impfdatum: 05.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test Burning sensation Cardiac disorder Dizziness Electrocardiogram Electrocardiogram abnormal Extra dose administered Feeling abnormal Lethargy Nausea Palpitations Paraesthesia X-ray

Symptomtext

She got her vaccine, first started to feel the lethargy. Later in the night her arm started to burn, has had some problems with paresthesia's. Then that went away and then her heart started to race, felt strange in her own body, her head felt light headed and she felt nausea. She called the UC and they told her to come in. They did 2 EKG's and asked to do another one. The 2nd one they asked if she had had a heart attack or a cardiac arrest and they wanted her to go to the ER. Her parents came to get her, they did blood work, EKG's and a chest x-ray and they want her to get a FU with a cardiologist. This lasted for about 4-5 hours and then went away. She went to medical Center. She did not have any reactions like this with the other vaccines, the last one just no energy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: In the ER as above.
Aktuelle Erkrankungen: Bladder infection under treatment.
Vorgeschichte: Celiac disease, anxiety, thyroid disease.
Andere Medikamente: Citalopram, Gabapentin, Propranolol, Lorazepam, Quetiapine, Unithroid, Cephalexin, Amanose, Quercetin.
Allergien: Gluten, sulfa drugs.
Vorherige Impfungen: -

VAERS 2211317

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

moderat

Staat: NC
Alter: 51,0
Geschlecht: F
Eingang: 01.04.2022
Impfdatum: 31.03.2022
Beginn: 01.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Paraesthesia oral Pruritus Rash

Symptomtext

itching all over body and tongue feeling tingling at 10 minutes after vaccine given, rash noticed next morning seen next day at 1100 am and mild rash and itching

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia oral
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: morphine, demerol, codeine, fresh peaches; reactions to serum based products in past (eye creams, rubella vaccine)
Vorherige Impfungen: rubella, 9/14/1998, hives and difficulty breathing

VAERS 2199388

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: NC
Alter: 52,0
Geschlecht: F
Eingang: 25.03.2022
Impfdatum: 25.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood glucose normal Condition aggravated Dizziness Nausea

Symptomtext

Pt reported nausea and dizziness and feeling as if she could faint after administration of vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: Paramedics found heart rate to be 76 bpm, blood pressure :130/84, blood sugar: 105 and oxygen saturation: 95% (3/25/22)
Aktuelle Erkrankungen: Total thyroidectomy Hashimoto's disease
Vorgeschichte: Total thyroidectomy Hashimoto's disease
Andere Medikamente: n/a
Allergien: penicillin
Vorherige Impfungen: Moderna #1 felt nauseous as well

VAERS 2189861

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

moderat

Staat: CA
Alter: 37,0
Geschlecht: M
Eingang: 21.03.2022
Impfdatum: 18.03.2022
Beginn: 18.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Neck pain Palpitations

Symptomtext

Heart palpitations, severe headache and neck pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: None yet.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: HCTZ/LISINOPROL, Trazedon, Sertraline, Buspirone
Allergien: Certain antibiotic, can't remember which one.
Vorherige Impfungen: Extremely I'll, exhausted. Age 36, 4/28/2021, moderna 2nd dose

VAERS 2182073

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

moderat

Staat: VA
Alter: 55,0
Geschlecht: F
Eingang: 16.03.2022
Impfdatum: 15.03.2022
Beginn: 15.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dyspnoea Hypertension

Symptomtext

Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Hypertension-Medium, Additional Details: Patient was taken by ambulance to Hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2698973

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: GA
Alter: 86,0
Geschlecht: F
Eingang: 19.10.2023
Impfdatum: 24.08.2022
Beginn: 29.08.2022
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Body temperature increased Loss of personal independence in daily activities Malaise Pain

Symptomtext

On 8/25/22 resident c/o not feeling well, unable to perform normal activities due to lethargy, Temp 101.9, Pulse rate 144, c/o body aches. On 8/26/22 symptoms improving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: None
Vorgeschichte: CKD-stage 3, Fibromyalgia
Andere Medikamente: See copy of scripts
Allergien: PCN
Vorherige Impfungen: As mentioned above after J and J vaccine

VAERS 2319533

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: FL
Alter: 67,0
Geschlecht: M
Eingang: 19.05.2023
Impfdatum: 01.04.2022
Beginn: 04.04.2022
Tage bis Beginn: 3,0
Dosis: 3
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Aphonia Balance disorder Drooling Dysphagia Gait disturbance Burning sensation Fatigue Feeling hot Influenza like illness Pain Limb discomfort Motor neurone disease Musculoskeletal stiffness Neuropathy peripheral Sinus congestion Slow speech

Symptomtext

Ongoing pain for 9 weeks, then stiffness in lips, face, throat, the drooling, difficulty swallowing, lost voice, now speech stronger but slowed. Losing balance, dragging his feet when walking, feet 'feel heavy and stuck to carpet', neuropathy in right forehead, cheek, arm and leg.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: 4,0
Labordaten: Per neurology, patient meets Criteria for ALS given upper and lower motor neuron signs.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: aspirin 81mg daily
Allergien: fish
Vorherige Impfungen: -

VAERS 2319533

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: FL
Alter: 67,0
Geschlecht: M
Eingang: 19.05.2023
Impfdatum: 01.04.2022
Beginn: 04.04.2022
Tage bis Beginn: 3,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Aphonia Balance disorder Drooling Dysphagia Gait disturbance Burning sensation Fatigue Feeling hot Influenza like illness Pain Limb discomfort Motor neurone disease Musculoskeletal stiffness Neuropathy peripheral Sinus congestion Slow speech

Symptomtext

Ongoing pain for 9 weeks, then stiffness in lips, face, throat, the drooling, difficulty swallowing, lost voice, now speech stronger but slowed. Losing balance, dragging his feet when walking, feet 'feel heavy and stuck to carpet', neuropathy in right forehead, cheek, arm and leg.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: 4,0
Labordaten: Per neurology, patient meets Criteria for ALS given upper and lower motor neuron signs.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: aspirin 81mg daily
Allergien: fish
Vorherige Impfungen: -

VAERS 2620800

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TN
Alter: 76,0
Geschlecht: F
Eingang: 25.04.2023
Impfdatum: 20.04.2022
Beginn: 06.02.2023
Tage bis Beginn: 292,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Cough Diarrhoea Fatigue Malaise SARS-CoV-2 test positive

Symptomtext

My COVID-19 symptoms began on 02/06/2023 in the morning. I had green diarrhea, constant cough, and fatigued. I took a home COVID-19 test which was positive in the morning. I then visited the ER where they gave me an option to take the anti viral infusion but the doctor advised me not to take it because I was in a perfect health. At the ER they also did COVID-19 test which was positive. I had no chest congestions or other health problems. I didn't take any medication and I recovered within 4 days. My body fought the infection by itself.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 06FEB2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; Low Thyroid; Crohn's Disease
Andere Medikamente: Levothyroxine; losartan; estradiol; vitamin for 50+; CONCERTA; PRESERVISION eye vitamin
Allergien: Poison oaks
Vorherige Impfungen: -

VAERS 2619795

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NY
Alter: 67,0
Geschlecht: F
Eingang: 24.04.2023
Impfdatum: 21.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 10,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Exposure to SARS-CoV-2 Fatigue Headache Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

On April 30th I hosted a group of children in my home, when I was then exposed to Covid 19. I then tested positive a few days after they had left on May 6th. I experienced fatigue with a sore throat that felt like strep. I also had a slight headache and chills that lasted about two days. I tested negative around the 7th day and felt 100% better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: At home Covid test 05/06/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Osteopenia; Micro valve prolapse; premature ventricular contractions; cataract; knee injury; breast cancer stage 1 2015- no relapse.
Andere Medikamente: Purple root extract; vitamin B2; magnesium threonate; calcium; multivitamin; NURTEC; RECLAST
Allergien: KEFLEX
Vorherige Impfungen: -

VAERS 2614775

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 85,0
Geschlecht: M
Eingang: 13.04.2023
Impfdatum: 11.04.2022
Beginn: 23.11.2022
Tage bis Beginn: 226,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Pyrexia SARS-CoV-2 test positive Vertigo Vomiting

Symptomtext

11/23/2022 I started vomiting and had a low grade fever. I tested positive for COVID-19 and reached out to urgent care they gave me a prescription of PAXLOVID. And was feeling better within 48 hours. About 20 days later I started having vomiting and vertigo and I couldn't hold anything down. I went to urgent care and they prescribed ZOFRAN. Vertigo and vomiting ended about 24 hours later and was feeling much better. It may have been a rebound COVID-19 case, I heard that it may have been a rebound case of COVID-19 that happens after taking PAXLOVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 23Nov2022 COVID-19 test positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Collagen; vitamin B; multivitamin vitamin D; coenzyme Q10
Allergien: Sulfa drugs; penicillin; soy oil; onions; garlic; oxycodone
Vorherige Impfungen: -

VAERS 2614603

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 77,0
Geschlecht: F
Eingang: 13.04.2023
Impfdatum: 09.04.2022
Beginn: 22.02.2023
Tage bis Beginn: 319,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Cough Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I started off with a sore throat. As the day progressed I became congested. I tested for COVID-19. I had a horrible cough, constantly blowing my nose, and weakness. I then contacted Telehealth line and the nurse prescribed the Paxlovid for me. I started taking it the same day. I did five days of Paxlovid and 5 days of masking up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 22FEB2023 - COVID-19 At Home Test - Positive; 08MAR2023 - COVID-19 At Home Test - Positive; 15MAR2023 - COVID-19 At Home Test - Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Type II Diabetes; Overweight; A-Fib
Andere Medikamente: Calcium; Multivitamin; Extra Strength Acetaminophen; Losartan; Metformin; Atorvastatin; Metoprolol Tartrate; Warfarin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2614144

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21-A

mild

Staat: HI
Alter: 37,0
Geschlecht: F
Eingang: 12.04.2023
Impfdatum: 18.03.2022
Beginn: 21.12.2022
Tage bis Beginn: 278,0
Dosis: 3
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Eye movement disorder Vertigo Vomiting

Symptomtext

I had my vaccination on 03/18/2022. On 12/21/2022 I got very bad vertigo. I am still working through it on 04/12/2023. I am still unsure what is causing it. My eyes were jiggling and I have vomiting dizziness. I saw physical therapist who gave me tips on the Epley Maneuver. I am working on getting referrals to ENT to see if it is something more serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Multi Vitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2612331

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 73,0
Geschlecht: M
Eingang: 10.04.2023
Impfdatum: 06.04.2022
Beginn: 21.07.2022
Tage bis Beginn: 106,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Pain SARS-CoV-2 test positive

Symptomtext

I had chills, felt achy, I was talking to my partner, she suggested that I take a COVID-19 test. It came back positive immediately. I called my doctor, had a virtual visit, I was prescribed the PAXLOVID that my partner went to the pharmacy to pick up for me. I started it that night. By the next day I was feeling better. I did get severe diarrhea from taking PAXLOVID and the taste in my mouth was horrible. I am feeling better thank goodness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 22JUL2023 home COVID-19 positive
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Gabapentin; losartan; iron; omeprazole; FLOMAX; vitamin D; LIPITOR
Allergien: Lisinopril
Vorherige Impfungen: -

VAERS 2611501

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: FL
Alter: 69,0
Geschlecht: F
Eingang: 07.04.2023
Impfdatum: 06.04.2022
Beginn: 05.07.2022
Tage bis Beginn: 90,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia COVID-19 Fatigue Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I had a high fever, bad body aches, my joints hurt. I stayed in bed for 2 days and I was extremely tired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: At home rapid COVD-19 test positive 7/5/2022
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Lovastatin; COREG (generic); vitamin C; multivitamin; iron supplement; aspirin
Allergien: None
Vorherige Impfungen: -

VAERS 2543549

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: PA
Alter: 62,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 02.04.2022
Beginn: 25.11.2022
Tage bis Beginn: 237,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Blood test abnormal Fatigue Neutrophil count increased Scar Staphylococcal infection White blood cell count increased Wound infection staphylococcal

Symptomtext

I developed Staph infection. It started on my lower left leg. I developed Staph infection. I woke up the next morning and it was significantly worse, so I went to the hospital. I was hospitalized and kept there for 4 days. I didn't run a fever at all, but I was very fatigued. They had me on two different antibiotics, but I am unable to recall the medication name. They had me on several medications actually, but I just can't recall the names of them. I still have some scarring, but the wound itself has healed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: 4,0
Labordaten: 29NOV2022 Blood panel, High white blood cell; High Neutrophil
Aktuelle Erkrankungen: N/A
Vorgeschichte: Vascular Ehlers Danlos Syndrome; Connective Tissue EDS; Lupus; Sjogren's Syndrome; Migraines
Andere Medikamente: Multivitamin; vitamin D3; losartan; atorvastatin; famotidine; montelukast; albuterol; medical marijuana
Allergien: Sulfa; codeine; citrus
Vorherige Impfungen: I had a reaction from a Tetanus shot once.

VAERS 2539294

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 53,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 19.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dental caries Pain in jaw

Symptomtext

After the Pfizer BiVal shot on 9/19/2022 I have experienced right jaw pain. I went to the dentist to make sure I didn?t have a cavity and also to my doctor on her recommendation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in jaw
Hospital-Tage: -
Labordaten: 1 office visit to dentist. 1 office visit to doctor. Both for pain in jaw. On muscle relaxants and anti inflammatory drugs. Told to come back in 2 months.
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure
Andere Medikamente: Atenolol
Allergien: Bananas, sulpha antibiotic
Vorherige Impfungen: -

VAERS 2517850

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NC
Alter: 75,0
Geschlecht: M
Eingang: 28.11.2022
Impfdatum: 24.05.2022
Beginn: 30.09.2022
Tage bis Beginn: 129,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Bedridden COVID-19 Chills Diarrhoea Headache Loss of personal independence in daily activities Pyrexia SARS-CoV-2 test positive

Symptomtext

Contracted COVID 19 on September 30; severe case with fever, chills, headaches, joint aches; diarrhea, etc.; treated with PAXLOVID; tested negative after 6 days but tested positive the 7th day; relapse lasted 5 days; no further treatment during relapse; isolated for 5 days after testing negative; total of 3 weeks in bed and unable to do normal activities.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Positive COVID 19 tests
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Rosuvastatin 40mg; Oxybutynin 10mg; Tamsulosin .4mg; aspirin 81mg; Photo Multivitamin; EPA-DHA1000; CO Q10 600; Vitamin D 2000
Allergien: -
Vorherige Impfungen: -

VAERS 2507862

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MO
Alter: 53,0
Geschlecht: F
Eingang: 14.11.2022
Impfdatum: 08.04.2022
Beginn: 01.07.2022
Tage bis Beginn: 84,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Nasal congestion Oropharyngeal pain Paranasal sinus hypersecretion Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I received my second Moderna booster for COVID-19 on 4/8/2022. Sometime in July 2022, I woke up one morning with a sore throat. Usually, if I wake up with a sore throat, it goes away quickly. However, this didn't go away, so I decided to take a home test for COVID-19. When I did, I got a positive result. For the most part, my symptoms were mild. I had a sore throat, a little bit of nasal congestion, some sinus drainage in the throat, and a little bit of congestion in the upper respiratory area. I also had fatigue, which I would say was worst symptom. The sore throat and the sinus drainage and congestion lasted for about 3 days. The fatigue lasted for 2 weeks, however. I informed my doctor of the situation, and she suggested that if I needed to, I could just take Mucinex and any OTC nasal decongestant to treat the symptoms. Fortunately, though, I never had to take any medicine. I've actually had colds that were worse than this. Even though it's been several months, some of the fatigue still lingers. The other symptoms resolved, however.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: July 2022--Home COVID-19 Test--Positive Result.
Aktuelle Erkrankungen: None.
Vorgeschichte: Narrowing of a Coronary Artery; Hypercholesterolemia.
Andere Medikamente: Lexapro; Lipitor; Allegra (As Needed); Advil (As Needed).
Allergien: Penicillin; Tetracycline; Diphenhydramine; Phenergan; Ketorolac Tromethamine.
Vorherige Impfungen: -

VAERS 2507080

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: -
Alter: 56,0
Geschlecht: F
Eingang: 08.11.2022
Impfdatum: 30.03.2022
Beginn: 30.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Headache Injection site pain Injection site swelling Malaise Pain in extremity Peripheral swelling Pyrexia

Symptomtext

Headache, Arthralgia, Fever, PAIN/SWELLING BILAT HANDS, MALAISE, POUNDING HEADACHE, PAIN/SWELLING INJECTION SITE, FEVER 101.4

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2496383

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MI
Alter: 32,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 12.04.2022
Beginn: 21.10.2022
Tage bis Beginn: 192,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain COVID-19 Cholecystectomy Hepatobiliary scan Hepatobiliary scan abnormal Immunodeficiency Laparoscopic surgery Nausea Pain Robotic surgery SARS-CoV-2 test positive Vomiting

Symptomtext

Patient had positive COVID test on 10/15/22 prior to admission. Still on COVID precautions during admission due to her being considered severely immunocompromised. Provider d/c note: "Patient presented to the ED for abdominal pain s/p RYGB on 9/13/22. On Admissions a HIDA was done that showed sgi decrease EF. She was scheduled for a RALC on Monday 10/24/22. The procedure went well and patient was alert and oriented in her room. She was in pain and Dilaudid x 1 received. She was in pain and plans were made for her to try and ambulate. The next day on 10/26 she was having some nausea and vomiting but was able to ambulate. Overall she improved and when seen at bedside on 10/28 was not nauseous and was deemed stable for discharge."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain
Hospital-Tage: 8,0
Labordaten: COVID Detected PCR on 10/22/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Primary hypertension Digestive Nausea with vomiting Musculoskeletal Neck muscle spasm Respiratory Obstructive sleep apnea Other Fatigue Median nerve neuropathy Class 3 severe obesity due to excess calories without serious comorbidity with body mass index (BMI) of 40.0 to 44.9 in adult Pelvic adhesions Spasm of muscle of lower back Microcytic anemia Elevated CA-125 Lupus (HCC) Dehydration History of Roux-en-Y gastric bypass Lesion of liver
Andere Medikamente: -
Allergien: Cat Dander
Vorherige Impfungen: -

VAERS 2495086

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: UT
Alter: 61,0
Geschlecht: F
Eingang: 01.11.2022
Impfdatum: 27.04.2022
Beginn: 05.09.2022
Tage bis Beginn: 131,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Diarrhoea Dysgeusia Fatigue Headache Illness Influenza virus test negative Laboratory test normal Oropharyngeal pain Pyrexia Respiratory syncytial virus test negative Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I got COVID-19 in September. I went to the doctor at the urgent care and tested positive. He prescribed PAXLOVID, I was sick from Sept 7 to Sept 30, but I did not go the hospital. I had sore throat, headache, diarrhea, running nose, fever and fatigue. I tested metal in my mouth, doctor said it could be the PAXLOVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: Sept2022 COVID-19 positive; 07Sept2022 flu normal; Sept2022 RSV/POC normal
Aktuelle Erkrankungen: N/A
Vorgeschichte: Multiple Sclerosis; Lupus; Bipolar
Andere Medikamente: Quetiapine fumarate; lisinopril HCTZ; multivitamins
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2495065

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IL
Alter: 74,0
Geschlecht: F
Eingang: 01.11.2022
Impfdatum: 27.04.2022
Beginn: 11.08.2022
Tage bis Beginn: 106,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia COVID-19 Chills Headache Myalgia Nasal congestion Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

Started on Aug. 11 at 3:00a.m. Woke up with plugged up head and terrible headache. Took a home Covid test and tested positive for Covid. Called pulmonologist that morning and he wanted me on Paxlovid. I called my doctor and she called in a prescription for Paxlovid. Started it on the 12th of August. I did a home rest every other day and they were positive until Aug. 16 when it was negative. I tested negative every other day for 8 days. My symptoms were an extremely congested head and a headache. I also had chills but no fever. Sore muscles and joints and a sore throat. I never did get a cough. Was able to work in yard and do the usual things I have to do. Rested as much as possible.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Just did home tests and took Paxlovid.
Aktuelle Erkrankungen: None
Vorgeschichte: COPD
Andere Medikamente: Calcium, Vit.D, daily multivitamin, probiotic, Anoro Ellipta inhaler
Allergien: Hydrocodone
Vorherige Impfungen: -

VAERS 2485222

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 68,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 21.04.2022
Beginn: 02.07.2022
Tage bis Beginn: 72,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Gastrointestinal disorder Headache Malaise Post-acute COVID-19 syndrome SARS-CoV-2 test positive

Symptomtext

The first two vaccines, I didn't have any trouble. The two boosters I did not feel well for 2 - 3 weeks. On 06/28/2022 I started to not feel well with a headache. On 07/02/2022 I tested positive for COVID-19. I did not have the upper respiratory issues but mine was more gastro issues. As of today, I continue to have issues with what the doctor determined as long COVID-19 symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 02JUL2022 COVID-19 Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Metronidazole
Allergien: Seasonal Allergies; Gluten; Modified Starches; Soy
Vorherige Impfungen: -

VAERS 2482801

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NY
Alter: 68,0
Geschlecht: F
Eingang: 19.10.2022
Impfdatum: 19.04.2022
Beginn: 01.09.2022
Tage bis Beginn: 135,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Nasopharyngitis SARS-CoV-2 test positive

Symptomtext

I was on a cruise when I started to feel like I was getting a cold. Towards the end of the trip, I felt that it was not good I was feeling that way. When I got home, I took a at home test, and it was positive. I contacted my provider and he prescribed PAXLOVID for 5 days. I felt a little tired. After I week I still tested positive and then after I started to test negative. I just had cold symptoms. I had a very mild case.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: Inflammatory Arthritis; Thyroid Disease; Osteoarthritis; Diabetes II; Carpal Tunnel Syndrome
Andere Medikamente: Hydroxychloroquine; levothyroxine; multivitamin; metformin; atorvastatin; nabumetone; TYLENOL.
Allergien: Lidocaine; NOVOCAIN
Vorherige Impfungen: -

VAERS 2482620

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 50,0
Geschlecht: F
Eingang: 19.10.2022
Impfdatum: 29.03.2022
Beginn: 01.04.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Biopsy Biopsy lymph gland Blood test Computerised tomogram Electrophoresis protein Exfoliative rash Flow cytometry Full blood count Laboratory test Lymphadenopathy Lymphoid tissue hyperplasia Metabolic function test Positron emission tomogram Rash erythematous Splenomegaly Ultrasound scan

Symptomtext

Approximately 10 days after the 2nd booster (4th shot) I developed enlarged lymph nodes in my neck followed by severe red, scaly, flat rash. This progressed to lymphadenopathy and an enlarged spleen,. Although it is beginning to resolve (rash went away 6 months after vaccine) many of the symptoms mimicked lymphoma and therefore I underwent extensive testing to determine the cause.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Exfoliative rash
Hospital-Tage: -
Labordaten: Dx ended up as Reactive Follicular Hyperplasia after CT, Ultrasound, Bloodwork including flow cytometry, SPEP, CBC, CMP, and more. PET scan, and finally inguinal excision/biopsy. This took place from May 2022 through October 2022
Aktuelle Erkrankungen: None
Vorgeschichte: Multiple Sclerosis
Andere Medikamente: Vitamin D
Allergien: Sulpha, Reglan, Compazine, Levoquin, Honeydew melon, Lye,
Vorherige Impfungen: -

VAERS 2475355

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: NY
Alter: 73,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 11.04.2022
Beginn: 19.09.2022
Tage bis Beginn: 161,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Nasopharyngitis Oropharyngeal pain Quarantine SARS-CoV-2 test positive

Symptomtext

On 9/19/22 I felt a sore throat and went to Urgent Care. Rapid Test was positive. PCR test was positive. UC gave me a letter to take to Medical Center Emergency Room requesting monoclonal antibody treatment, which I received the same day. I had symptoms of a mild cold. I quarantined at home for a week and wore an N95 mask for another week. I felt fine after 1 week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: On 9/19/22 I felt a sore throat and went to Urgent Care. Rapid Test was positive. PCR test was positive. UC gave me a letter to take to Medical Center Emergency Room requesting monoclonal antibody treatment, which I received the same day. I had symptoms of a mild cold. I quarantined at home for a week and wore an N95 mask for another week. I felt fine after 1 week.
Aktuelle Erkrankungen: none
Vorgeschichte: Afib Seasonal allergies (Grass) high blood pressure high cholesterol Acid reflux
Andere Medikamente: Levothyroxin - 88 mcg Aciphex-20 mg Loratadine Metroprolol - 25 mg (2x/day) Xarelto - 20 mg Simvastatin - 20 mg Melatonin - 5 mg Nasonex nasal spray (1x per day) Vitamin D3 - 2000 iu /day
Allergien: none
Vorherige Impfungen: -

VAERS 2473612

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CT
Alter: 61,0
Geschlecht: F
Eingang: 10.10.2022
Impfdatum: 09.04.2022
Beginn: 01.06.2022
Tage bis Beginn: 53,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Biopsy skin abnormal Drug interaction Rash

Symptomtext

I developed a skin rash that started on my left arm and covered most of my body. I went to the doctor did a biopsy and said that it was a drug interaction. Doctor gave a cream, but it did not work.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: 3Aug2022 - Biopsy - Drug interaction
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma
Andere Medikamente: N/A
Allergien: Concast,
Vorherige Impfungen: -

VAERS 2473082

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21a

mild

Staat: NC
Alter: 67,0
Geschlecht: M
Eingang: 09.10.2022
Impfdatum: 20.09.2022
Beginn: 03.10.2022
Tage bis Beginn: 13,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Lacrimation increased Pyrexia SARS-CoV-2 test positive Sinus operation

Symptomtext

Also received the senior flu shot, same arm, same time. Adverse event was that I became infected with COVID 13 days after receiving the Omicron variant booster. I tested positive two days later (on day 15). This was the fifth in my series. All prior vaccines were Moderna. Note that my wife started displaying symptoms 8 days past my inoculation and tested positive 10 days past. She had four boosters, but not the omicron variant.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Oct 4, 2022 - Home Test - Negative Oct 5, 2022 - Local Primary Care - COVID-19 PCR - POSITIVE - Symptoms were mild, no loss of smell or taste. Mild fever (<100), nasal drainage, watery eyes, tired. No pulmonary impacts, including shortness of breath, weakness, etc, experienced. All symptoms disappeared by Oct 8.
Aktuelle Erkrankungen: -
Vorgeschichte: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2472317

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: KS
Alter: 63,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 03.04.2022
Beginn: 28.06.2022
Tage bis Beginn: 86,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Dysgeusia Fatigue SARS-CoV-2 test positive Throat irritation

Symptomtext

06/28/2022 I woke up with a scratchy throat, and tiredness. I tested positive on 06/29/2022 . I did a tele health with my doctor that day. She prescribed me Paxlovid for 5 days. This was a mild case. After couple of days I started feeling better. I had a metallic taste from the medication. On 07/08/2022 I got a scratchy throat again. I had a rebound case. I just got better by my own.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 Test- Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma; Thyroid; High cholesterol; Osteoarthritis
Andere Medikamente: Levothyroxine; Albuterol; Delora; Pravastatin
Allergien: None
Vorherige Impfungen: -

VAERS 2472190

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CA
Alter: 69,0
Geschlecht: M
Eingang: 07.10.2022
Impfdatum: 06.04.2022
Beginn: 22.07.2022
Tage bis Beginn: 107,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Headache Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

Several months after the vaccine was administered, I had fatigue, headache, major sore throat, slight feverish. I took a COVID-19 home test on 7/23/22 and the results were positive. I was traveling and I called a provider and was prescribed Paxlovid. It took me about 8 days to recover.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 7/23/22 - COVID-19 home test - positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: GERD
Andere Medikamente: Atorvastatin; coQ10; vitamin D; Famotidine; Tamsulosin; vitamin B12
Allergien: lactose intolerant
Vorherige Impfungen: -

VAERS 2471873

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: VT
Alter: 78,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 07.04.2022
Beginn: 28.07.2022
Tage bis Beginn: 112,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Malaise SARS-CoV-2 test positive Vomiting

Symptomtext

I was not feeling well, vomited and thinking I had the flu. I did home COVID-19 that came back positive so I called my PCP and made a appointment for a telehealth visit. My PCP called in the Paxlovid to my pharmacy and I am now feeling better although I did get a rebound case of COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Home COVID-19 test
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Rosuvastatin; Vitamin D3 50, 000; Vitamin D3
Allergien: No
Vorherige Impfungen: -

VAERS 2470860

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: GA
Alter: 80,0
Geschlecht: M
Eingang: 06.10.2022
Impfdatum: 06.04.2022
Beginn: 19.09.2022
Tage bis Beginn: 166,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain upper COVID-19 Cough Oropharyngeal pain SARS-CoV-2 test positive Salivary hypersecretion Sneezing Upper-airway cough syndrome Vomiting

Symptomtext

I started with a sore throat and I took Tylenol and water and I was on a river cruise. Came back on 19 or 20 Sep22. That evening, we did a self test and was positive. The next morning I did a PCR test and I was positive .The sore throat went away I was sneezing, coughing and dripping. I called my doctor and was told to quarantine. I would have not got to the doctor as it felt like a normal cold, Friday on 23Sep22 at 4pm afternoon, I had a terrible pain in the stomach. I did not throw up and had saliva and finally went I threw up the pain remained for a while. The doctor asked me to use Prilosec . I did not any temperature.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain upper
Hospital-Tage: -
Labordaten: 9/19/22- Home Test was Positive; 9/20/22 PCR - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure ; TIA in Jan2022
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2468796

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: PA
Alter: 68,0
Geschlecht: F
Eingang: 04.10.2022
Impfdatum: 04.04.2022
Beginn: 18.09.2022
Tage bis Beginn: 167,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Animal attack Aphonia COVID-19 Chest discomfort Cough Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

After having a sore throat and tightness in chest, took a home COVID-19 test and it was negative. Over the next couple of days I started having a fever with a really bad cough. Took another COVID-19 test and it was still negative. The next day I had a fever and started to lose my voice. Finally tested positive through home COVID-19 test. Called Dr. and was prescribed benzonatate 200mg. Only took one dose. Two days later I was attacked by a neighborhood cat and was put on doxycycline for 10 days. Took another COVID-19 test on 09/27/2022 and was negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Home COVID-19 test - negative; home COVID-19 test - negative; home COVID-19 test - positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Calcium
Allergien: Penicillin; iodine with contrast
Vorherige Impfungen: -

VAERS 2468492

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IL
Alter: 69,0
Geschlecht: F
Eingang: 04.10.2022
Impfdatum: 30.03.2022
Beginn: 20.07.2022
Tage bis Beginn: 112,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Dyspepsia Fatigue Head discomfort Injection site pain SARS-CoV-2 test positive Throat irritation

Symptomtext

I had a little tenderness in my at the injection site for a day. I tested positive for COVID-19 via a home test on 07/20/2022. I had scratchy throat, tired, digestion upset and stuffy head. I contacted my doctors office and was given the prescription for Paxlovid. That helped with my symptoms. After I completed the prescription, I had a rebound of COVID-19. I did not take anything for my symptoms during the rebound stage. No long term COVID-19 symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home test for COVID-19 was positive on 07/20/2022.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroid; High cholesterol
Andere Medikamente: N/A
Allergien: Sulfur
Vorherige Impfungen: Shingles vaccine about 10 years ago. Several itching at the injection site.

VAERS 2456074

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MN
Alter: 61,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 01.09.2022
Beginn: 01.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered Injection site reaction Rash Rash erythematous Rash pruritic

Symptomtext

Rash on neck, under arms, upper chest, and navel every time. The most recent vaccination I also now have an itchy red rash at injection site. All symptoms begin on 2nd day after vaccines. I also developed this type of rash after my 2nd Shingrix vaccine on 9/27/19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site reaction
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: Mild asthma
Andere Medikamente: Lexapro, Vit D, Pepcid
Allergien: Adhesive tape
Vorherige Impfungen: 58

VAERS 2435999

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: -
Alter: 76,0
Geschlecht: F
Eingang: 13.08.2022
Impfdatum: 26.04.2022
Beginn: 10.05.2022
Tage bis Beginn: 14,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Pyrexia

Symptomtext

Narrative: The patient received her fourth dose of Moderna COVID-19 Vaccine (Booster) on 4/26/22. On 5/10/22 a nurse documented an ADR of fever with Moderna COVID-19 Vaccine and added that the patient was hospitalized on 4/27/22. No documentation of the hospitalization was faxed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2405778

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 73,0
Geschlecht: M
Eingang: 09.08.2022
Impfdatum: 09.05.2022
Beginn: 20.07.2022
Tage bis Beginn: 72,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Headache Nasal congestion SARS-CoV-2 test positive

Symptomtext

Starting 07/20/2022, I felt like I was getting a cold: stuffy nose and mild headache. On 07/22/2022, it started getting worse and I didn't test until later that evening. I ended up testing positive. My wife tested positive for COVID-19 the day prior. On 07/23/2022, I went to a walk in clinic, where they tested me again, and it was positive. They prescribed me PAXLOVID and I ended up starting it that day. I had a stuffy nose, cough and a headache. The symptoms started getting better after I started the PAXLOVID. Last Friday, 08/05/2022, I tested myself at home and was negative. On Monday, 08/08/2022, I tested myself again and was positive. I talked to my daughter, who is nurse, and she told me to stop testing myself. I am feeling fine as of today, just intermittent stuffy nose and cough. I was scheduled for a check up colonoscopy during this time but it was rescheduled due to me having COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: At-home COVID-19 test (07/22/2022): positive; at-home COVID-19 test (08/05/2022): negative; at-home COVID-19 test (08/08/2022): positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes Type II; Hyperthyroidism
Andere Medikamente: Metformin; glipizide; lisinopril; amlodipine; atorvastatin; vitamin D; ONE A DAY multivitamin; baby aspirin; levothyroxine; TRULICITY
Allergien: Clindamycin
Vorherige Impfungen: -

VAERS 2399112

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

mild

Staat: IN
Alter: 77,0
Geschlecht: M
Eingang: 02.08.2022
Impfdatum: 31.03.2022
Beginn: 07.05.2022
Tage bis Beginn: 37,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Atrophy of globe C-reactive protein Ear disorder Ear pain Facial pain Hyperaesthesia Inappropriate schedule of product administration Magnetic resonance imaging head abnormal Pain Red blood cell sedimentation rate

Symptomtext

injection dates: 3/30/21, 5/4/21, 11/6/21, 3/31/22 10 days ago new onset right hemifacial pain. Seen by PCP and found to not have an inner ear infection per scope but the ear canal was sensitive and placed on a course of Augmentin. No improvement noted. The right temporal head regions is sensitive to the touch. He has some moderate to severe shooting pain deep within the ear that can shoot into the V1 distribution. Duration is about 5 seconds and frequency is several times per day. No change in severity/frequency since onset. Swallowing can be a trigger but nothing else has been noted. No vision changes. No dental pain. MRI showed advanced global atrophy but no nothing to explain the face pain

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: MRI brain, CRP, sed rate
Aktuelle Erkrankungen: -
Vorgeschichte: Peri anal mass - benign nodule. Enlarged aorta, u/s 1/2019, remains same size.
Andere Medikamente: ?Vitamin D 5000 units 5000 UNIT Capsule 1 capsule Orally BID ?Aspirin 81 MG Tablet Chewable 1 tablet Orally Once a day ?Losartan Potassium-HCTZ 50-12.5 MG Tablet 1 tablet Orally Once a day ?Simvastatin 40 MG Tablet 1 tablet in the
Allergien: none
Vorherige Impfungen: -

VAERS 2388364

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 25.07.2022
Impfdatum: 22.04.2022
Beginn: 26.06.2022
Tage bis Beginn: 65,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Malaise SARS-CoV-2 test positive

Symptomtext

I got COVID. I had symptoms on 6/26/2022 and tested positive on 6/27/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: home test for COVID
Aktuelle Erkrankungen: none
Vorgeschichte: hypothyroidism, asthma
Andere Medikamente: Flovent 220 mcg one puff daily , levothyroxine 0.125 mg daily. Vitamin D1000 i.u. daily , Vitamin B12 1000 mcg daily
Allergien: PCN
Vorherige Impfungen: -

VAERS 2379430

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CA
Alter: 67,0
Geschlecht: F
Eingang: 22.07.2022
Impfdatum: 21.04.2022
Beginn: 12.07.2022
Tage bis Beginn: 82,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood urine present Dysuria Ear pain Flank pain Headache Laboratory test Malaise Oropharyngeal pain Pelvic pain Pollakiuria Respiratory tract congestion

Symptomtext

Frequent urination, pain at the end of voiding, headache, flank pain, and passing blood with urination, and pelvic pain. When the blood came I went to urgent care 2 days later. I was referred to a Urologist that ordered a CAT Scan with IV contrast. I was to go today but then I got sick and not sure if I have COVID-19. Today the symptoms I feel are congestion, sore throat, left ear pain and headache. I have not taken a COVID-19 test.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: Lab tests - blood in urine and some kind of cells.
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma; High blood pressure; Diabetes
Andere Medikamente: Potassium; amlodipine; atorvastatin; aspirin; B complex
Allergien: COMPAZINE; high dose flu shot
Vorherige Impfungen: High Dose Flu vaccine in 2020 after I got the shot I went to bed and woke up with my heart beating fast and felt like I was goin

VAERS 2379131

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

mild

Staat: VA
Alter: 77,0
Geschlecht: F
Eingang: 22.07.2022
Impfdatum: 08.04.2022
Beginn: 14.07.2022
Tage bis Beginn: 97,0
Dosis: 4
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Malaise SARS-CoV-2 test positive

Symptomtext

On July 14, 2022 I tested positive for COVID-19. I took a rapid test at home on July 14, 2022. I did a tele visit with my doctor. My Dr. told me to isolate and said that my symptoms as mild.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: At home COVID-19 test on July 14, 2022
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: Synthroid
Allergien: Estrogen All anti inflammatory meds Sulfa
Vorherige Impfungen: -

VAERS 2373913

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 64,0
Geschlecht: F
Eingang: 19.07.2022
Impfdatum: 18.04.2022
Beginn: 12.07.2022
Tage bis Beginn: 85,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Cough Headache Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

7/12/2022 Runny nose, cough, headache, and chills. 7/14 Took an at home COVID 19 test, positive. Doctor recommended Mucinex, cold medicine for symptoms and rest. Lasted until present when symptoms started to feel better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 7/14 at home COVID 19 test, positive.
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes; Chronic migraine; High Blood Pressure; High Cholesterol
Andere Medikamente: Atorvastatin; Amlodipine; Topamax; Fluoxetine; Metformin; Metoprolol; Sumatriptan;
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2372412

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: GA
Alter: 75,0
Geschlecht: F
Eingang: 18.07.2022
Impfdatum: 10.04.2022
Beginn: 02.07.2022
Tage bis Beginn: 83,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Blood test abnormal Colitis Computerised tomogram intestine Diarrhoea Rectal haemorrhage Vomiting White blood cell count increased

Symptomtext

I've had diarrhea, vomiting, abdominal pain and rectal bleeding.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain
Hospital-Tage: -
Labordaten: CT scan, colitis; blood work, elevated white blood count.
Aktuelle Erkrankungen: No
Vorgeschichte: High blood pressure
Andere Medikamente: Losartan; metoprolol; clonidine; amlodipine
Allergien: No
Vorherige Impfungen: -

VAERS 2371957

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IL
Alter: 76,0
Geschlecht: F
Eingang: 16.07.2022
Impfdatum: 14.04.2022
Beginn: 17.06.2022
Tage bis Beginn: 64,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood pressure decreased COVID-19 Chills Headache Oropharyngeal pain Palatal swelling Quarantine SARS-CoV-2 test positive

Symptomtext

Contracted COVID On 6-17-22. Used home test to verify. Husband contracted on 6-13-22. Blood Pressure dropped to 74/54. Taken to Emergency Room to get re-hydrated and then returned home. Emergency Room confirmed with their COVID test that I had it. I was shivering and had a headache in the front of the forehead. Did not have a fever. My throat was very sore and roof of mouth swelled up. Both sore throat and swelling continued even after completion of Paxlovid and 10 day quarantine. Blood pressure continues to remain low at times.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: CONDITIONS:Systemic Lupus Erythematosis(SLE) Osteoarthritis] Torn Rotator Cuff (Pulled Muscle-Right Side & Left Side) Retinitis Pigmentosa/Parafovial Ring Schetoma,Grave's Disease, Vitiligo,Irritable Bowel Syndrome, GERD, Transient Global Amnesia (5-7-14), Shingles (Zoster): 7-9-16. Lichenoid Keratosis: 11-1-17, Atrial Fibrillation: 6-30-20, Bursitis: 10-9-20. Aortic Valve Stenosis: 01-06-2022
Vorgeschichte: See Item 11 above
Andere Medikamente: PRESCRIPTIONS Escital Opram (Generic Lexapro):10 mg After Breakfast Started 3-14-22 Dexilant 60 mg Daily Before Evening Dinner Amlodipine Besylate: 2.5 mg tablet- Daily After Evening Dinner STARTED 3-10-22 Methenamine Hippurate: 1 GM-TWIC
Allergien: AMPICILLIN, BUPRENEX, CODEINE, COMPAZINE, DARVOCET, DEPAKOTE, DILANTIN, FLOXIN, GABAPENTIN, PLAQUENIL, SULFA DRUGS, TRAMADOL, LORAZEPAM (ATIVAN)
Vorherige Impfungen: -

VAERS 2370887

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 72,0
Geschlecht: M
Eingang: 15.07.2022
Impfdatum: 14.04.2022
Beginn: 11.07.2022
Tage bis Beginn: 88,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Exposure to SARS-CoV-2 Fatigue Malaise Nasal congestion Oropharyngeal pain Quarantine SARS-CoV-2 test positive

Symptomtext

I was informed that I was exposed to COVID-19 on 7/9/2022 after coming home from a trip. In the late evening I started to feel slight chills, fatigue, nasal congestion, and a slight sore throat. I took a PCR test that day. The next morning I woke up, and my symptoms were worse. I took an at home test that day that came back positive. I called my doctor, and he prescribed PAXLOVID and ZYRTEC D. After about 2 days later I started to feel about 60 percent better. On 7/14/2022 I started to feel much better I just feel fatigued. I am still in isolation until 7/21/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: PCR COVID test positive, rapid COVID-19 test positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Heart Disease; High Blood Pressure
Andere Medikamente: Levothyroxine; atorvastatin; clopidogrel; losartan; metoprolol; niacin; low dose aspirin; testosterone injection
Allergien: N/A
Vorherige Impfungen: -

VAERS 2370654

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NJ
Alter: 62,0
Geschlecht: F
Eingang: 15.07.2022
Impfdatum: 14.04.2022
Beginn: 25.06.2022
Tage bis Beginn: 72,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Malaise Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

COVID-19 symptoms started evening of 06/25/2022; tested positive on 06/28/2022. My symptoms were severe congestion, slight cough, fever, and chills. Fever and chills lasted for 48 hours, other symptoms lasted 5 days. I took over the counter Tylenol and Nyquil to help sleep. The Doctor did prescribe Paxlovid but my pharmacy didn't get it. I did have telemedicine visit with PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 Positive 06/28/2022
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Rosuvastatin; Multivitamin; Fish Oil
Allergien: None
Vorherige Impfungen: -

VAERS 2368960

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 65,0
Geschlecht: F
Eingang: 14.07.2022
Impfdatum: 13.04.2022
Beginn: 21.06.2022
Tage bis Beginn: 69,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Headache Malaise Oropharyngeal pain Pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive Symptom recurrence

Symptomtext

When I caught COVID-19 I woke up with a really bad sore throat. It felt like I had strep. Throughout the day I had a sniffle in my nose and it was running. I had a slight cough and a vague headache. The next morning I had a sore throat, runny nose, cough, and a slight fever. On June 23, 2022 I did a telehealth visit, and I was prescribed paxlovid. I started the first dose that evening. My symptoms started getting better the next day. I had a very low grade fever. I was less achy but still not great. That continued, but my symptoms were getting better. Throughout having COVID-19 I was feeling fatigued and tired. On day 10 I finally tested negative, but then a few days later I tested positive again for COVID-19. My symptoms were back, but they were less acute. I had a sore throat again and I felt achy. When I had negative in-between those times I was still fatigued and resting a lot. Now I currently have no more symptoms after testing negative again for the 2nd time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 6/22/2022- COVID-19 Antigen Test- Positive; 7/1/2022- COVID-19 Antigen Test- Negative; 7/6/2022- COVID-19 Antigen Test- Positive; 7/10/2022- COVID-19 Antigen Test- Negative; 7/11/2022- COVID-19 Antigen Test- Negative
Aktuelle Erkrankungen: None
Vorgeschichte: Obese
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2368078

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CA
Alter: 70,0
Geschlecht: M
Eingang: 13.07.2022
Impfdatum: 11.04.2022
Beginn: 21.06.2022
Tage bis Beginn: 71,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain COVID-19 Chills Cough Headache Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

04/11/2022 vaccination, 06/21/2022 I had cough, body aches, fever, chills, headache, back ache. COVID-19 negative. 06/22/2022 COVID-19 negative. 06/23/2022 PCR positive. Dr. put me on PAXLOVID but then had to change because I am on PROZAC. Changed to 'mono-?'.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Back pain
Hospital-Tage: -
Labordaten: COVID-19 positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: PROZAC; levothyroxine; PRALUENT PEN
Allergien: N/A
Vorherige Impfungen: -

VAERS 2368023

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 72,0
Geschlecht: F
Eingang: 13.07.2022
Impfdatum: 12.04.2022
Beginn: 28.06.2022
Tage bis Beginn: 77,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Headache Loss of personal independence in daily activities Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Well I had a runny nose with mild headache and a little sore throat off and on with fatigue it was mild. I didn't have much cough I thought it was contributed to the runny nose. I started the PAXLOVID and that caused a horrible taste in my mouth and was bitter when I was eating and I didn't get rid of those symptoms till 2 days after I stopped taking the PAXLOVID. I didn't go out or do anything.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 home test positive 6/29/22. COVID-19 PCR positive 6/29/22.
Aktuelle Erkrankungen: None
Vorgeschichte: Atrial Fibrillation; Arthritis
Andere Medikamente: Esterase; metoprolol; atorvastatin; PRADAXA; calcium with vitamin D; vitamin C; men's ONE A DAY
Allergien: Codeine; AUGMENTIN; Hay fever
Vorherige Impfungen: -

VAERS 2367562

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IA
Alter: 70,0
Geschlecht: F
Eingang: 13.07.2022
Impfdatum: 11.04.2022
Beginn: 17.06.2022
Tage bis Beginn: 67,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Feeling abnormal Nasopharyngitis Pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had been with my granddaughter, she woke up with a fever, sneezing, excess mucus. The next day she tested positive for COVID-19, I tested with home COVID-19 test the next day and it was positive. I called my doctor to get the PAXLOVID that I started on June 18, 2022. Although the only symptoms I really had was body aches the nest day I felt better. On June 28, 2022 I started feeling like I had a summer cold, runny nose, fever. I finally tested negative on July 4, 5, and 6, 2022. I was not desperately sick just miserable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: Home COVID-19 test
Aktuelle Erkrankungen: No
Vorgeschichte: Chronic Luekemia
Andere Medikamente: TASIGNA; ELIQUIS; diltiazem; metoprolol; DYAZIDE; atorvastatin; vitamin D3; FLONASE; fexofenadine
Allergien: No
Vorherige Impfungen: Pneumonia, I felt horrible, 10 years ago.

VAERS 2366278

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TN
Alter: 72,0
Geschlecht: F
Eingang: 12.07.2022
Impfdatum: 11.04.2022
Beginn: 05.07.2022
Tage bis Beginn: 85,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Diarrhoea Fatigue Headache Influenza virus test negative Myalgia Nasopharyngitis Night sweats Oropharyngeal pain Pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive Streptococcus test negative

Symptomtext

After I took the vaccine I had typical body aches, headaches, night sweats, chills, and exhaustions. They ressolved within 24 hours. In July 5th 2022 I contracted COVID. I had a severe headache, body aches, muscle pains, low grade fevers, chills, cough, sore throat, and runny nose, and diaherra. On July 8th I was given prescription for Paxlovid and all my symptoms by the 9th and 10th were gone. Today I am having very mild cold symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID test that came back postive. Influenza test came back negative and strep test came back negative
Aktuelle Erkrankungen: None
Vorgeschichte: hypertension
Andere Medikamente: atenolol; hydroxyzine; antihistamine;
Allergien: lisinopril
Vorherige Impfungen: -

VAERS 2364680

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 56,0
Geschlecht: M
Eingang: 11.07.2022
Impfdatum: 10.04.2022
Beginn: 20.06.2022
Tage bis Beginn: 71,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Dysphagia Exposure to SARS-CoV-2 Fatigue Malaise Nasopharyngitis Oropharyngeal pain Productive cough Pyrexia Respiratory symptom Rhinorrhoea SARS-CoV-2 test positive Secretion discharge Throat clearing

Symptomtext

I was returning from the east coast and got a notification I was exposed on a flight on 06/18 - 06/19. On 06/19, I was having mild respiratory symptoms and had to clear my throat a lot. Also, I felt extremely fatigued. On 06/20, I was coughing and my nose was running constantly. I did an at home test on 06/20 and it was Positive. The symptoms worsened and I had pharyngeal pain, trouble swallowing and excessive mucus in the throat area causing me to have to cough up a lot of phlegm. Also, I had a fever of 101.7 around this time. I started having difficulty swallowing so I contacted telehealth and they told me I should start Paxlovid. I picked it up as soon as possible (day 4 of symptoms) and started it. The symptoms diminished quite rapidly after starting the antiviral and basically went down to that of a common cold and then resolved shortly after.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: At-home COVID-19 test (06/20/2022): Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Type II Diabetes; Atopic Dermatitis
Andere Medikamente: Cetirizine; atorvastatin; losartan; metformin; buspirone; naproxen; ibuprofen
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2364674

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 56,0
Geschlecht: F
Eingang: 11.07.2022
Impfdatum: 08.04.2022
Beginn: 18.06.2022
Tage bis Beginn: 71,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Fatigue Head discomfort Hyperhidrosis Malaise Muscle fatigue Pyrexia SARS-CoV-2 test positive Throat clearing

Symptomtext

6/18/2022 Felt like throat needed clearing. This progressed into a cough . I got a fever peaking at 102 on 6/19. I tested positive on 6/19 with an At Home Rapid COVID 19 test. Televisit 6/20. I started taking A decongestant, Mucinex, and Tylenol on doctor's recommendation. Symptoms got worse, head congestions and cough worsened through 6/22. All symptoms up to 6/22 included chills and sweats. 6/23 fever broke and symptoms gradually improved onward. Fatigue lingers to time of reporting. Muscle Fatigue is particularly noticeable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 6/19 with an At Home Rapid COVID 19 test, positive.
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma; Essential Tremor
Andere Medikamente: Bupropion; Zyrtec; Propranolol; Estradiol; Norethisterone; Vitamin D3; Multivitamin; Omega 3; Biotin; B12; Calcium
Allergien: Sulfa, Metronidazole; Augmentin; dust mites; mold; pollen; cats
Vorherige Impfungen: -

VAERS 2364479

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 68,0
Geschlecht: M
Eingang: 11.07.2022
Impfdatum: 09.04.2022
Beginn: 21.06.2022
Tage bis Beginn: 73,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Headache Nasal congestion Pain SARS-CoV-2 test positive

Symptomtext

Primarily it was intense body aches and pains with headache. I also had nasal congestion and dry cough. I had intense fatigue. All of this came on within 24 hours. On the second day it was much worse. My symptoms peaked on the 3rd day and began to fade on day 4. By the end of the 6th day it was much better. I got the anti-viral on day 3. (Molnupiravir) I took this for 5 days beginning June 23rd.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: PCR COVID-19 test, positive, hospital.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Arterial Fibrillation; Patent Foramen Ovale; Sleep Apnea; GERD; Reflux
Andere Medikamente: Pradaxa; lamotrigine; metoprolol; omeprazole; lovastatin; fish oil; vitamin D3; B12
Allergien: Atorvastatin
Vorherige Impfungen: -

VAERS 2363955

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

mild

Staat: SC
Alter: 69,0
Geschlecht: F
Eingang: 09.07.2022
Impfdatum: 07.04.2022
Beginn: 02.06.2022
Tage bis Beginn: 56,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest X-ray normal Cough Fatigue Malaise Pyrexia Respiratory symptom Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Had URI SX of congestion coughing slight fever at beginning of cruise May 27-June 3,2022. Tested neg for Covid on May 26, 22. Ran out of cough syrup on June 2, 22 and was very sick especially fatigued by then. Called ship infirmary who sent personnel with meds and Covid kit to stateroom. Tested positive. Moved to isolation on ship and for 5 days later at relatives home. Flew home June 7,22 and still tested positive June 8,22. Called PCP Dr. who prescribed Paxlovid which I took for 5 days. Tested neg for Covid June 9,22. Was fatigued but without URI symptoms for 10 more days. It was a lousy honeymoon.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Chest X-ray done June 20, 22 when I saw Dr. X-ray normal. Still very fatigued. Canceled trip to see my new granddaughter. Fatigue lasted until about June 14, 22.
Aktuelle Erkrankungen: My wife had a cold and sinus infection prior to cruise and I think that I got it sometime around getting Covid. Had URI symptoms before testing positive 6 days later
Vorgeschichte: Hypertention and glaucoma
Andere Medikamente: Lisinopril, bupropion, duloxetine,,trazodone, Meloxicam, glucosamine chondroitin, vitamin D3, womens plus 50 daily Vitamin, hair and nail supplement,Allegra, omeprozole. Latanoprost and combid drops for glaucoma
Allergien: Spring trees, some grasses and perfumes, cats, mold
Vorherige Impfungen: -

VAERS 2362732

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: AZ
Alter: 79,0
Geschlecht: M
Eingang: 08.07.2022
Impfdatum: 07.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 16,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Malaise SARS-CoV-2 test positive

Symptomtext

Two weeks after receiving vaccine I was diagnosed with COVID-19. Tested due to contact and had very mild symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19
Aktuelle Erkrankungen: No
Vorgeschichte: High blood pressure
Andere Medikamente: Lotrel; celebrex; pravastatin, travatan, tamsulosin; flonase
Allergien: No
Vorherige Impfungen: -

VAERS 2362674

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 71,0
Geschlecht: F
Eingang: 08.07.2022
Impfdatum: 07.04.2022
Beginn: 26.05.2022
Tage bis Beginn: 49,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Lacrimation increased Laryngitis Oropharyngeal pain Productive cough Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I received my second Moderna booster for COVID-19 on 4/7/2022. While I was vacationing abroad on 5/26/2022, I awoke with a flaming sore throat at 3 AM. Later that morning, I took a rapid test, and the result was negative. Later that evening, I developed laryngitis and a little bit of a runny nose. I took another test that same evening and got a positive result. On 5/27/2022, I took another test and got another positive result. I still had a runny nose and laryngitis, plus watery eyes. I then developed a cough. My husband bought me a thermometer and Ricola cough drops, which didn't help. Since I had tested positive, I could no longer participate in the tour group I had been in, so I took a train to a major city and undertook a PCR test, which also yielded a positive result. I sent my test results to my doctor back home, and she recommended that I gargle with salt water, rest, and isolate for the first 5 days of the illness. On 5/28/2022 and 5/30/2022, I had a fever of 38.5 Celsius. My energy returned the evening of 5/30/2022 after my fever had broke, though I did still a residual intermittent productive cough. The productive cough lasted until about 6/6/2022, and it gradually diminished during that period. My doctor sent a letter authorizing me to fly, and although I tested positive at an airport testing site, I was still finally able to fly back home on 6/7/2022. When I was back home, I tested myself again on 6/10/2022, and I again got a positive result. I finally got a negative test result on 6/13/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None.
Vorgeschichte: Hypertension; Arteriosclerosis; High Cholesterol; Pre-Glaucoma and Water on Retina of Left Eye; Asthma; Osteoporosis.
Andere Medikamente: Low-Dose Aspirin; Atorvastatin; Lisinopril; Ketorolac Eye Drops; Dorzolamide Eye Drops with Timolol; Rhopressa Eye Drops; Flovent; Osteo-K Minis; Glucosamine Sulfate; CoQ10.
Allergien: None.
Vorherige Impfungen: -

VAERS 2362589

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MD
Alter: 71,0
Geschlecht: M
Eingang: 08.07.2022
Impfdatum: 06.04.2022
Beginn: 16.06.2022
Tage bis Beginn: 71,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Nasal congestion Pain SARS-CoV-2 test positive

Symptomtext

I started getting symptoms of nasal issues like an allergy. I had aches as well. I got a positive COVID-19 test. I contacted my doctor and was prescribed Paxlovid for 5 days. The body aches went away the next day but I did have nasal congestion. I had mild symptoms. Then around 6/26/2022, I had a relapse. I had a lot of nasal congestion and tiredness. Those symptoms lasted for about 1 day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 test - positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin; Fish Oil
Allergien: None
Vorherige Impfungen: -

VAERS 2362448

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NY
Alter: 70,0
Geschlecht: F
Eingang: 08.07.2022
Impfdatum: 05.04.2022
Beginn: 20.06.2022
Tage bis Beginn: 76,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test

Symptomtext

Sore throat, runny nose. Paxlovid

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Health covid test, 6/23/2022
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Vitamin D, Calcium, psyllium, omega 3, metoprolol
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2361232

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 64,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 05.04.2022
Beginn: 07.06.2022
Tage bis Beginn: 63,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Diarrhoea Fatigue Feeling abnormal Headache Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I contracted COVID-19 on 06/07/2022 with symptoms of fever of 103, headache, body aches, and fatigue. I was improving in 3 days after initial onset when on the 5th day my symptoms returned and worsened. I developed with new symptoms of brain fog, cough, and diarrhea. I still have lingering symptoms of cough, fatigue, and brain fog which are recurring intermittently. I was prescribed Paxlovid on 06/14/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: COVID-19 rapid nasal home test was positive on 06/14/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Rheumatoid Arthritis; Vasculitis; Psoriatic Arthritis
Andere Medikamente: Humira; Medrol; Lipitor
Allergien: Cipro; Codeine; Cephalosporins
Vorherige Impfungen: -

VAERS 2360936

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: KS
Alter: 72,0
Geschlecht: F
Eingang: 07.07.2022
Impfdatum: 31.03.2022
Beginn: 26.06.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Headache Influenza virus test negative Malaise Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I went on vacation and I started to feel really sick. I tested positive for COVID-19 on 6/26/22. I had a headache, body aches, fever, cough, and fatigue. I was prescribed Paxlovid by the doctor. I didn't start feeling better until 7/2/22, after we returned from vacation home from vacation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 Test- 6/26/22- Positive; Flu Test- 6/26/22- Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Pantoprazole; Oxybutynin Chloride; Citalopram; Simvastatin; Allopurinol; Telmisartan; Flonase; Bystolic
Allergien: N/A
Vorherige Impfungen: -

VAERS 2359812

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 69,0
Geschlecht: F
Eingang: 06.07.2022
Impfdatum: 05.04.2022
Beginn: 16.06.2022
Tage bis Beginn: 72,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Illness Malaise Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Throat irritation

Symptomtext

I contracted COVID-19 on 06/16/2022 with symptoms of scratchy throat, congestion, and runny nose. I tested negative on my first visit to urgent care on 06/16/2022 and was told to take Zyrtec. On day 3 of my illness I went back to urgent care where I tested positive, and was prescribed Paxlovid. I was ill for 5 days before my symptoms began to resolve. The Paxlovid left a metallic taste in my mouth, but I am now fully recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 rapid antigen test was positive on 06/19/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Glaucoma; Osteoporosis; Arthritis
Andere Medikamente: Hydrochlorothiazide; Timolol Malleate; Latanoprost; Vitamin C; Vitamin D; Calcium
Allergien: Sulfa
Vorherige Impfungen: COVID-19 Moderna Dose 2 I experienced fatigue and body aches for a few hours.

VAERS 2359625

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CA
Alter: 50,0
Geschlecht: F
Eingang: 06.07.2022
Impfdatum: 01.04.2022
Beginn: 30.05.2022
Tage bis Beginn: 59,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal discomfort Ageusia Anosmia COVID-19 Cough Exposure to SARS-CoV-2 Pain Productive cough Pyrexia Rhinorrhoea SARS-CoV-2 test positive Sneezing Throat irritation

Symptomtext

My symptoms began on Monday 5/30. Around 8am I was sneezing. I also had a runny nose, scratchy throat and cough. Then it progressed into more symptoms. I was exposed on 5/26. I wasn't feeling anything but I thought to test myself that following Sunday. It came back negative. Then due the symptoms that started Monday I tested myself Tuesday and it came back negative. That Wednesday, I had a a bad productive cough, achiness, loss of taste and smell. I also had lower gastrointestinal upsets for a few days. I had a low grade fever of 99.5 - 100 degrees.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: At home COVID-19 test-negative; At home COVID-19 test- positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hashimoto's thyroiditis
Andere Medikamente: NP Thyroid; Liothyronine; Low Estrogen Birth Control Pill; Metformin; Allegra; Omega3 Fatty Acid Fish Oil; Vitamin D3; Vitamin B12; Zinc, Selenium; Magnesium Citrate; Vitamin B1 with Benfotiamine, Vitamin K2
Allergien: Dust, Pollen, Mold
Vorherige Impfungen: -

VAERS 2358314

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NJ
Alter: 56,0
Geschlecht: M
Eingang: 05.07.2022
Impfdatum: 02.04.2022
Beginn: 19.06.2022
Tage bis Beginn: 78,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia COVID-19 Cough Fatigue Oropharyngeal pain Pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I tolerated the vaccine well?apart from localized soreness, I did not have the fatigue or fever that I felt after my primary vaccine series and the first booster. On June 18, I felt unusually tired and, the following morning, performed an at-home antigen test; it was positive. I felt fatigue, cough, and sore throat. That day, I began a five-day course of Paxlovid, and the symptoms abated on day 6. On days 7?9, I tested negative, before testing positive again on day 11, with renewed symptoms of fatigue, runny nose, cough, loss of taste, and fever of 101 degrees F. The symptoms abated on day 14, but as of today (day 17), I still feel somewhat fatigue and am still testing positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: The only tests I performed were at-home lateral flow tests.
Aktuelle Erkrankungen: -
Vorgeschichte: I have a mild asthma for which I have been prescribed albuterol and Symbicort inhalers. The asthma comes in waves: Every year or so, I use the Symbicort for a few months, then stop. I have not used either inhaler since my booster shot in April 2022 (the event I am reporting now).
Andere Medikamente: atorvastatin 20mg daily over-the-counter multivitamin tablet vitamin D supplement
Allergien: penicillin
Vorherige Impfungen: I do not know what you define as ?averse,? but I had strong side effects to my first covid shot (in 2021) and to my second shing

VAERS 2357896

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CA
Alter: 69,0
Geschlecht: M
Eingang: 05.07.2022
Impfdatum: 04.04.2022
Beginn: 01.07.2022
Tage bis Beginn: 88,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Oropharyngeal pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive Taste disorder

Symptomtext

I started having a runny nose mild sore throat, mild 24 hour fever. I called my doctor when I tested positive and he prescribed Paxlovid that I started that night and I am almost finished. I felt like a had a mild cold for about two or three days. I am almost finished with the Paxlovid and aside from the taste I feel better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Home COVID-19 Test
Aktuelle Erkrankungen: No
Vorgeschichte: Prostate Cancer
Andere Medikamente: Simvastatin, Lexapro, Pantoprazole
Allergien: No
Vorherige Impfungen: -

VAERS 2357788

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 60,0
Geschlecht: F
Eingang: 05.07.2022
Impfdatum: 01.04.2022
Beginn: 20.06.2022
Tage bis Beginn: 80,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Exposure to SARS-CoV-2 Exposure to communicable disease Influenza A virus test negative Influenza B virus test Malaise SARS-CoV-2 test negative Streptococcus test negative

Symptomtext

My husband was exposed to COVID-19, Strep and Influenza. He had received a call to alerted to a COVID-19 outbreak at work. I tested both of us at home, my husband was positive and I was negative. I took both of us to the Emergency Room. I tested negative for COVID-19, Strep, Influenza A & B but felt very ill and had all the signs and symptoms. We were both prescribed a Z-Pak and Tamiflu.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Home COVID-19 PCR COVID-19 Influenza Test Strep Test
Aktuelle Erkrankungen: No
Vorgeschichte: HIgh Blood Pressure
Andere Medikamente: Losartan, Hydrochlorothiazide
Allergien: No
Vorherige Impfungen: -

VAERS 2347556

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: AR
Alter: 72,0
Geschlecht: M
Eingang: 01.07.2022
Impfdatum: 31.03.2022
Beginn: 21.06.2022
Tage bis Beginn: 82,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Malaise Nasal congestion Pain in extremity Pyrexia SARS-CoV-2 test positive

Symptomtext

I only had a sore arm after receiving the vaccine. I tested positive for COVID-19 on June 21, 2022. I took a home test and called my doctors office (telehealth visit) and I was prescribed PAXLOVID. I also took TYLENOL to help with my symptoms. I had a fever and bad nasal congestion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Home test for COVID-19 and it was positive June 21, 2022.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: CRESTOR
Allergien: None
Vorherige Impfungen: -

VAERS 2347508

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 62,0
Geschlecht: M
Eingang: 01.07.2022
Impfdatum: 31.03.2022
Beginn: 15.05.2022
Tage bis Beginn: 45,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Dysphonia Exposure to SARS-CoV-2 Oropharyngeal pain Pain Productive cough Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Received notice on my cell that I had been exposed to someone with a positive test while on a cruise vacation (May 14/15) 4 to 5 days after the fact. At that time, I had experienced a runny nose and some body aches prior to being notified. I contacted the Clinic to schedule a Covid test. I tested positive on May 20th. Dr. advised me to schedule a virtual visit to discuss Paxlovid therapy due to my pre-existing conditions. I spoke with PA-C at the Clinic and she prescribed the Paxlovid therapy for me. My brother picked up the RX for me and I started that day. I had 2 therapies that day as well as for the following 4 days afterwards. May 21 to May 25. My symptoms remained minor with a sore throat, phlegm producing throat, and cough. Some minor body aches as well, but no major symptoms besides those. I did have a horse voice for a number of days as well. I never had any fever, my taste and smell were not effected, and it did not go into my chest, so my breathing did not seem to be effected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: May 20, drive thru Covid test came back positive. That was the only test to date.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetic 2, VST, Previous Colon Cancer, Kidney Stones, tachycardia, Sleep Apnea,
Andere Medikamente: Metformin 2250mg, Glimepiride 4mg, Vit D3 100 mg, Bupropion 300Mg, Iron 65mg, B12 10,000mg, Metoprolol Tartrate 250mg, Docusate Sodium 100mg, Hydrochlorothiazide 25mg, Paroxetine HCL 20mg, Aspirin 81mg, Tamsulosin 0.4 mg, Atorvastatin 2
Allergien: N/A
Vorherige Impfungen: -

VAERS 2346668

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 64,0
Geschlecht: F
Eingang: 01.07.2022
Impfdatum: 30.03.2022
Beginn: 05.06.2022
Tage bis Beginn: 67,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Headache Malaise Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

V-safe requested I complete VAERS form. I attended my medical school reunion which required proof of booster and negative rapid test to enter. Events on 6/3/22 and 6/4/22. I became symptomatic 6/5/22 at 2 AM with sore throat, headache and cough. My I-Health Rapid Covid test was positive later that day despite having received 4 vaccines (1st 3 were Pfizer). This was my first documented episode of Covid despite being a primary care physician for the past 2 years of the pandemic. Subsequently 21 more people from my medical school reunion class tested positive over the next 5 days - I have dates of all of their last booster shots and many had received 4 shots like me and got Covid for the first time at the reunion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: I-Health Rapid Covid test positive 6/5/22. Weak positive #2 test 6/12/22. #3 test negative 6/14/22. Took Paxlovid beginning on 6/7/22.
Aktuelle Erkrankungen: None
Vorgeschichte: Osteoporosis
Andere Medikamente: Forteo sc daily
Allergien: None
Vorherige Impfungen: -

VAERS 2310757

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: PA
Alter: 50,0
Geschlecht: M
Eingang: 06.06.2022
Impfdatum: 22.04.2022
Beginn: 28.05.2022
Tage bis Beginn: 36,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Cough Head discomfort Headache Nasopharyngitis Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

May 26, 2022 I started having a sore throat, headache, head congestion. On May 27, the cough kicked it in, it felt like a head cold with a really bad cough. It wasn't a deep cough, it was an upper cough in my chest. I did a home COVID-19 test early Friday morning that came back faint. Later that day I took another COVID-19 test that came positive. Saturday I got a PCR COVID-19 test at an urgent care, it came back positive. I got a telehealth appointment prescribed MUCINEX. The NP at a pharmacy prescribed molnupiravir, I started feeling better by Sunday, much better by Tuesday.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: Home COVID-19 test. PCR COVID-19 test.
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes
Andere Medikamente: Metformin; OZEMPIC; ACTOS; TRICOR; CRESTOR; bupropion; CYMBALTA; aspirin; JARDIANCE; SYNTHROID; losartan; VASCEPA
Allergien: Compazine
Vorherige Impfungen: -

VAERS 2308968

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IN
Alter: 72,0
Geschlecht: M
Eingang: 03.06.2022
Impfdatum: 01.06.2022
Beginn: 01.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Feeling hot

Symptomtext

From onset for about 24 hours extreme fatigue, also even though temp was 98.6, the feeling that of having a fever.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OSA, IBS
Andere Medikamente: Losartan Potassium, Spironolactone, Crestor, Prevacid, Nasacort, Fexofenadine HCL, Turmeric & Ginger, Vit "E", Glucosamine Sulfate, Saw-Palmetto, Multi- Vit, B complex, enteric Garlic, Fish oil, enteric aspirin.
Allergien: Milk
Vorherige Impfungen: dose # 1 of Moderna date 02/05/2021, age 71, adverse as above only about 36 hrs. dose #2 of Moderna date 03/05/2021, age 71, mi

VAERS 2308561

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 03.06.2022
Impfdatum: 28.04.2022
Beginn: 27.05.2022
Tage bis Beginn: 29,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Headache Nasal congestion Oropharyngeal pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Positive COVID 19, sore throat, headache, fever, coughing, and runny, stuffy nose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: Positive COVID 19.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Nexium; multivitamins
Allergien: N/A
Vorherige Impfungen: -

VAERS 2305265

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NC
Alter: 65,0
Geschlecht: F
Eingang: 01.06.2022
Impfdatum: 26.04.2022
Beginn: 24.05.2022
Tage bis Beginn: 28,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Cough Ear congestion Fatigue Headache Malaise Myalgia Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I took a 2 week group trip out of the country and my COVID-19 symptoms began on my flight home on 05/24/2022. I experienced symptoms of cough, sore throat, congestion, ear congestion, low-grade fever, myalgia, fatigue, chills, and headache. I was prescribed Paxlovid on 05/28/2022 when I went to the clinic. I began taking Symbicort and Flonase 05/25/2022. When I began taking Paxlovid I stopped taking my supplements to avoid any drug interactions. I was ill for 6 days before my symptoms began to resolve. I still have lingering congestion and cough at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 rapid nasal swab pre flight test was negative on 05/23/2022. COVID-19 rapid nasal swab home test was negative 05/25/2022. COVID-19 rapid nasal swab home test was positive on 05/27/2022.
Aktuelle Erkrankungen: No
Vorgeschichte: Osteoporosis; Chronic Rhinitis
Andere Medikamente: Vitamin D 2000 iu; nicotinamide 500mg 2x daily; vitamin MK7; RDA concentration vitamin B
Allergien: No
Vorherige Impfungen: COVID-19 Modern Dose 2, 3, 4 and Shingrix resulted in 24 hours of fever.

VAERS 2305060

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CO
Alter: 73,0
Geschlecht: F
Eingang: 01.06.2022
Impfdatum: 15.04.2022
Beginn: 23.05.2022
Tage bis Beginn: 38,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Feeling abnormal Headache Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I felt fine after receiving the vaccine, but on May 24, 2022, I wasn't feeling good so I went to the Clinic. I had a fever of 99.9 degrees, a sore throat, and a headache. I tested positive for COVID, and I was prescribed PAXLOVID. My symptoms lasted for about 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID Test - positive (5/24/2022)
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: SYNTHROID
Allergien: A cold medicine makes me get a rash.
Vorherige Impfungen: -

VAERS 2303813

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 60,0
Geschlecht: F
Eingang: 31.05.2022
Impfdatum: 22.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Chills Fatigue Lymphadenopathy Pyrexia

Symptomtext

I experienced a fever of 102 for 7 days. I also had chills, swollen glands and experienced fatigue for a long time. It took about a month or my energy to come back.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: Rheumatoid arthritis, Allergies, Asthma, Depression, Fibro myalgia, Vertigo
Andere Medikamente: Atenolol, Zyrtec, Nasacort AQ, Victoza, Centroid, Vitamin D, Estradiol, Mybetriq, Estradiol vaginal cream, Madroxy, Lamotrigine, Zolaf, Provigil, Baclofen, Norco, Meloxicam, B complex, Multivitamin w/o copper/iron, Vitamin C, Boswelia, Magn
Allergien: Eggs, Egg-based, Sulfa, Aspirin, Methadone, Oxycodone, Wellbutrin, Insect bites, MSG corn, almonds, walnuts, lilac, Tomatoes, potatoes, Tobacco, Seasonal allergies
Vorherige Impfungen: flu vaccine-highly allergic

VAERS 2298877

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 77,0
Geschlecht: M
Eingang: 27.05.2022
Impfdatum: 14.04.2022
Beginn: 21.05.2022
Tage bis Beginn: 37,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I came down with a sore throat and a cough May 21. It got worse, and on May 23, I tested just barely positive with a saliva home test kit. I retested May 24 with a saliva kit, and it was a strong positive. I confirmed with a nasal swab test kit. May 25 I felt much better. May 26, felt better. May 27 (today), still feel better, but I tested again and I'm still positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 5-23: saliva home test kit 5-24: saliva home test kit and nasal swab test kit. 5-27: nasal swab
Aktuelle Erkrankungen: none
Vorgeschichte: high blood pressure
Andere Medikamente: hctz 25 mg, lisinoprel 10 mg, amlodioine 5 mg
Allergien: mountain juniper
Vorherige Impfungen: -

VAERS 2294944

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NJ
Alter: 62,0
Geschlecht: F
Eingang: 25.05.2022
Impfdatum: 12.04.2022
Beginn: 22.05.2022
Tage bis Beginn: 40,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Nasal congestion SARS-CoV-2 test positive Throat irritation Vaccine breakthrough infection

Symptomtext

A little over a month after 4th dose vaccination, I started having increased nasal congestion, scratchy throat and fatigue. On 5-22-2022, I took a home test for Covid and it was positive. The following day, I called the doctors office and I went in to see them on 5-24 in which they did a rapid test that was positive as well as the PCR. They told me to manage my symptoms over the counter with Mucinex and Delsym and to boost my immune system with vit C, vit D and zinc. I am feeling about the same today. I am reporting a breakthrough case of Covid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 5-22-2022 home Covid test positive result. 5-24-2022 in office Covid test positive result as well as the PCR being positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Rheumatoid Arthritis; Benign Brain Tumor
Andere Medikamente: Centrum Silver MVI 1 daily
Allergien: PCN
Vorherige Impfungen: -

VAERS 2292819

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MA
Alter: 67,0
Geschlecht: M
Eingang: 24.05.2022
Impfdatum: 11.04.2022
Beginn: 22.05.2022
Tage bis Beginn: 41,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I contracted COVID-19 on 05/22/2022 with symptoms of cough, sore throat, fatigue, and congestion. I was prescribed Paxlovid 05/23/2022. I am feeling better than yesterday, but my symptoms have not begun to resolve yet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 home rapid nasal swab was positive 05/23/2022.
Aktuelle Erkrankungen: N/a
Vorgeschichte: Type II Diabetes; Hypertension; Elevated Cholesterol
Andere Medikamente: Atorvastatin Jardiance Rybelsus Triamterene Aspirin Vitamin B12 Vitamin D3
Allergien: N/a
Vorherige Impfungen: -

VAERS 2292600

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TN
Alter: 53,0
Geschlecht: F
Eingang: 24.05.2022
Impfdatum: 05.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 15,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Malaise Ultrasound liver

Symptomtext

See previous notes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Numerous blood tests in multiple locations. PCP twice, urgent care and immunologist. Ultrasound of liver.
Aktuelle Erkrankungen: Liver enzymes went off the charts AST/ALT 500/899. Major fatigue, fever - back, neck and severe jaw pain. RDW and other blood work out of wack. Every time I've had a vaccination I've become sick but this was the worst. 4th shot.
Vorgeschichte: Adrenal cortical hypofunction, antinuclear Factor positive, diverticulosis, hypercalcemia, hypertension, osteoporosis, stage 2 kidney disease, cirrhosis, relative polycythemia.
Andere Medikamente: None.
Allergien: Penicillin, gluten, cow milk, cheese, Lipitor, NSAIDS, shellfish, shrimp, wheat, oats, walnuts, pecans, apples, coconut, lamb, goat milk, onion, cantaloupe, rye, navy bean, chalk.
Vorherige Impfungen: Same symptoms, less liver enzymes. Feel extremely sick for at least 2 months after each shot. See vaccine schedule for all dat

VAERS 2287164

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 54,0
Geschlecht: F
Eingang: 20.05.2022
Impfdatum: 07.04.2022
Beginn: 16.05.2022
Tage bis Beginn: 39,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Oropharyngeal pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough COVID Case: Initially, fatigue and runny nose. Then, sore throat and feverish without fever. Very sore throat. I started Paxlovid on Tuesday.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 05/16/2022, At Home Rapid test positive. 05/17/2022 PCR Test at pharmacy positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Multiple Sclerosis
Andere Medikamente: Dimethyl fumarate 240mg 2x day; fish oil; vitamin D; multivitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2285425

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: KY
Alter: 79,0
Geschlecht: F
Eingang: 19.05.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Malaise

Symptomtext

Patient says she experienced chills for 4-5 days and took tylenol for relief and was also sick to her stomach

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: Atorvastatin
Vorherige Impfungen: -

VAERS 2284788

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: OH
Alter: 56,0
Geschlecht: F
Eingang: 19.05.2022
Impfdatum: 12.05.2022
Beginn: 18.05.2022
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Headache Pharyngeal swelling Rhinorrhoea SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough Case of COVID, throat is a little swollen, a headache, very tired, and running nose, the fever was low grade just about a 99.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Erythromycin
Vorherige Impfungen: -

VAERS 2280658

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MA
Alter: 60,0
Geschlecht: M
Eingang: 17.05.2022
Impfdatum: 15.04.2022
Beginn: 11.05.2022
Tage bis Beginn: 26,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Body temperature increased COVID-19 Chills Cough Fatigue Headache Nausea Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I had a low grade temp of 99.8, chills, cough, and sore throat. The next day I received a positive COVID-19 test. I was prescribed Paxlovid. My symptoms progressed to headache and nausea. Within 48 hours of Paxlovid my symptoms resolved except fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 test
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2280629

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NY
Alter: 72,0
Geschlecht: F
Eingang: 17.05.2022
Impfdatum: 08.04.2022
Beginn: 12.05.2022
Tage bis Beginn: 34,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Dysphonia Hordeolum Myalgia Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive Upper-airway cough syndrome

Symptomtext

I contracted Covid19 on 05/12/2022 with symptoms of post nasal drip, congestion, hoarse voice, sore throat, and myalgia. I received Monoclonal antibodies on 05/13/2022. I developed a sty in my eye due to allergies I believe. My symptoms are in the process of resolving as of today day 5 of illness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myalgia
Hospital-Tage: -
Labordaten: Covid19 rapid nasals swabs were positive 05/12/2022 at home and at the urgent care.
Aktuelle Erkrankungen: No
Vorgeschichte: Allergies; atrial fibrillation; ovarian cysts; benign growths in thyroid; cataracts
Andere Medikamente: Norvask 5 mg; vitamin C 500mg twice daily; vitamin D 2000mg daily; 50+ multivitamin; aspirin 325mg daily; two Fiber Well tablets daily
Allergien: No
Vorherige Impfungen: Pneumonia vaccine, swollen painful arm, in 2021.

VAERS 2278981

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: WA
Alter: 58,0
Geschlecht: F
Eingang: 16.05.2022
Impfdatum: 04.04.2022
Beginn: 05.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Blood electrolytes Blood test Dizziness Head impulse test Vaccine positive rechallenge Vertigo

Symptomtext

After each of my 4 COVID shots, I have experienced vertigo that eventually diminishes to dizzy spells. Each shot it seems to get more intense and last longer. I am already over a month after this shot and still experience dizzy spells. I I did consult with another Dr, and she suggested OTC Zyrtec (cetirizine HCI 10mg). I had mild success with it, so added Flonase ( fluticasone propionate 50mcg) and have improved a little after a few days of taking both, though today have been dizzy. I may still act on a referral to a vestibular audiologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: Physical exam, a head twist test, blood test to check electrolyte balance 05/09/2022. Dr. said I may have crystals in my left ear causing the vertigo/dizziness, per the head twist test -- hence possible referral to a vestibular audiologist. We decided to wait 2 weeks, to try 2 weeks of Zyrtec/Flonase, to see if resolves. If not, I will ask to see that specialist.
Aktuelle Erkrankungen: None
Vorgeschichte: Moderate cough-variant asthma
Andere Medikamente: Montelukast Sodium 10mg, Symbicort 160/4.5mcg, Albuterol Sulfate 108 mcg, Mucinex ( Max 1200 mg), Zantac (famotidine, 10mg), Flintstones immune support chewable multi-vitamin
Allergien: Spinach - causes skin rash; autumn ragweed allergy
Vorherige Impfungen: COVID, all 4 shots Moderna, lots 040a21a, 038b21a, 939904, 0652k21a - unreported till now

VAERS 2278445

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MN
Alter: 83,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 06.04.2022
Beginn: 03.05.2022
Tage bis Beginn: 27,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Nasal congestion Oropharyngeal pain Pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had a sore throat, runny nose and mild temp of 99 and very mild body aches, nasal congestion and sore throat was moderate. I wasn't very ill at any time. The Dr. had me take antiviral for 8 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Covid Test Positive Home.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: HTZ, Glucosamine
Allergien: Leroxidine
Vorherige Impfungen: -

VAERS 2271896

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CA
Alter: 66,0
Geschlecht: M
Eingang: 11.05.2022
Impfdatum: 07.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 23,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Malaise Nasal congestion No adverse event Pyrexia SARS-CoV-2 test positive Sneezing Throat irritation Vaccine breakthrough infection

Symptomtext

No adverse reaction to vaccine. Using system to report onset of Covid19 symptoms and positive antigen tests confirming that the patient had a Covid19 breakthrough case following travel. Symptoms were mild: throat irritation, cough, nasal congestion and sneezing, tiredness. Low fever, did not exceed 101 degrees F. O2 levels as measured by pulse oximeter were consistently 96-99%. Patient's doctor was notified of the positive test and the doctor's office called to consult with the patient on May 3. Status of symptoms did not warrant further medical attention. Last positive antigen test May 8. Tested negative on May 11.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Only tests were at-home antigen tests reported under Item 18. These were completed five times between April 30 and May 11. All positive except the test on May 11.
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: Levothyroxine
Allergien: -
Vorherige Impfungen: -

VAERS 2328546

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: -
Alter: 94,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 08.04.2022
Beginn: 10.04.2022
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cellulitis Erythema Injection site erythema Injection site oedema Injection site warmth Peripheral swelling Pruritus

Symptomtext

Narrative: Patient received his second COVID booster on 4/8/22 with Moderna (SPIKEVAX) mRNA vaccine. He previously received primary series on 1/8/21 and 2/5/21, as well as first booster on 11/24/21, all with Moderna vaccine. No reported adverse reactions following those doses. On 4/10/22, his left arm was noted with swelling, redness and reported itching. Acetaminophen 650mg was administered with some documented relief of itching. Injection site still noted with redness and warmth. Cold compress was applied. Diphenhydramine 25mg was administered later that night (00:49). FNP evaluated site on morning of 4/11/22 and observed erythema, edema and warmth extending from shoulder to mid-upper arm. He wad diagnosed with cellulitis and started on renally-dosed sulfamethoxazole/trimethoprim. Close monitoring continues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2328542

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: -
Alter: 48,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 07.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Headache Myalgia Pain

Symptomtext

Headache, Myalgia, weakness (general) Narrative: Per nursing report: " c/o of body aches, weakness and headaches"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2328498

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: -
Alter: 92,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 07.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Ageusia Pain Pruritus Rash

Symptomtext

Narrative: 91 yr pt received second Moderna booster on 4/7/22 (1st booster was 10.29.2021); called telephone triage 4 days later to report widespread body itching, body aches, and loss of taste. Evidence of rash/bumps. Patient started applying lubriderm which helped and able to sleep at night. Telephone triage provided additional care instructions including continuation of lubriderm and may consider taking an anti-histamine such as benadryl if needed and see provider within 3 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2268918

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: PA
Alter: 70,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 09.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 5,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache SARS-CoV-2 test positive Throat irritation Vaccine breakthrough infection

Symptomtext

Breakthrough case of COVID-19. It started with a scratchy throat and headache. I tested positive on 04/14/2022. I was prescribed Paxlovid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: Rapid Test COVID-19 on 04/14/2022 - Positive
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Amlodipine 5mg Levothyroxine 0.05mg Hydrochlorothiazide 25mg Valsartan 160mg Calcium Vitamin D 2000iu Multivitamin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2268748

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IL
Alter: 67,0
Geschlecht: F
Eingang: 10.05.2022
Impfdatum: 28.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Injection site nodule Injection site pruritus Pruritus

Symptomtext

Patient developed a knot at the site of injection that turned into itching around injections site and spread to her back. it lasted for about a week, then self resolved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site nodule
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Rotator cuff tear of right shoulder
Vorgeschichte: Carpal tunnel on right wrist, prediabetes, anxiety disorder, right shoulder cuff tear, GERD, hypertension, hyperlipidemia, squamous cell carcinoma of right cheek, functional diarrhea
Andere Medikamente: aspirin, atorvastatin, cholestyramine, docusate, escitalopram, gabapentin, HCTZ, lisinopril, magnesium, methocarbamol, metoprolol succinate, omeprazole, oxycodone/apap, KCl, topiramate
Allergien: Adhesive tape (hiaves), Bactrim (nausea)
Vorherige Impfungen: -

VAERS 2273228

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 05.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Fatigue Headache Injection site pain Pain

Symptomtext

Narrative: 76yr patient reported body aches, pain at injection site, fatigue, and minor headache after receiving 2nd booster of Moderna. Denied swelling and redness at injection site. Did not report prior ADR/ADE's with previous booster or series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2270695

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: -
Alter: 57,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: 08.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Headache Impaired work ability Lymphadenopathy Myalgia Pain in extremity

Symptomtext

Headache, Myalgia, swollen lymph node, sore arm at site of administration Narrative: Employee had to leave work early due to the headache. All symptoms were resolved within 36 hours

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: yes, same side effects after each dose of the moderna covid 19 vaccine

VAERS 2267144

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: CT
Alter: 69,0
Geschlecht: F
Eingang: 08.05.2022
Impfdatum: 27.04.2022
Beginn: 27.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Muscle spasms Vomiting

Symptomtext

At 3:30 pm following vaccine she began vomiting and developed muscle spasms in legs and toes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vomiting
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Tylenol
Allergien: -
Vorherige Impfungen: -

VAERS 2266069

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TN
Alter: 81,0
Geschlecht: F
Eingang: 06.05.2022
Impfdatum: 14.04.2022
Beginn: 15.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dysstasia Fall Pyrexia

Symptomtext

This nurse received a call from pt on 05/06/22 at approx 1330 to report previous adv rxn to vaccine. (Vaccine was administered 04/14/22) Pt reports: the morning following vaccination, pt unable to maintain standing position and fell to the floor. She was able to contact emergency services and was transported to the hospital. Pt reports a fever of 102F at the hospital. No other adv rxn reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: unknown
Allergien: -
Vorherige Impfungen: -

VAERS 2264575

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NY
Alter: 58,0
Geschlecht: F
Eingang: 05.05.2022
Impfdatum: 06.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia COVID-19 Fatigue Malaise Oropharyngeal pain Pain Rhinorrhoea SARS-CoV-2 test negative SARS-CoV-2 test positive

Symptomtext

I came down with symptoms the day after my booster vaccine. I then got tested for a positive COVID-19 Test. Saturday evening, I still was not feeling well, and so on Sunday I received a PCR test and it came back positive. Sniffles, sore throat, body aches and joint aches, no fever, no chills. I got antivirals and started them Monday, and within 24 hours I barely had sniffles and didn't have a sore throat anymore. I was very tired though and fatigued. I am now feeling well and back to normal and no recurring symptoms. I did have a telehealth visit on Sunday and then on Monday with my own doctor. When I went to pick up the antivirals prescription, the pharmacist requested I had proof of my positive test.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Multiple Rapid Tests: 2 came negative and 1 came positive PCR Test: Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Prediabetes completely under control
Andere Medikamente: K2 D3 Supplement
Allergien: N/A
Vorherige Impfungen: -

VAERS 2261765

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: KY
Alter: 72,0
Geschlecht: M
Eingang: 03.05.2022
Impfdatum: 28.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Aphasia Lymphadenopathy Rash Rash erythematous

Symptomtext

Patient's family member states that 3 days after receiving vaccine, patient reports not "being able to form words". Also complained of a swollen lymph node under arm pit of arm where vaccine was given. She also states patient had a fine red rash all over his body. All symptoms have resolved as of today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2260187

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: CA
Alter: 96,0
Geschlecht: F
Eingang: 02.05.2022
Impfdatum: 01.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 30,0
Dosis: 4
Route/Site: UN / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Feeling hot Pain Swelling

Symptomtext

Redness, swelling, warm to touch and pain, Zyrtec 10mg given, Prednisone 30mg PO GIVEN

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Lisinopril, Coreg,
Allergien: clindamycin, PCN, Tramadol, Cephalexin, Fish Allergy
Vorherige Impfungen: -

VAERS 2259833

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IL
Alter: 61,0
Geschlecht: F
Eingang: 30.04.2022
Impfdatum: 06.04.2022
Beginn: 25.04.2022
Tage bis Beginn: 19,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Headache Malaise Nasal congestion Pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive Sinus congestion Throat irritation Vaccine breakthrough infection Vomiting

Symptomtext

I developed a case of COVID which I do NOT attribute to the vaccine - it was a breakthrough case. Since Monday evening April 25 I have had symptoms, starting with throat irritation and sinus congestion. I had a positive rapid test at home on April 26 and went for a PCR that day. April 27 I had fever (100.4 F.), aches, nasal congestion, bad headache, vomiting for about an hour, and severe runny nose for several more days. Coughing developed on April 29 and has gotten slightly better today. The fever has reduced (without medication) to 99.4 through today. I had NO breathing problems and have been recovering at home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: April 26 - PCR test positive for COVID
Aktuelle Erkrankungen: -
Vorgeschichte: vasomotor rhinitis, osteoarthritis
Andere Medikamente: generic Astelin nasal spray, generic Zyrtec 0.5 mg, Shaklee Vita-Lee, Shaklee Osteomatrix, Nordic Naturals omega-3, generic vitamin C 500 mg
Allergien: weed pollen
Vorherige Impfungen: -

VAERS 2258961

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CA
Alter: 73,0
Geschlecht: F
Eingang: 29.04.2022
Impfdatum: 13.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Lip blister Stomatitis

Symptomtext

The next day after receiving the vaccine I started to get chills. I developed mouth sores all over my tongue, and soft palate. I also had blisters that were all over my lips. I went to see my Doctor on 4/16/22 they prescribed me acyclovir and oral topical lidocaine to help treat the blisters and sores. The sores lasted for about a week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic Kidney disease
Andere Medikamente: Atenolol Lovastatin Levothyroxine Vitamin D3, Calcium Low dose aspirin
Allergien: None
Vorherige Impfungen: -

VAERS 2258164

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: NY
Alter: 73,0
Geschlecht: F
Eingang: 29.04.2022
Impfdatum: 06.04.2022
Beginn: 06.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Injection site pain Neck pain Pain Pain in extremity

Symptomtext

Site: Pain at Injection Site-Medium, Additional Details: sore arms that radiates to neck, shoulder, and down the arm. Slight pain when raising arm, may follow up with her orthopedic. Today 4/25/22 she states its slightly better but will see if she follows up with md and will continue monitoring pain and limitations

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2258044

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WI
Alter: 66,0
Geschlecht: M
Eingang: 29.04.2022
Impfdatum: 28.03.2022
Beginn: 25.04.2022
Tage bis Beginn: 28,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abnormal dreams Chills Headache Heart rate Insomnia

Symptomtext

headache; had a weird dream where the alarm went off which woke up the patient at 3:30 AM and the patient was not able to get back to sleep; had a weird dream where the alarm went off which woke up the patient at 3:30 AM and the patient was not able to get back to sleep; started to get a little chilled; This spontaneous case was reported by a consumer and describes the occurrence of ABNORMAL DREAMS (had a weird dream where the alarm went off which woke up the patient at 3:30 AM and the patient was not able to get back to sleep), INSOMNIA (had a weird dream where the alarm went off which woke up the patient at 3:30 AM and the patient was not able to get back to sleep), CHILLS (started to get a little chilled) and HEADACHE (headache) in a 66-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 057M21A and 065K21A) for COVID-19 vaccination. Concurrent medical conditions included Bladder disorder (not able to sleep through the night because of the bladder) and Sleep decreased (Not able to sleep throughout the night). Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication. On 28-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Apr-2022, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. On 25-Apr-2022, after starting mRNA-1273 (Spikevax), the patient experienced CHILLS (started to get a little chilled). On 26-Apr-2022, the patient experienced ABNORMAL DREAMS (had a weird dream where the alarm went off which woke up the patient at 3:30 AM and the patient was not able to get back to sleep) and INSOMNIA (had a weird dream where the alarm went off which woke up the patient at 3:30 AM and the patient was not able to get back to sleep). On 26-Apr-2022 at 8:00 AM, the patient experienced HEADACHE (headache). At the time of the report, ABNORMAL DREAMS (had a weird dream where the alarm went off which woke up the patient at 3:30 AM and the patient was not able to get back to sleep), INSOMNIA (had a weird dream where the alarm went off which woke up the patient at 3:30 AM and the patient was not able to get back to sleep), CHILLS (started to get a little chilled) and HEADACHE (headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Apr-2022, Heart rate: around 105 (excess of 100) (High) has been around 105, maintained in excess of 100 all day. It was reported that the patient was experiencing some side effects after receiving the vaccine. Last night after receiving the shot, the patient started to get a little chilled, although the patient kept the house at a temperature of 70 degrees. It was not uncommon for the patient to not sleep throughout the night because of the patient's bladder, however the patient was usually able to fall back asleep. On 26-Apr-2022 at 08:00 A.M, the patient had a headache for the majority of the day and it lasted longer than most of the patient's usual headaches. The patient took a low dose aspirin as regular medications. It was also mentioned that the patient had not taken any additional medications for the symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Test Date: 20220426; Test Name: Heart rate; Result Unstructured Data: has been around 105, maintained in excess of 100 all day
Aktuelle Erkrankungen: Bladder disorder (not able to sleep through the night because of the bladder); Sleep decreased (Not able to sleep throughout the night)
Vorgeschichte: -
Andere Medikamente: ASPIRIN [ACETYLSALICYLIC ACID]
Allergien: -
Vorherige Impfungen: -

VAERS 2252289

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: CA
Alter: 52,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 26.04.2022
Beginn: 26.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Skin warm Urticaria

Symptomtext

Pt reported having "warm skin" and developed hives on upper and lower extremities. Pt denied other symptoms but was taken to a higher level of care within the facility for observation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 2245988

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: OR
Alter: 71,0
Geschlecht: F
Eingang: 21.04.2022
Impfdatum: 05.04.2022
Beginn: 05.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Balance disorder Blood lactic acid Decreased appetite Differential white blood cell count Extra dose administered Fatigue Feeling abnormal Full blood count Pyrexia Sleep disorder Vomiting

Symptomtext

In the middle of night I woke up with 103 fever and vomiting, called ambulance, very wobbly and spaced out. Ambulance transported me to hospital, Tylenol, Zofran, had me drink a lot of water. Fever went down and I rested there at ER, hospital called my husband around 6 to pick me up. When I got home I stayed very tired and in bed for a few days didn't eat much those days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: CBC w/differentials, lactic acid.
Aktuelle Erkrankungen: None
Vorgeschichte: Lung disease
Andere Medikamente: Sirolimus; Citalopram; Albuterol; Trilogy; Rosuvastatin; Lisinopril; Zyrtec; Vitamin D; Baby Aspirin; Multivitamin; Resveratrol
Allergien: Bactrim
Vorherige Impfungen: Dose 3 Pfizer Covid vaccine.

VAERS 2241194

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 69,0
Geschlecht: M
Eingang: 19.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Fatigue Feeling abnormal Feeling cold Feeling hot Headache Pyrexia

Symptomtext

Two hours after receiving 2nd Moderna booster had severe chills. "I shook so hard my teeth were chattering and even wrapped in a down comforter could not get warm." Two hours after this had severe headache and got hot. Had low grade fever (99.4 F). Headache lasted until late at night despite taking Tylenol. Next day complains of "foggy head" and fatigue. 3rd day felt better but still had fatigue. No significant side effects with first 3 Moderna injections.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: none
Vorgeschichte: hypertension, psoriasis, hyperlipidemia, obesity
Andere Medikamente: Humira, atorvastatin, telmisartan 40 mg,
Allergien: oxycodone, codeine, ambien
Vorherige Impfungen: -

VAERS 2241122

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 67,0
Geschlecht: M
Eingang: 19.04.2022
Impfdatum: 15.04.2022
Beginn: 16.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Heart rate increased Nausea

Symptomtext

Systemic: PATIENT STATES HEART RATE 117. TOOK AGAIN AND 124. PT ALSO FEELS "WOOZY"-Mild, Systemic: Nausea-Mild, Additional Details: PT REPORTED HR @117 &FELT "WOOZY." CALLED FROM STORE WHILE SHOPPING.CALLED PTLATER TO CHECK ON HIM.STATED RESTING/SLIGHTLY NAUSEOUS(NO VOMITING).HR 124.ENCOURAGED TO GO TO NEAREST URGENT CARE IF AT ALL WORRIED.TOLD HIM THAT HR IS NORMALLY @70-100 WHILE RESTING. PT TO CONT W/FLUIDS &MONITOR BP. MAY TAKE APAP IF OK MEDICALLY.INFORMED PT ABOUT VAERS.ASKED HIM IF HE WAS GETTING BETTER, AND HE STATED YES JUST SLOWLY. GOING TO "TAKE IT EASY TODAY." TOLD PATIENT TO CALL US ANYTIME WITH ADDITIONAL QUES

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2238173

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WA
Alter: 72,0
Geschlecht: F
Eingang: 17.04.2022
Impfdatum: 13.04.2022
Beginn: 16.04.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Immunisation reaction Injection site pruritus Injection site rash

Symptomtext

"Covid Arm" - itchy rash at injection site about 2 inches in diameter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Prediabetes, arthritis, asthma
Andere Medikamente: Atorvastatin, fish oil, calcium citrate, D3, B12, berberine
Allergien: Aspirin, tartrazine, ibuprofen, sulfa antibiotics
Vorherige Impfungen: -

VAERS 2234186

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: -
Alter: 59,0
Geschlecht: M
Eingang: 14.04.2022
Impfdatum: 08.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Fatigue Pyrexia

Symptomtext

Severe fatigue, fever to 101, chills. Lasted about 36 hours. Felt great after 2nd night with no lingering symptoms

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: athsma
Andere Medikamente: Allegra D, flonase
Allergien: pollens, molds. No known drug allergies
Vorherige Impfungen: -

VAERS 2233693

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: VA
Alter: 55,0
Geschlecht: F
Eingang: 14.04.2022
Impfdatum: 30.03.2022
Beginn: 02.04.2022
Tage bis Beginn: 3,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash Rash pruritic

Symptomtext

Patient was seen in office 4/13/22 for complaints of itchy rash that was present on patient's upper and lower extremities, back, neck, feet, and hands. Patient reported receiving the COVID Moderna Booster vaccine 3 weeks prior and rash had developed 3 days after receiving the vaccine. The rash had continued to spread since beginning. Per Immunization System the patient received the Moderna COVID booster on 3/30/22 at pharmacy. Patient was started on Vistaril and Prednisone for treatment of rash.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: N/A Patient was started on Vistaril and Prednisone for treatment of rash on visit date 4/13/22.
Aktuelle Erkrankungen: J42 Chronic bronchitis J30.89 Perennial allergic rhinitis J45.20 Mild intermittent asthma, unspecified whether complicated
Vorgeschichte: J42 Chronic bronchitis J30.89 Perennial allergic rhinitis J45.20 Mild intermittent asthma, unspecified whether complicated
Andere Medikamente: Multiple Vitamins tablet Nasacort Allergy 24HR 55 mcg/inh spray albuterol 2.5 mg/3 mL (0.083%) solution Proventil HFA 90 mcg/inh aerosol Symbicort 160 mcg-4.5 mcg/inh aerosol ProAir HFA 90 mcg/inh aerosol
Allergien: None
Vorherige Impfungen: -

VAERS 2233636

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: MO
Alter: 64,0
Geschlecht: F
Eingang: 14.04.2022
Impfdatum: 11.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Chills Headache Pain in extremity Vomiting

Symptomtext

Dry vomit, severe chills, extreme lost of energy, head ache, arm sore

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: -
Vorgeschichte: Copd
Andere Medikamente: -
Allergien: Codine
Vorherige Impfungen: Same as described

VAERS 2231489

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: ME
Alter: 60,0
Geschlecht: F
Eingang: 13.04.2022
Impfdatum: 07.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 6,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash Rash erythematous Skin warm

Symptomtext

Patient received 2nd dose of moderna on 4/7/22. Said today (~week later) she started developing a bright red rash around most parts of her body - arm,legs, trunk, face. This rash was warm to the touch. Patient just started benadryl to see if that will help. Is going to monitor and possibly call doctor if continues or gets worse.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: N/a
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: hydrochlorothiazide, dicyclomine
Allergien: tetracyclines, penicillin
Vorherige Impfungen: -

VAERS 2231216

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 69,0
Geschlecht: F
Eingang: 13.04.2022
Impfdatum: 01.04.2022
Beginn: 02.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Joint swelling Pain in extremity Swelling Tenderness

Symptomtext

pt states after getting the booster her arm was sore and she had a really bad headache. The next day her left arm pit was swollen. She states she has a third nipple and it was swollen around that are under the arm pit. She also had a swollen left wrist. She iced it and wrapped it. The headache and swelling of the wrist subsided after a couple of days but she still has some tenderness and slight swelling under the left arm pit. She had an already scheduled appt w/ Oncologist so she had them check her armpit. She was told it was probably from her booster shot but to come back if the swelling does not go down and they would run test. She has a FU visit in a couple of months with her Oncologist so she will have it checked then if it still swollen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: thyroid disease, AFIB, Cancer Survivor (twice) GERD, HBP, Glaucoma, macular degeneration,
Andere Medikamente: metoprolol, levothyroxine, Rosuvastatin, pantoprazole, Benadryl, presa vision (ARIDS) Refresh plus eye drops, Vitamin D3,
Allergien: macrodantin, coumadin, multaq, glaucoma eye drops,
Vorherige Impfungen: -

VAERS 2231177

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: VA
Alter: 59,0
Geschlecht: F
Eingang: 13.04.2022
Impfdatum: 08.04.2022
Beginn: 09.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Dizziness Fatigue Headache Influenza like illness Lethargy Malaise Nausea Pain Pain in extremity Peripheral swelling Pyrexia Skin warm Sleep disorder

Symptomtext

At about 2am the morning after vaccine, I woke up and was having chills. Arm was extremely sore, hot, and swollen. I had a headache, nauseous, and just not feeling well at all. The next morning when I got up for the day I was dizzy and was running slightly over 100 fever. Head was killing me and aching all over. Tired and lethargic went back to bed for the rest of the day. Maintained 100 fever through out the day. Arm pain continued to hurt and get worse. The following day my fever stay around 99. Still achy, fatigued, and had flu like symptoms. Symptoms are improving but still experiencing fatigue on 04/13/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: Diabetes 2; Seizures; Stroke in 2009; Migraines
Andere Medikamente: Atorvastatin Baclofen Bupropion Clopidogrel Donepezil Fluoxetine Furosemide Glimepiride Novolog Hydroxyzine Jardiance Losartan Metformin Montelukast Oxcarbazepine Topiramate Zolpidemtartate Ca B12 B3 Biotin Multi-vitamin
Allergien: Bandage adhesive
Vorherige Impfungen: Always experience mild reaction to Flu vaccine.

VAERS 2228767

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IL
Alter: 81,0
Geschlecht: F
Eingang: 12.04.2022
Impfdatum: 11.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Feeling hot Gait disturbance Heart rate increased Hyperhidrosis

Symptomtext

Case received second Moderna booster at 0815 on morning of 04-11-22; She states she had a very busy day afterwards and that she was "pushing herself" around the time she was in her basement cleaning when she suddenly felt very dizzy and felt like she was going to pass out.She also felt hot and she had sweat on her forehead.She is unable to state exactly how long this lasted. She did not pass out and the faint feeling began to ease as she lowered herself to the floor.She got herself up the stairs by taking one step at a time in a sitting position.She checked her pulse which was 102 (slightly elevated for her).As she was continuing to feel better she decided she did not need medical help. Case upset about this as she is very active in her daily life and has never had any side effects to any vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: osteoarthritis
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2228335

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 41,0
Geschlecht: M
Eingang: 12.04.2022
Impfdatum: 06.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain

Symptomtext

Site: Pain at Injection Site-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Additional Details: Patient stated that they had pain with the arm where they got the vaccine. He said it was a 9 out of 10 initially but had reduced in intensity since then. He does not have a regular Dr that he sees. He had not taken any pain reliever since getting the vaccine. He was advised to start that to see if it helps.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2226045

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: WI
Alter: 91,0
Geschlecht: M
Eingang: 11.04.2022
Impfdatum: 07.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Pruritus

Symptomtext

Within 24 hours of vaccination patient developed widespread itching (no rash) and lost sense of taste.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Atrial Fibrillation BPH Skin Cancer Peripheral Neuropathy Vitamin B12 Deficiency Elevated BP
Andere Medikamente: Diltiazem 360mg daily Rivaroxaban 20mg daily Tamsulosin 80mg daily
Allergien: None
Vorherige Impfungen: -

VAERS 2225892

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: FL
Alter: 56,0
Geschlecht: F
Eingang: 11.04.2022
Impfdatum: 08.04.2022
Beginn: 10.04.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash Swelling

Symptomtext

Swelling and rash in clavicle area, close to neck.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None.
Vorgeschichte: Hypertension; Hypothyroidism.
Andere Medikamente: Diovan; Synthroid; Wellbutrin; Allegra;- Vitamin C; Zinc.
Allergien: Keflex; Latex.
Vorherige Impfungen: -

VAERS 2225483

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NY
Alter: 75,0
Geschlecht: F
Eingang: 10.04.2022
Impfdatum: 31.03.2022
Beginn: 01.04.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Fatigue Gait disturbance Hypoaesthesia Lymphadenopathy Malaise

Symptomtext

Patient stated that upon waking up the next day should felt ill, she experienced dizziness, and her left leg should could not feel at all. She made her way to the bathroom and after 25 minutes she could feel her leg again. She was tired for 3-6 days. Dizziness resolved first day. Then on 4/9 (9th day) she stated that the dizziness was back and she was having trouble walking. She also complained that she had lymph nodes behind her ears that were swollen. She mentioned no treatment or medication taken. She was advised to make an appointment with her provider for evaluation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2225465

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: MA
Alter: 70,0
Geschlecht: M
Eingang: 10.04.2022
Impfdatum: 04.04.2022
Beginn: 05.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cellulitis Infection Injection site erythema Injection site pain Injection site swelling

Symptomtext

Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Error: Infection / Cellulitis (diagnosed by MD)-, Additional Details: Patient went to urgent care after noticing extensive redness and swelling at injection site. MD at urgent care told patient that it was not a reaction to the vaccine but cellulitis caused by something unsanitary at the pharmacy where he was vaccinated. Patient then returned to pharmacy today 4/7/22 to issue a complaint.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2222949

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: KY
Alter: 57,0
Geschlecht: F
Eingang: 08.04.2022
Impfdatum: 04.04.2022
Beginn: 04.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Injection site rash Rash

Symptomtext

Pt presented four days after vaccination stated rash had started on feet and spread all over body, upon visit 4 days later rash had resolved to all areas except injection site R deltoid, Order noted Decadron 6mg IM was administered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: Diabetes
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: PT states only been with Moderna and had never reported it to any one prior to this event

VAERS 2222754

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: NY
Alter: 70,0
Geschlecht: M
Eingang: 08.04.2022
Impfdatum: 30.03.2020
Beginn: 30.03.2022
Tage bis Beginn: 730,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Flushing Hyperhidrosis Injection site bruising Pyrexia

Symptomtext

Site: Bruising at Injection Site-Mild, Systemic: Chills-Mild, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Mild

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2220427

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NJ
Alter: 58,0
Geschlecht: M
Eingang: 07.04.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Flushing Influenza like illness Rash

Symptomtext

Rash on left forearm and feeling of flushed accompanied by minor flu like symptoms

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: No
Vorgeschichte: Obese, high blood pressure, panic attacks, seizure syndrome, herniated discs, arthritis
Andere Medikamente: Coreg, altace, Lipitor, allopurinol, Xanax, vicodin, aspirin, areds2,
Allergien: N/A
Vorherige Impfungen: -

VAERS 2220287

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

mild

Staat: CO
Alter: 50,0
Geschlecht: F
Eingang: 07.04.2022
Impfdatum: 03.04.2022
Beginn: 05.04.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Axillary pain Injection site pain Injection site pruritus Injection site swelling Injection site warmth Lymph node pain Pyrexia Sleep disorder

Symptomtext

Covid Arm - starting on Tuesday (April 5) injection site became itchy, warm to the touch. By Wednesday (April 6) evening visible swollen area, approx 3 inch diameter. Now, morning of Thursday (April 7) area remains raised, itchy, tender and warm. Other symptoms - feverish and unable to sleep on Monday night. Left armpit lymph nodes became painful Monday night at about 7 pm, sudden onset. Over the past three days armpit ache has varied - it comes and goes. Only treatment was 2 Advil taken on Tuesday when armpit was painful.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Axillary pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None.
Vorgeschichte: High blood pressure.
Andere Medikamente: Lexapro; Amlodipine.
Allergien: Shrimp; Losartan.
Vorherige Impfungen: -

VAERS 2218714

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CO
Alter: 57,0
Geschlecht: F
Eingang: 06.04.2022
Impfdatum: 31.03.2022
Beginn: 31.03.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Joint stiffness Lymphadenopathy Oropharyngeal pain

Symptomtext

swollen glands, fatigue, headache, stiff joints, sore throat since vaccination on 3-31-22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2218643

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IN
Alter: 65,0
Geschlecht: F
Eingang: 06.04.2022
Impfdatum: 02.04.2022
Beginn: 02.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Disturbance in attention Fatigue Headache Heart rate increased Injection site pain Myalgia Nausea Pyrexia

Symptomtext

I received the 4th booster vaccine on 4/2/2022 at approx. 11:00 a.m. by 2:00 p.m. I experienced severe pain at the injection site, I began to feel a rapid heartbeat which dissipated after approx. one hour, I then became extremely fatigued and had a headache which was moderate. On April 2nd. I developed a fever of approx. 100 and treated that with 325 mg. of acetaminophen, I felt extremely fatigued and had muscle aches and nausea. On April 3rd. my fever went away, but the nausea continued, and I had trouble concentrating. I went to the Dr. office and advised them of the situation and was told to report the adverse effects to the CDC and to call them back if I was still experiencing side effects on Fri. April 8th. On Tues. April 5th I felt completely better, now today which is April 6th I am again experiencing extreme nausea, fatigue, and trouble focusing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: No tests were taken.
Aktuelle Erkrankungen: Mild COPD, chronic neck pain, and idiopathic urticaria
Vorgeschichte: Mild COPD, Chronic idiopathic urticaria, chronic cervical issues.
Andere Medikamente: Tramadol 50 mg. tablets 3 times per day, Valium 5 mg. tablets 3 times per day, multivitamin once per day, Vitamin D3 1000 IU Once per day, Cetirizine 10 mg. once per day, Melatonin 50 mg. once per evening.
Allergien: I have idiopathic urticaria and allergist is unable to determine the cause.
Vorherige Impfungen: I experienced similar side effects after my second dose of the Moderna Vaccine, I did not however have nausea nor did the side e

VAERS 2218097

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 06.04.2022
Impfdatum: 04.04.2022
Beginn: 05.04.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Interchange of vaccine products Lymph node pain Lymphadenopathy

Symptomtext

Received vaccination on April 4, 2022. When woke up on April 5, 2022, Lymph nodes in her armpit under the same arm that she received her Moderna booster in were all swollen and sore. First vaccination was March 2021 and it was Janssen. She is taking Ibuprofen and using warm compresses to ease the pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lymph node pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2213372

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

mild

Staat: NJ
Alter: 71,0
Geschlecht: F
Eingang: 03.04.2022
Impfdatum: 02.04.2022
Beginn: 02.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Cough Extra dose administered Fatigue Pain Pyrexia

Symptomtext

Aches, fever, chills, cough, tiredness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: IBS, insulin dependent diabetes, moderate hearing loss
Andere Medikamente: Novolog insulin, irbesartan,atorvastatin, magnesium, centrum vitamin, c500, b6, ibguard,lactaid, probiotic
Allergien: Sulf, penicillin, cortisone
Vorherige Impfungen: -

VAERS 2213182

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 81,0
Geschlecht: F
Eingang: 02.04.2022
Impfdatum: 31.03.2022
Beginn: 01.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest discomfort Chills Sleep disorder

Symptomtext

Awakened from sleep with fullness in chest, something like acid reflux at about 3:00am, 4-1-22. Fell back to sleep within 15 min. Symptoms gone upon awakening. Same symptoms occurred about 10:00 am, 4-1-22 along with chills. Fell asleep within 10-15 min. Slept for 45 min. Awakened without symptoms. Continued to feel better remainder of day. No further symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None. Did not report symptoms or consult anyone. No symptoms other than sore arm for 3 previous injections.
Aktuelle Erkrankungen: None
Vorgeschichte: Pulmonary Hypertension, congenital heart disease, polymyalgia rheumatica, degenerative disc disease, kidney disease.
Andere Medikamente: Adempas 2.5mg taken at 01:55 pm. 35 min before vaccination.
Allergien: Morphine, Bactrim, Fentanyl.
Vorherige Impfungen: -

VAERS 2209356

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: IL
Alter: 19,0
Geschlecht: F
Eingang: 31.03.2022
Impfdatum: 31.03.2022
Beginn: 31.03.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Nausea Visual impairment Vomiting

Symptomtext

Patient experienced dizziness, lightheadedness, and vision that was in and out within 5 minutes of administration of Moderna Covid-19 shot. Patient was advised to lay down with feet propped up to prevent fall due to lightheadedness. At about 10 minutes after administration patient felt nauseous and was vomiting. Patient was given a cold compress and water.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None reported
Vorgeschichte: None reported
Andere Medikamente: N/A
Allergien: None reported
Vorherige Impfungen: -

VAERS 2201672

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: TX
Alter: 50,0
Geschlecht: F
Eingang: 28.03.2022
Impfdatum: 25.03.2022
Beginn: 26.03.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Anosmia Balance disorder Blood pressure increased Chills Fatigue Gait disturbance Headache Hyperhidrosis Mental impairment Mood altered Movement disorder Muscle spasms Photophobia Pyrexia Sluggishness Walking aid user

Symptomtext

Adverse side effects I'm having after being administered the 4th Moderna Booster Shot for Covid Protection, it was issued to me at the same place (Pharmacy by a Female Intern ) on Friday March 25, 2022 sometime late morning to afternoon. I took the 3rd one, except this 4th one came with some unexpected side effects: 2nd day woke up with a bad pounding headache that I could barely open my eyes; my blood pressure machine couldn't take a reading because it wouldn't go that high and stopped at 235/180; HR: 135; P: 120 later in the evening retook my blood pressure and it read: 173/108 Pulse: 84 I took my Valsartan right away I was feeling very drained, sluggish, unable to think, altered my mood as well; I was very sensitive to light, couldn't smell, or taste anything. Other side effects the same day included fever, chills, sweats, lots of muscle spasms, my gait was floppy spaghetti-like, therefore; I used a walker for part of the day and afternoon. The 3rd day which is today the 28th of March I woke up with my head bopping and my head wouldn't stop shaking, I don't have fever anymore but I still have sweats and chills, my walking is stable at times. I didn't know if I needed to have a cat scan due to the bopping head effect, or what could be done? Sincerely, The Patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Not yet taken
Aktuelle Erkrankungen: None
Vorgeschichte: Type 2 Diabetes, Hypertension/CHF, Hyperlipidemia, Back Surgery (7/09/21=Hemilaminectomy)
Andere Medikamente: I'm Type 2 Diabetic and take Insulin only on PRN basis since I was hospitalized with Covid back in 2020 I have not had normal blood sugars. I've been diagnosed with having Hypertension, Hyperlipidemia; and CHF. Rx's: Lantus 15 units am
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2192829

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: AL
Alter: 37,0
Geschlecht: F
Eingang: 22.03.2022
Impfdatum: 19.03.2022
Beginn: 19.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Rash

Symptomtext

Patient states she broke out in a rash all over her body and face.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: Blood Pressure
Andere Medikamente: Amlodipine, Metoprolol on hold never filled
Allergien: none reported
Vorherige Impfungen: -

VAERS 2189990

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: CA
Alter: 47,0
Geschlecht: F
Eingang: 21.03.2022
Impfdatum: 18.03.2022
Beginn: 18.03.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Lymphadenopathy Myalgia Pyrexia

Symptomtext

Patient reported on 3/21/22 that she has been experiencing muscle ache, headache, fever, and swollen lymph node under the left arm since her 2nd Moderna vaccination on 3/18/22. She denies any shortness of breath, swelling of the lips or tongue, or difficulty breathing. Pharmacist informed patient that these symptoms are normal but to address concern with her doctor if condition worsens.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2189144

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

mild

Staat: NM
Alter: 62,0
Geschlecht: F
Eingang: 19.03.2022
Impfdatum: 16.03.2022
Beginn: 17.03.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site inflammation Injection site swelling

Symptomtext

Patient reports swollen ,, inflammed left shoulder just below injection site of left deltoid. Patient advised to use OTC ibuprofen

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site inflammation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Rheumatoid Arthritis
Andere Medikamente: none known
Allergien: none
Vorherige Impfungen: -

VAERS 2721381

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: AR
Alter: 80,0
Geschlecht: M
Eingang: 06.12.2023
Impfdatum: 04.04.2022
Beginn: 01.12.2023
Tage bis Beginn: 606,0
Dosis: 4
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

hospitalized with covid; fully vaccinated with 2 boosters

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: positive covid pcr 12/1/23
Aktuelle Erkrankungen: unknown
Vorgeschichte: COPD, Diabetes and Hypertension
Andere Medikamente: unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2639674

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 79,0
Geschlecht: F
Eingang: 01.06.2023
Impfdatum: 28.04.2022
Beginn: 20.09.2022
Tage bis Beginn: 145,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Appendicectomy Appendix disorder Computerised tomogram abdomen abnormal Discomfort Magnetic resonance imaging abdominal abnormal

Symptomtext

I was on vacation, I started feeling uncomfortable on my side like I was getting an UTI. I decided to pop into an urgent care to get medication to stop it before it got too bad. Upon examination, the doctor said that I needed to go to the emergency room to get my appendix area looked at with a CT scan and MRI. The hospital did an MRI and CT scan that revealed I needed to have my appendix removed. I stayed overnight in the hospital; they removed my appendix that morning and I was able to leave later that day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Appendicectomy
Hospital-Tage: 1,0
Labordaten: 00OCT2022 CT scan, positive for enlarged appendix; 00OCT2022 MRI, positive for enlarged appendix
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Lisinopril; calcium; vitamin D; magnesium; probiotic 10; multivitamin; stool softener; ibuprofen; TYLENOL; CLARITIN
Allergien: No
Vorherige Impfungen: -

VAERS 2635502

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MI
Alter: 87,0
Geschlecht: M
Eingang: 23.05.2023
Impfdatum: 26.04.2022
Beginn: 24.11.2022
Tage bis Beginn: 212,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 3/30/21 Lot# 030A21A; Moderna 4/26/21 Lot# 007B21A; Moderna 11/12/21 Lot# 034F21A; MOderna 4/26/22 Lot# 065K21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2633505

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CA
Alter: 69,0
Geschlecht: F
Eingang: 18.05.2023
Impfdatum: 14.04.2022
Beginn: 09.07.2022
Tage bis Beginn: 86,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test Electroencephalogram Encephalitis Epilepsy Magnetic resonance imaging

Symptomtext

Epileptic seizures and encephalitis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood test
Hospital-Tage: -
Labordaten: Multiple EEGs, MRIs, blood tests
Aktuelle Erkrankungen: UTI
Vorgeschichte: -
Andere Medikamente: Sertraline, Rosuvastatin
Allergien: Peanut
Vorherige Impfungen: -

VAERS 2625988

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: OR
Alter: 69,0
Geschlecht: F
Eingang: 03.05.2023
Impfdatum: 03.03.2021
Beginn: 19.09.2022
Tage bis Beginn: 565,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 immunisation Suspected COVID-19

Symptomtext

SUSPECTED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via another pharmaceutical company (Pfizer Inc.) concerned a 71 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypothyroidism, and codeine allergy. Patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805022 expiry: unknown) dose was not reported, 1 in total was administered on 03-MAR-2021 to left arm for covid-19 prophylaxis. Age at time of vaccination 69 years old. No concomitant medications were reported. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient received non-company suspect vaccine included Pfizer Biontech covid-19 vaccine (tozinameran) (dose number in series 2) (form of admin, route of admin, and batch number were not reported) dose was not reported, administered on 25-OCT-2021 to left arm for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with tozinameran (dose number in series 2). The patient received non-company suspect vaccine included Moderna covid-19 vaccine (elasomeran) (dose number in series 3) (form of admin and route of admin were not reported, batch number: 065K21A, expiry: unknown) dose was not reported, administered on 01-APR-2022 to left arm for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with elasomeran (dose number in series 3). The patient receive non-company suspect vaccine included Pfizer Biontech covid-19 vaccine (tozinameran) (dose number in series 4) (form of admin and route of admin were not reported, batch number: GH97206, expiry: unknown) dose was not reported, administered on 19-SEP-2022 to right arm for covid-19 prophylaxis which was associated with revaccination with different covid-19 vaccine (dose number in series 4). On 11-APR-2023, the patient experienced covid-19 infection (suspected covid-19 infection) (dose number in series 4). The patient received treatment with non-company suspect drug Paxlovid (nirmatrelvir/ritonavir) (route of administration and form of admin were not reported, batch number:GF7861, expiry: unknown) dose and frequency were not reported administered from 14-APR-2023 to 19-APR-2023 for covid-19 treatment. On 23-APR-2023, the patient again experienced cold symptoms similar to the original covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s, tozinameran (dose number in series 2), elasomeran, and tozinameran (dose number in series 4) was not applicable; and action taken with nirmatrelvir/ritonavir was not reported. The patient had not recovered from suspected covid-19 infection, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 immunisation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy; Hypothyroidism.
Vorgeschichte: Comments: Patient was not pregnant at the time of reporting.
Andere Medikamente: PAXLOVID.
Allergien: -
Vorherige Impfungen: -

VAERS 2618516

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: TX
Alter: 72,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 14.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 17,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cataract operation Cough Nasopharyngitis SARS-CoV-2 test positive

Symptomtext

I thought I had a bad cold; I used a home COVID-19 test that came back positive. I called my doctor, had a telehealth visit, I was prescribed the Paxlovid. I started feeling better, I just had a lingering cough that didn't seem to want to go away. I keep getting mild colds where the cough seems to want to linger. I have been given steroids and antibiotics to help clear it up. During my eye exam, my eye doctor did say that the steroids caused my cataracts to get worse. I did get cataract surgery on both eyes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 23MAY2023 Home COVID-19 - positive
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Dilantin; Lipitor; Ezetimibe; Metoprolol; Hydrochlorothiazide; Multivitamin; Calcium; Vitamin D; Fish Oil; Baby Aspirin; Benadryl
Allergien: Farm Raised Seafood; MSG
Vorherige Impfungen: -

VAERS 2616101

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: AR
Alter: 72,0
Geschlecht: F
Eingang: 17.04.2023
Impfdatum: 24.02.2021
Beginn: 01.10.2021
Tage bis Beginn: 219,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Diabetes mellitus Glucose tolerance impaired Glycosylated haemoglobin increased Insulin therapy

Symptomtext

I went into my doctors for my routine exam, I had put off my exam as both my doctor and I both had gotten COVID-19 so my routine blood work and exam had to be rescheduled a couple of times. I finally got into see her in the fall of 2021, this time my bloodwork came back showing that I went from pre-diabetic to diabetes. I am now taking metformin to help control my A1C. Currently my A1C is being controlled with the metformin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diabetes mellitus
Hospital-Tage: -
Labordaten: 00OCT21 A1C positive for diabetes
Aktuelle Erkrankungen: No
Vorgeschichte: Coronary Artery Disease; Hypothyroid; Arthritis
Andere Medikamente: Losartan; levothyroxine; simvastatin; baby aspirin; multivitamin; magnesium; calcium
Allergien: Lisinopril
Vorherige Impfungen: -

VAERS 2616087

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: WI
Alter: 76,0
Geschlecht: F
Eingang: 17.04.2023
Impfdatum: 14.04.2022
Beginn: 01.09.2022
Tage bis Beginn: 140,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation COVID-19 Cardiac dysfunction Catheterisation cardiac abnormal Echocardiogram Echocardiogram abnormal

Symptomtext

In September of 2022 I had a mild case of COVID-19, I recovered from the virus. I was in for a routine exam with my cardiologist in October of 2022, he noticed I was in Atrial Fibrillation. I was sent for an echocardiogram, TEE, heart catheterization all tests showed that the bottom of my heart is not functioning correctly. Currently the doctor is leaning towards the virus causing the heart problem.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Atrial fibrillation
Hospital-Tage: -
Labordaten: 00NOV2022 Echocardiogram - positive for bottom of heart not working, 00NOV2022 TEE - positive for bottom of heart not working; 00NOV2022 Heart Catheterization - positive for bottom of heart not working;
Aktuelle Erkrankungen: No
Vorgeschichte: Allergies; Breast Cancer Survivor
Andere Medikamente: Losartan; Metoprolol; Lorazepam; Vitamin C; Vitamin D; Multivitamin; Glucosamine/Chondroitin; Magnesium; Zyrtec; Flonase as needed; Advil as needed; Tylenol as needed; CBD Oil;
Allergien: Penicillin; Darvon: Codeine: Vicodin; Norco
Vorherige Impfungen: -

VAERS 2610189

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MI
Alter: 67,0
Geschlecht: F
Eingang: 05.04.2023
Impfdatum: 04.04.2022
Beginn: 26.12.2022
Tage bis Beginn: 266,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive Sinus congestion

Symptomtext

Got Covid 12/26/2022 tested positive. Started PAXLOVID 12/30/2023. Really bad sinus congestion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Covid test, 26Dec2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hyperthyroidism
Andere Medikamente: Levothyroxine
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2599613

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K-21A

gering

Staat: MI
Alter: 76,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 05.05.2022
Beginn: 22.10.2022
Tage bis Beginn: 170,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Pfizer 2/28/21 Lot# EN6201; Pfizer 3/21/21 Lot# EN6207; Moderna 12/1/21 Lot# 012h; THIS IS THE INFORMATION IN THE LOCAL DATABASE Moderna 5/5/22 Lot# 065k-21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2592465

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MI
Alter: 88,0
Geschlecht: F
Eingang: 07.03.2023
Impfdatum: 05.05.2022
Beginn: 31.07.2022
Tage bis Beginn: 87,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines mOderna 1/13/21 Lot# 011L20A; Moderna 2/10/21 Lot# 011L20A; Moderna 11/3/21 Lot# 071F21A; Moderna 5/5/22 Lot# 065k21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2589901

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MA
Alter: 53,0
Geschlecht: U
Eingang: 02.03.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Circumstance or information capable of leading to medication error No adverse event Transcription medication error

Symptomtext

a patient who received a dose of the Moderna COVID-19 vaccine from lot number 065K21A/may have documented the incorrect NDC number which does not correspond to this lot number; the assumption is that the 53 year old patient may have been administered the 6-11 year old Moderna product; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of TRANSCRIPTION MEDICATION ERROR (a patient who received a dose of the Moderna COVID-19 vaccine from lot number 065K21A/may have documented the incorrect NDC number which does not correspond to this lot number), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (the assumption is that the 53 year old patient may have been administered the 6-11 year old Moderna product) and NO ADVERSE EVENT (No adverse event) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TRANSCRIPTION MEDICATION ERROR (a patient who received a dose of the Moderna COVID-19 vaccine from lot number 065K21A/may have documented the incorrect NDC number which does not correspond to this lot number), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (the assumption is that the 53 year old patient may have been administered the 6-11 year old Moderna product) and NO ADVERSE EVENT (No adverse event). At the time of the report, TRANSCRIPTION MEDICATION ERROR (a patient who received a dose of the Moderna COVID-19 vaccine from lot number 065K21A/may have documented the incorrect NDC number which does not correspond to this lot number), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (the assumption is that the 53 year old patient may have been administered the 6-11 year old Moderna product) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for TRANSCRIPTION MEDICATION ERROR (a patient who received a dose of the Moderna COVID-19 vaccine from lot number 065K21A/may have documented the incorrect NDC number which does not correspond to this lot number) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (the assumption is that the 53 year old patient may have been administered the 6-11 year old Moderna product). Concomitant medication was not provided. Treatment information was not provided. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Circumstance or information capable of leading to medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2584814

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MI
Alter: 83,0
Geschlecht: M
Eingang: 21.02.2023
Impfdatum: 12.04.2022
Beginn: 10.10.2022
Tage bis Beginn: 181,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 3/13/21 Lot# 002B21A; Moderna 4/10/21 Lot# 025B21A; Moderna 11/27/21 Lot# 027H21B; Moderna 4/12/22 Lot# 065K21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567715

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MI
Alter: 49,0
Geschlecht: F
Eingang: 25.01.2023
Impfdatum: 27.03.2022
Beginn: 16.08.2022
Tage bis Beginn: 142,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 11/19/21 LOt# 067F; Moderna 12/19/21 Lot# 067H21A ; Moderna 3/27/22 Lot# 065K21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2546425

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 30.12.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) in a 62-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). No concomitant medication was reported. 26 doses were received with Lot 065K21A,. No treatment medication was reported. This case was linked to MOD-2022-691013 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545858

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 58,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Unevaluable event

Symptomtext

None stated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545068

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 57,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in refrigerator on 23-Mar-2022 and administered on 05-May-2022; no adverse event; Monovalent doses administered after the BUD to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.), PRODUCT STORAGE ERROR (The vial was stored in refrigerator on 23-Mar-2022 and administered on 05-May-2022) and NO ADVERSE EVENT (no adverse event) in a 57-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: J and J (0.5 ml) on 28-Oct-2021. Past adverse reactions to the above products included No adverse event with J and J. On 05-May-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .25 milliliter. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in refrigerator on 23-Mar-2022 and administered on 05-May-2022) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.), PRODUCT STORAGE ERROR (The vial was stored in refrigerator on 23-Mar-2022 and administered on 05-May-2022) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and PRODUCT STORAGE ERROR (The vial was stored in refrigerator on 23-Mar-2022 and administered on 05-May-2022). The concomitant medication was not reported. The treatment medication was not reported. The information was unknown whether the patient received any other vaccine in the 4th week prior to COVID-19 vaccine. The dose administered to the patient passed 14 days after BUD of the vaccine. Most recent FOLLOW-UP information incorporated above includes: On 21-Dec-2022: Significant follow up included added reporter, past days and dose details. On 22-Dec-2022: Live Significant follow up: Updated narrative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544599

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 38,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544597

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 42,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544596

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 28,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544595

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 50,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544593

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 53,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544591

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544588

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 57,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544578

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 64,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544574

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 45,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544572

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 61,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544569

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 83,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544568

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 48,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544564

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 62,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544560

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 57,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544558

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 61,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544554

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 51,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544550

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 30,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544548

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 50,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544131

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 50,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to) and NO ADVERSE EVENT (no adverse event) in a 50-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not reported. Total 26 doses from Lot 065K21A Monovalent doses were administered after the BUD to patients. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544130

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 56,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) in a 56-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). Concomitant medications were not reported. Total 26 doses from Lot 065K21A Monovalent doses were administered after the BUD to patients. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544129

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 63,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent dose administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) in a 63-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544120

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 67,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) in a 67-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 26-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). Patient ID was reported as unknown. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant drug was reported. No treatment drug was reported. This case was linked to MOD-2022-691014 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544117

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 57,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 26-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). Patient ID was reported as 6359660. No concomitant drug was reported. No treatment drug was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544115

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 64,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) in a 64-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). The concomitant medication was not reported. The treatment medication was not reported. The information was unknown whether the patient received other vaccines in the 4 wees prior to COVID-19 vaccination. This case was linked to MOD-2022-691041 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544114

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 45,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) in a 45-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient). Patient ID was reported. Concomitant medication was not reported. Reportedly, in this report the patient was eligible for COVID-19 vaccine. Treatment medication was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544112

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 61,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Monovalent doses administered after the BUD to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). No concomitant medications were reported. Total 77 Monovalent doses were administered after the BUD to patients 12 and up.37 doses from Lot 059H21,26 doses from Lot 065K21A, and 12 doses from Lot 058A22-2A. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544110

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 83,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) in an 83-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 19-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). Patient ID was reported as Unknown. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant drug was reported. Reportedly, the patient was eligible for COVID-19 vaccine. No treatment drug was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544108

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 48,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 48-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 12-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). No concomitant medications were provided. It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that 77 Monovalent doses administered after the BUD to patients 12 and up. 26 doses from Lot 065K21A. No treatment medication was provided. This case was linked to MOD-2022-691046 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544096

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 61,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) in a 61-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient). Concomitant medication was not reported. Reportedly, in this report the patient was eligible for COVID-19 vaccine. Treatment medication was not reported. This case was linked to MOD-2022-691012 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544095

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 51,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) in a 51-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). Patient ID was reported as Unknown No concomitant medications was reported. It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that 77 Monovalent doses administered after the BUD to patients 12 and up. Breakdown of doses is as follows- 37 doses from Lot 059H21, 26 doses from Lot 065K21A, and 12 doses from Lot 058A22-2A. No treatment drug details was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544082

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 30,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Monovalent dose administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) in a 30-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). Concomitant medication was not reported. Patient ID was reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, in this report the patient was eligible for COVID-19 vaccine. Breakdown of doses were reported as 37 doses from lot 059H21, 26 doses from lot 065K21A, and 12 doses from lot 058A22-2A Treatment medication was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543843

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 56,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543842

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 47,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543839

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 29,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543836

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 51,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543833

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 54,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543832

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 58,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543829

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543348

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 47,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) in a 47-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). Concomitant medications were not reported. Total 26 doses from Lot 065K21A Monovalent doses were administered after the BUD to patients. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543347

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 54,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Monovalent dose administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient ID was reported. Concomitant product use was not provided by the reporter. It was reported that 77 Monovalent doses administered after the BUD to patients 12 and up. Breakdown of doses were as follows- 37 doses from Lot 059H21, 26 doses from Lot 065K21A, and 12 doses from Lot 058A22-2A. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543346

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: -
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

Monovalent doses administered after the BUD to patient; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) in an adolescent female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient). No concomitant medication information was provided. No treatment medications were provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543315

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 29,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) in a 29-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). Concomitant medications were not reported. Total 26 doses from Lot 065K21A Monovalent doses were administered after the BUD to patients. Treatment medications were not reported. This case was linked (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543314

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 48,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) in a 48-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). Concomitant medications were not reported. Total 26 doses from Lot 065K21A Monovalent doses were administered after the BUD to patients. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543313

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 51,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 28.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

no adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) in a 51-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 28-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). Concomitant medications were not reported. Total 26 doses from Lot 065K21A Monovalent doses were administered after the BUD to patients. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543311

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 28,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Monovalent dose administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) in a 28-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Jun-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent dose administered after the BUD to patient). It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant product use was not provided by the reporter. It was reported that 77 Monovalent doses administered after the BUD to patients 12 and up. Breakdown of doses were as follows- 37 doses from Lot 059H21, 26 doses from Lot 065K21A, and 12 doses from Lot 058A22-2A. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543308

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 53,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 26.05.2022
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

Monovalent doses administered after the BUD to patients.; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) in an adolescent male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-May-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.) and NO ADVERSE EVENT (no adverse event) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients.). No concomitant medications were reported. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543207

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 58,0
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 58-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Jun-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). Concomitant medication was not reported. Treatment medication was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543206

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 38,0
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Monovalent doses administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) in a 38-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Jun-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patient). Concomitant medication was not reported. Patient ID was reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, in this report the patient was eligible for COVID-19 vaccine. Breakdown of doses were reported as 51 doses from batch numberAS7140C and 60 doses from Batch number AS7148B. Treatment medication was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543199

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 42,0
Geschlecht: F
Eingang: 26.12.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 42-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. No Medical History information was reported. On 02-Jun-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant product use was not provided by the reporter. It was reported that 77 Monovalent doses administered after the BUD to patients 12 and up. Breakdown of doses is as follows- 37 doses from Lot 059H21, 26 doses from Lot 065K21A, and 12 doses from Lot 058A22-2A. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2537798

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: AR
Alter: 55,0
Geschlecht: F
Eingang: 20.12.2022
Impfdatum: 01.04.2022
Beginn: 14.12.2022
Tage bis Beginn: 257,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

Hospitalized; has covid and fully vaccinated with booster

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: positive covid pcr 12/18/22
Aktuelle Erkrankungen: unknown
Vorgeschichte: Asthma, CVA, Hypertension and Other (Bipolar Disorder, Schizophrenia, Depression, Anxiety)
Andere Medikamente: unknown
Allergien: promethazine, azithromycin, penicillins
Vorherige Impfungen: -

VAERS 2528537

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: OH
Alter: 18,0
Geschlecht: F
Eingang: 11.12.2022
Impfdatum: 14.07.2022
Beginn: 01.09.2022
Tage bis Beginn: 49,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Alopecia

Symptomtext

Vaccine induced Alopecia (if unfamilliar with the term it means hair loss &/or balding).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Alopecia
Hospital-Tage: -
Labordaten: In process
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Penicillin Prednisone
Vorherige Impfungen: -

VAERS 2518030

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 28.11.2022
Impfdatum: 20.04.2022
Beginn: 09.11.2022
Tage bis Beginn: 203,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19

Symptomtext

HOSPITALIZED WITH COVID

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2478576

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: TX
Alter: 80,0
Geschlecht: F
Eingang: 14.10.2022
Impfdatum: 01.04.2022
Beginn: 01.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Feeling abnormal

Symptomtext

pt states she came out of two month long brain fog that she didn't realize she was in. When she came out of this she counted back and it was about 2 days after getting her 4th Covid vaccine that the brain fog started. She after a couple of months it was like somebody turned a light on and she had not realized she was in this fog. She no longer has these symptoms and did not have any problems after the last Covid booster. 1st Covid dose was 1/19/2021 lot# 042C20A, 2nd dose on 2/23/2021 lot# 030M20A, 3rd dose, 10/23/20221 lot # 017F21A, 5th dose 9/12/2022 lot # 457140C.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Feeling abnormal
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: adult acme, rosacea, L4 and L5 problems, allergies, bladder issues,
Andere Medikamente: citalopram 20mg, furosemide 60mg, simvastatin 10mg, losartan 50mg, calcitonin (salmon)200 units/nasal spray, 81 mg aspirin, doxycycline hyalate 20mg x 2 daily, slow iron tablet w/ orange juice, azatadine nose spray, potassium chloride 20 m
Allergien: feathers, grass, cedar and juniper trees, pollen, cefdinir, wool,
Vorherige Impfungen: 2022 she received the high dose flu shot and developed a large whelp from the injection site down to her elbow.

VAERS 2477348

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CA
Alter: 66,0
Geschlecht: U
Eingang: 13.10.2022
Impfdatum: 08.04.2022
Beginn: 24.05.2022
Tage bis Beginn: 46,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Hysteroscopy abnormal Muscle spasms Smear cervix normal Urine analysis normal Uterine dilation and curettage Uterine polyp Vaginal haemorrhage

Symptomtext

I experienced vaginal bleeding similar to having a period. I had the cramps. I experienced vaginal bleeding from May 24-29. It started up again on June 4 to June 11 of 2022. The second episode had more clotting. 1 large clot came out and then it stopped. I went to the urgent care on the 1st day it started and they thought it was a bladder infection, but it was not. The urinalysis was normal. I was prescribed keflex but I did not take it. On May 31, I had a pap smear with my primary doctor, and it was showing no cervical cancer detected. I then had a Hysteroscopy on June 22,2022 and Uterine Polyps were found. I had a DNC on July 26. I have completely recovered from this since having the DNC

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hysteroscopy abnormal
Hospital-Tage: -
Labordaten: Urinalysis-May 24, 2022-Normal Hysteroscopy-June 22,2022-Uterine Polyps found -
Aktuelle Erkrankungen: N/A
Vorgeschichte: Sleep Apnea; Obesity; High Blood Pressure; Sciatica
Andere Medikamente: Losartan
Allergien: Lamictal
Vorherige Impfungen: Moderna Dose 3

VAERS 2473626

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: AZ
Alter: 75,0
Geschlecht: F
Eingang: 10.10.2022
Impfdatum: 08.04.2022
Beginn: 11.06.2022
Tage bis Beginn: 64,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pyelonephritis acute Urinary tract infection Urine analysis

Symptomtext

Developed UTI that led to acute pyelonephritis in June 2022. NOTE: Developed another UTI on 8/19/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyelonephritis acute
Hospital-Tage: -
Labordaten: UA on several occasions. June, and later in August USND of kidneys, ureters and bladder in August Referred to Urologist due to chronic UTI (also had one in Nov. 2021 - had 1st Moderna booster on 11-17-2021). Scheduled for cystoscopy in mid-October 2022.
Aktuelle Erkrankungen: none
Vorgeschichte: Hypertension, GERD, Left Carotid Stenosis
Andere Medikamente: Metropolol, Plavix, Crestor, Cozaar, Famotidine, Fexofenadine, Atrovent nasal solution, estradiol vag suppository, vit D3, fish oil, centrum for women, probiotic.
Allergien: Sulfa (macrodantin), Bactrim, Nitrofurantoin, Simvastatin, Amoxicillin, Erythromycin, Augmentin, Tramadol
Vorherige Impfungen: -

VAERS 2456138

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 11.04.2022
Beginn: 20.09.2022
Tage bis Beginn: 162,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Unevaluable event

Symptomtext

Fully vaccinated and boosted twice.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2456138

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 11.04.2022
Beginn: 20.09.2022
Tage bis Beginn: 162,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Unevaluable event

Symptomtext

Fully vaccinated and boosted twice.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2448834

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: OH
Alter: 77,0
Geschlecht: F
Eingang: 17.09.2022
Impfdatum: 14.05.2022
Beginn: 05.09.2022
Tage bis Beginn: 114,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Unevaluable event

Symptomtext

Admitted to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2443448

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 64,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2443447

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 68,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2443446

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 68,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2443445

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 75,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: Na
Allergien: NA
Vorherige Impfungen: -

VAERS 2443439

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 62,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2443263

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 59,0
Geschlecht: U
Eingang: 13.09.2022
Impfdatum: 03.06.2022
Beginn: 03.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: Na
Aktuelle Erkrankungen: Na
Vorgeschichte: Na
Andere Medikamente: Na
Allergien: Na
Vorherige Impfungen: -

VAERS 2443260

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 49,0
Geschlecht: U
Eingang: 13.09.2022
Impfdatum: 03.06.2022
Beginn: 03.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2443259

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 42,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 03.06.2022
Beginn: 03.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2443250

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 54,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: n//a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2443247

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 34,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2443237

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 53,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 02.06.2022
Beginn: 02.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2443233

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 58,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 07.06.2022
Beginn: 07.06.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2443228

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 46,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 07.06.2022
Beginn: 07.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2443222

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 61,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 07.06.2022
Beginn: 07.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2443017

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 42,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2443009

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 50,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2443006

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 68,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2443001

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 56,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442998

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 54,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442997

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 53,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442995

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 51,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442991

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442989

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 26,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442982

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442980

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 91,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 04.06.2022
Beginn: 04.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442978

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 61,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 31.05.2022
Beginn: 31.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442968

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 82,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 31.05.2022
Beginn: 31.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2442963

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 42,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 31.05.2022
Beginn: 31.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2442959

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 53,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2438747

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: KY
Alter: 89,0
Geschlecht: M
Eingang: 10.09.2022
Impfdatum: 19.08.2022
Beginn: 26.08.2022
Tage bis Beginn: 7,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Unevaluable event

Symptomtext

Admitted to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2434057

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 52,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2434053

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2434049

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 63,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 26.05.2022
Beginn: 26.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2434045

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 66,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2434043

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 76,0
Geschlecht: U
Eingang: 08.09.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2434040

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 61,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433930

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 58,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 24.05.2022
Beginn: 24.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433927

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 72,0
Geschlecht: U
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433926

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 73,0
Geschlecht: U
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433923

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 78,0
Geschlecht: U
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433922

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433918

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 57,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433914

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 71,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433909

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 52,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433902

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 76,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433900

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 71,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433896

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 78,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433894

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433889

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 72,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433886

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 79,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433879

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 28,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433765

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 65,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433762

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2433761

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 79,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433723

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 41,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433714

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 66,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 21.05.2022
Beginn: 21.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433704

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 57,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2433694

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 65,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2430008

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 76,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2430005

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 72,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2430003

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 28,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429805

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 36,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429801

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 70,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429795

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 35,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429790

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 38,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429785

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 38,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429784

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 41,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429778

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 31,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429771

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 37,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 14.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429764

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 79,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 10.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429650

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 79,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 10.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429647

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 62,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 10.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429646

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 59,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 10.05.2022
Beginn: 10.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429643

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 61,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429641

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 65,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429636

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 74,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429632

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 74,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429629

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 30,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429625

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 34,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429623

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 51,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429618

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 30,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429615

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 30,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429610

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 59,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429607

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 33,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429598

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 31,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429593

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 40,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429589

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 59,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429586

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 24,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429584

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 27,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429582

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 64,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429579

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 25,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429577

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 41,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429574

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 51,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429571

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 41,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429564

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 56,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429562

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 61,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2429559

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 67,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 07.05.2022
Beginn: 07.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429553

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 32,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2429551

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 60,0
Geschlecht: M
Eingang: 06.09.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2427609

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MI
Alter: 44,0
Geschlecht: F
Eingang: 02.09.2022
Impfdatum: 20.04.2022
Beginn: 12.08.2022
Tage bis Beginn: 114,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Abscess Breast cellulitis COVID-19 Chemotherapy SARS-CoV-2 test positive Seroma Ulcer

Symptomtext

Patient up to date on COVID vaccinations who admitted with cellultis and found incidentally positive for COVID. Provider note: "44 year old female with triple-negative metaplastic carcinoma of the left breast with a biopsy-proven metastasis to her axillary lymph nodes and with local ulcerations/invasion of her skin. She completed neoadjuvant chemotherapy 5 weeks ago. She was scheduled for modified radical mastectomy on 8/24/22, but now presents with cellulitis of her left breast due to a seroma vs abscess in the left pectoralis musculature. Also incidentally found to be COVID +."

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abscess
Hospital-Tage: 5,0
Labordaten: COVID detected PCR on 08/12/22
Aktuelle Erkrankungen: -
Vorgeschichte: Current smoker Obstructive sleep apnea Schizoaffective disorder, bipolar type Attention deficit hyperactivity disorder Chronic obstructive pulmonary disease LADA (latent autoimmune diabetes in adults), managed as type 2 Triple negative metaplastic carcinoma of left of breast with bulky nodal metasteses Hyperlipidemia Dyslipidemia Diabetes mellitus type 1.5 (*) Class 2 severe obesity due to excess calories with serious comorbidity and body mass index (BMI) of 35.0 to 35.9 in adult (*) Malignant neoplasm of overlapping sites of left breast in female, estrogen receptor negative (*) Breast cancer metastasized to axillary lymph node, left (*)
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2426690

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 58,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426681

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 66,0
Geschlecht: F
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2426677

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 31,0
Geschlecht: F
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2426657

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 67,0
Geschlecht: F
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426656

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 60,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426654

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 73,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426653

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 72,0
Geschlecht: U
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426652

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 48,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426650

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 42,0
Geschlecht: U
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426647

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 74,0
Geschlecht: F
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426645

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 76,0
Geschlecht: F
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426644

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 72,0
Geschlecht: U
Eingang: 01.09.2022
Impfdatum: 03.05.2022
Beginn: 03.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426643

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 49,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426637

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 27,0
Geschlecht: F
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426585

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 22,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426569

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 79,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2426560

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 42,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2426547

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 65,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2426542

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 87,0
Geschlecht: M
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2426538

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 57,0
Geschlecht: F
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond-use-date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2426529

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 37,0
Geschlecht: U
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Dose administered beyond-use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2426509

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 44,0
Geschlecht: F
Eingang: 01.09.2022
Impfdatum: 30.04.2022
Beginn: 30.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Dose administered beyond use date.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2391135

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: PA
Alter: 72,0
Geschlecht: M
Eingang: 26.07.2022
Impfdatum: 25.04.2022
Beginn: 30.05.2022
Tage bis Beginn: 35,0
Dosis: 4
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood creatinine increased Blood urea increased Glomerular filtration rate decreased Joint swelling

Symptomtext

Developed swollen ankles at some point between date of vaccination and date symptom was recognized in late May. Creatine level and BUN elevated upon work up for Kidney Disease or reaction to Amlodipine medication. No suggestion from doctor at this point that it's related to vaccination but never had swollen ankles before.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood creatinine increased
Hospital-Tage: -
Labordaten: Creatinine 1.31 mg/dl; eGFR ml/min/1.73m2 value = 58
Aktuelle Erkrankungen: -
Vorgeschichte: hypertension, hyperlipedemia
Andere Medikamente: amlodipine, losartan, bupropion, rosuvastatin
Allergien: iodine
Vorherige Impfungen: -

VAERS 2435642

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 22.07.2022
Impfdatum: 31.03.2022
Beginn: 19.04.2022
Tage bis Beginn: 19,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2370731

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: MO
Alter: 60,0
Geschlecht: F
Eingang: 15.07.2022
Impfdatum: 12.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cardiac disorder Electrocardiogram ambulatory abnormal Electrocardiogram normal Supraventricular extrasystoles

Symptomtext

I was under evaluation for cardiac issues with a Holter monitor and they determined I had 17.6% of PACs.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac disorder
Hospital-Tage: -
Labordaten: PCP did an EKG that showed normal rhythm; 48hr Holter monitor from April 14-16th- this showed 17.6% of my heartbeat were PACs. They then ordered a 30 day Holter monitor from May 11- June 9th came back 5% PACs
Aktuelle Erkrankungen: No
Vorgeschichte: High blood pressure; High cholesterol
Andere Medikamente: Hydrochlorothiazide HCTZ; Simvastatin
Allergien: Sulfur drugs
Vorherige Impfungen: -

VAERS 2370667

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: NH
Alter: 66,0
Geschlecht: M
Eingang: 15.07.2022
Impfdatum: 14.04.2022
Beginn: 16.06.2022
Tage bis Beginn: 63,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose increased Dysuria Micturition urgency Pollakiuria Urinary incontinence Urinary tract infection Urine analysis abnormal Urine odour abnormal White blood cells urine

Symptomtext

On 6-16, 2022 I was having urinary frequency and urgency and lost bladder control. This lasted for about a week. My blood sugar was also elevated for over 2 days. A week later, i started noticing a urinary odor and pain upon urination. On 7-9, I emailed the clinic and they told me to come in on 7-11 for a urinary test. On 7-12, they told me the urinary test was positive for infection. They performed more tests and sent me a prescription of Nitrofurantoin x 7 days. I started it last night. I feel the urinary problem is starting to improve.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood glucose increased
Hospital-Tage: -
Labordaten: Urinalysis WBC-HPF on 7-11-2022 - positive for infection done at Outpatient Clinic Urine RBC-HPF on 7-11-2022 done at Outpatient Clinic
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes type 2, Hyperlipidemia, Glaucoma, GERD, High Blood Pressure
Andere Medikamente: Flintstones complete vitamin, Caltrate supplement, Lantus insulin, Novolog insulin, Omeprazole, Losartan, Metformin, Rosuvastatin, Fish Oil, Alogliptin, Latanoprost eye drops
Allergien: None
Vorherige Impfungen: -

VAERS 2370091

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: TN
Alter: -
Geschlecht: U
Eingang: 15.07.2022
Impfdatum: 08.07.2022
Beginn: 04.04.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error Product temperature excursion issue

Symptomtext

Dose administered after 30-day Use By Date; Vial reached a maximum temperature of 15C for 1 hour & 43 minutes; Vial stored in refrigerator on 04-Apr-2022 and administered on 08-Jul-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT TEMPERATURE EXCURSION ISSUE (Vial reached a maximum temperature of 15C for 1 hour & 43 minutes) and PRODUCT STORAGE ERROR (Vial stored in refrigerator on 04-Apr-2022 and administered on 08-Jul-2022) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 04-Apr-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vial reached a maximum temperature of 15C for 1 hour & 43 minutes) and PRODUCT STORAGE ERROR (Vial stored in refrigerator on 04-Apr-2022 and administered on 08-Jul-2022). On 08-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT TEMPERATURE EXCURSION ISSUE (Vial reached a maximum temperature of 15C for 1 hour & 43 minutes) and PRODUCT STORAGE ERROR (Vial stored in refrigerator on 04-Apr-2022 and administered on 08-Jul-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Vial was initially stored in the refrigerator on 4-Apr-2022. On 4-Apr-2022 after the vial was placed in the refrigerator to thaw, the refrigerator was left open and the vial reached a maximum temperature of 15C for 1 hour & 43 minutes. The Excursion tool was used at that time which gave the results involving the 24 cumulative time frame. At the time of excursion storage condition was refrigerated. The vial was stored in fridge currently. Any vaccine state change after visual inspection was not sure. One vial was impacted. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2367767

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IA
Alter: 68,0
Geschlecht: M
Eingang: 13.07.2022
Impfdatum: 03.04.2022
Beginn: 01.05.2022
Tage bis Beginn: 28,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Blood test abnormal Diplopia Myasthenia gravis Ophthalmological examination Vision blurred

Symptomtext

I started to see blurred vision. Then developed into double vision. I contacted my eye doctor. I had 3 blood tests and checked my eyes. The blood work indicated Myasthenia gravis. After the results, I called my doctor and went to a eye neurologist and was told I was definitely diagnosed with MG. I have researched and seen a spike in MG after vaccination. It has affected my life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood test abnormal
Hospital-Tage: -
Labordaten: Blood work - Myasthenia gravis
Aktuelle Erkrankungen: -
Vorgeschichte: Glaucoma; Asthma
Andere Medikamente: Eye Drops for Glycoma; Vitamin E; Multivitamin
Allergien: Sulfa; Prednisone
Vorherige Impfungen: -

VAERS 2362189

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MO
Alter: 66,0
Geschlecht: M
Eingang: 08.07.2022
Impfdatum: 12.04.2022
Beginn: 02.07.2022
Tage bis Beginn: 81,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Interchange of vaccine products SARS-CoV-2 test

Symptomtext

This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (After 5 day course of Paxlovid tested positive for Covid on day 7) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065k21a) for COVID-19 treatment. Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for an unknown indication. Previously administered products included for Product used for unknown indication: Pfizer / BioNTech (Dose number: 1, batch/Lot No: ER8729, location of injection: arm right and vaccine administration time: 02:00 PM) on 10-Apr-2021, Pfizer / BioNTech (Dose number: 2, batch/Lot No: EW0170, location of injection: arm right and vaccine administration time: 01:00 PM) on 01-May-2021, Pfizer / BioNTech (Dose number: 3, batch/Lot No: FG3527 and location of injection: arm right and vaccine administration time: 03:00 PM) on 04-Nov-2021. Past adverse reactions to the above products included No adverse event with Pfizer / BioNTech, Pfizer / BioNTech and Pfizer / BioNTech. Concurrent medical conditions included Penicillin allergy. On 12-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 02-Jul-2022, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). On 02-Jul-2022 at 4:00 PM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (After 5 day course of Paxlovid tested positive for Covid on day 7). At the time of the report, COVID-19 (After 5 day course of Paxlovid tested positive for Covid on day 7) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive. The patient was not taking any other medications/products (concomitant) within 2 weeks of starting COVID-19 treatment. Treatment received for event was reported as no. Company comment: This Spontaneous case reported by a patient concerns a 66-year-old, male patient with no relevant medical history reported, who experienced the unexpected, non serious AESI of COVID-19 (After 5 day course of Paxlovid tested positive for Covid on day 7) about 2 months and 20 days after receiving the 4 dose of mRNA1273 Vaccine in the Covid 19 vaccination series. Patient previously received the 2 primary doses and the 3 dose with Pfizer vaccines, with no adverse events reported for Pfizer vaccines. Interchange of vaccine products was noted. No details on symptoms, comorbidities, other labs and diagnostic tests, and treatment details was provided. In June 2022, the patient was started on Nirmatrelvir, Ritonavir (PAXLOVID) at an unspecified dose, for an unknown indication. On 02-Jul-2022 patient experienced COVID-19. After 5 day course of Paxlovid, he was tested positive for Covid on day 7. On an unknown date SARS-CoV-2 test was positive. No treatment was received for the event. The event outcome was unknown. Ongoing Covid 19 pandemia and use of Paxlovid remain as confounders. The benefit-risk relationship of mRNA-1273 is not affected by this report. Events? seriousness assessed as per medical judgement. Sender's Comments: This Spontaneous case reported by a patient concerns a 66-year-old, male patient with no relevant medical history reported, who experienced the unexpected, non serious AESI of COVID-19 (After 5 day course of Paxlovid tested positive for Covid on day 7) about 2 months and 20 days after receiving the 4 dose of mRNA1273 Vaccine in the Covid 19 vaccination series. Patient previously received the 2 primary doses and the 3 dose with Pfizer vaccines, with no adverse events reported for Pfizer vaccines. Interchange of vaccine products was noted. No details on symptoms, comorbidities, other labs and diagnostic tests, and treatment details was provided. In June 2022, the patient was started on Nirmatrelvir, Ritonavir (PAXLOVID) at an unspecified dose, for an unknown indication. On 02-Jul-2022 patient experienced COVID-19. After 5 day course of Paxlovid, he was tested positive for Covid on day 7. On an unknown date SARS-CoV-2 test was positive. No treatment was received for the event. The event outcome was unknown. Ongoing Covid 19 pandemia and use of Paxlovid remain as confounders. The benefit-risk relationship of mRNA-1273 is not affected by this report. Events? seriousness assessed as per medical judgement.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19 Virus test; Test Result: Positive; Result Unstructured Data: Positive.
Aktuelle Erkrankungen: Penicillin allergy
Vorgeschichte: -
Andere Medikamente: PAXLOVID
Allergien: Penicillin allergy
Vorherige Impfungen: -

VAERS 2347516

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 68,0
Geschlecht: M
Eingang: 01.07.2022
Impfdatum: 31.03.2022
Beginn: 30.05.2022
Tage bis Beginn: 60,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Sinusitis

Symptomtext

Symptoms (congestion, runny nose, cough) started May 30th. Tested positive for COVIC-19 Friday. Paxlovid for 5 days beginning June 3rd. Later in June 9th received Amoxicillin because I also had a sinus infection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 2 home test COVID-19, positive PCR COVID-19, positive
Aktuelle Erkrankungen: N//a
Vorgeschichte: N/A
Andere Medikamente: Statin; Sudafed
Allergien: Sulfa; Horse Serum
Vorherige Impfungen: -

VAERS 2347455

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 41,0
Geschlecht: M
Eingang: 01.07.2022
Impfdatum: 08.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

We inadvertently administered the vaccine past the 30-day Use by Date. According to the manufacturer the vaccine administered on June 8 and 9, 2022 from lot number 065K21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none reported
Vorgeschichte: none reported
Andere Medikamente: n/a
Allergien: none reported
Vorherige Impfungen: -

VAERS 2347452

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 43,0
Geschlecht: F
Eingang: 01.07.2022
Impfdatum: 08.06.2022
Beginn: 08.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

We inadvertently administered the vaccine past the 30-day Use by Date. According to the manufacturer the vaccine administered on June 8, 2022 from lot number 065K21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none reported
Vorgeschichte: none reported
Andere Medikamente: n/a
Allergien: none reported
Vorherige Impfungen: -

VAERS 2347447

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 47,0
Geschlecht: M
Eingang: 01.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Drug ineffective Expired product administered

Symptomtext

We inadvertently administered the vaccine past the 30-day Use by Date. According to the manufacturer the vaccine administered on June 9, 2022 from lot number 065K21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Drug ineffective
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: not reported
Vorgeschichte: not reported
Andere Medikamente: n/a
Allergien: non reported
Vorherige Impfungen: -

VAERS 2347443

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 42,0
Geschlecht: M
Eingang: 01.07.2022
Impfdatum: 09.06.2022
Beginn: 09.06.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

We inadvertently administered the vaccine past the 30-day Use by Date. According to the manufacturer the vaccine administered on June 8 and 9, 2022 from lot number 065K21A likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none reported
Vorgeschichte: none reported
Andere Medikamente: n/a
Allergien: none reported
Vorherige Impfungen: -

VAERS 2317274

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: ID
Alter: 62,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 23.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given 25 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. The patient's past medical history included Lung disorder. Concurrent medical conditions included Drug allergy (Baclofen), Drug allergy (Hydrocodone), Alcohol abuse, Heart disease, unspecified, Hypertensive (Hypertensive disorder), Hypercholesterolemia, Migraine and Osteoporosis. Concomitant products included ACETYLSALICYLIC ACID (ASPIR), ATORVASTATIN, BUSPIRONE, CETIRIZINE HYDROCHLORIDE (CETRIZINE), CLOPIDOGREL, CYCLOBENZAPRINE, LEVOTHYROXINE SODIUM (EUTHYROX), ISOSORBIDE MONONITRATE, MECLIZINE [MECLOZINE], METOPROLOL TARTRATE, MONTELUKAST, MULTIVITAMIN [VITAMINS NOS], NITROGLYCERIN, OMEPRAZOLE, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) and VENLAFAXINE for an unknown indication. On 23-May-2022 at 11:19 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-May-2022 at 11:19 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Alcohol abuse; Drug allergy (Hydrocodone); Drug allergy (Baclofen); Heart disease, unspecified; Hypercholesterolemia; Hypertensive (Hypertensive disorder); Migraine; Osteoporosis
Vorgeschichte: Medical History/Concurrent Conditions: Lung disorder
Andere Medikamente: ASPIR; ATORVASTATIN; BUSPIRONE; CETRIZINE; CLOPIDOGREL; CYCLOBENZAPRINE; EUTHYROX; ISOSORBIDE MONONITRATE; MECLIZINE [MECLOZINE]; METOPROLOL TARTRATE; MONTELUKAST; MULTIVITAMIN [VITAMINS NOS]; NITROGLYCERIN; OMEPRAZOLE; PRILOSEC [OMEPRAZOLE
Allergien: -
Vorherige Impfungen: -

VAERS 2317274

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: ID
Alter: 62,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 23.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given 25 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. The patient's past medical history included Lung disorder. Concurrent medical conditions included Drug allergy (Baclofen), Drug allergy (Hydrocodone), Alcohol abuse, Heart disease, unspecified, Hypertensive (Hypertensive disorder), Hypercholesterolemia, Migraine and Osteoporosis. Concomitant products included ACETYLSALICYLIC ACID (ASPIR), ATORVASTATIN, BUSPIRONE, CETIRIZINE HYDROCHLORIDE (CETRIZINE), CLOPIDOGREL, CYCLOBENZAPRINE, LEVOTHYROXINE SODIUM (EUTHYROX), ISOSORBIDE MONONITRATE, MECLIZINE [MECLOZINE], METOPROLOL TARTRATE, MONTELUKAST, MULTIVITAMIN [VITAMINS NOS], NITROGLYCERIN, OMEPRAZOLE, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) and VENLAFAXINE for an unknown indication. On 23-May-2022 at 11:19 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-May-2022 at 11:19 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Alcohol abuse; Drug allergy (Hydrocodone); Drug allergy (Baclofen); Heart disease, unspecified; Hypercholesterolemia; Hypertensive (Hypertensive disorder); Migraine; Osteoporosis
Vorgeschichte: Medical History/Concurrent Conditions: Lung disorder
Andere Medikamente: ASPIR; ATORVASTATIN; BUSPIRONE; CETRIZINE; CLOPIDOGREL; CYCLOBENZAPRINE; EUTHYROX; ISOSORBIDE MONONITRATE; MECLIZINE [MECLOZINE]; METOPROLOL TARTRATE; MONTELUKAST; MULTIVITAMIN [VITAMINS NOS]; NITROGLYCERIN; OMEPRAZOLE; PRILOSEC [OMEPRAZOLE
Allergien: -
Vorherige Impfungen: -

VAERS 2317273

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 25,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine given 21 days after refrigerator shelf life / Vaccine used beyond 30 days of refrigeration; Vaccine given 21 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 21 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf life / Vaccine used beyond 30 days of refrigeration) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Concurrent medical conditions included Penicillin allergy. Concomitant products included ALBUTEROL SULFATE, SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), ATENOLOL, BENZONATATE, VITAMIN D3, FLUOXETINE, FLUTICASONE PROPIONATE, LISINOPRIL, LORATADINE, MELOXICAM, METFORMIN HYDROCHLORIDE (METFORMIN ER), MONTELUKAST, OMEPRAZOLE, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and DULAGLUTIDE (TRULICITY) for an unknown indication. On 19-May-2022 at 12:11 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2022 at 12:11 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 21 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf life / Vaccine used beyond 30 days of refrigeration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 21 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf life / Vaccine used beyond 30 days of refrigeration) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Other concomitant medications: Dexcom G6 sensor, Dexcom G6 transmitter, One Touch Delica Plus Lancet, One touch utlra test strips, one touch utlra2 meter, OptiChamber Diamond VHC spacer No treatment medication information provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Penicillin allergy
Vorgeschichte: -
Andere Medikamente: ALBUTEROL SULFATE; ALBUTEROL SULFATE HFA; ATENOLOL; BENZONATATE; VITAMIN D3; FLUOXETINE; FLUTICASONE PROPIONATE; LISINOPRIL; LORATADINE; MELOXICAM; METFORMIN ER; MONTELUKAST; OMEPRAZOLE; SYMBICORT; TRULICITY
Allergien: -
Vorherige Impfungen: -

VAERS 2317273

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 25,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine given 21 days after refrigerator shelf life / Vaccine used beyond 30 days of refrigeration; Vaccine given 21 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 21 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf life / Vaccine used beyond 30 days of refrigeration) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Concurrent medical conditions included Penicillin allergy. Concomitant products included ALBUTEROL SULFATE, SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), ATENOLOL, BENZONATATE, VITAMIN D3, FLUOXETINE, FLUTICASONE PROPIONATE, LISINOPRIL, LORATADINE, MELOXICAM, METFORMIN HYDROCHLORIDE (METFORMIN ER), MONTELUKAST, OMEPRAZOLE, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and DULAGLUTIDE (TRULICITY) for an unknown indication. On 19-May-2022 at 12:11 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2022 at 12:11 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 21 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf life / Vaccine used beyond 30 days of refrigeration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 21 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf life / Vaccine used beyond 30 days of refrigeration) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Other concomitant medications: Dexcom G6 sensor, Dexcom G6 transmitter, One Touch Delica Plus Lancet, One touch utlra test strips, one touch utlra2 meter, OptiChamber Diamond VHC spacer No treatment medication information provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Penicillin allergy
Vorgeschichte: -
Andere Medikamente: ALBUTEROL SULFATE; ALBUTEROL SULFATE HFA; ATENOLOL; BENZONATATE; VITAMIN D3; FLUOXETINE; FLUTICASONE PROPIONATE; LISINOPRIL; LORATADINE; MELOXICAM; METFORMIN ER; MONTELUKAST; OMEPRAZOLE; SYMBICORT; TRULICITY
Allergien: -
Vorherige Impfungen: -

VAERS 2317272

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 58,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired device used Product storage error

Symptomtext

Vaccine given 21 days after refrigerator shelf live; Vaccine given 21 days after refrigerator shelf live; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED DEVICE USED (Vaccine given 21 days after refrigerator shelf live) and PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf live) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Concurrent medical conditions included House dust allergy, Drug allergy (lisinopril), Drug allergy (lovastatin), Food allergy (mold allergy), Pollen allergy (pollen extracts), Alcohol abuse, Cerebrovascular accident, Heart disease, unspecified, Osteoporosis, Breast tumor malignant and Hypercholesterolemia. Concomitant products included ALBUTEROL SULFATE, SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), AMITRIPTYLINE, ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN, SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM DS), FAMOTIDINE, HYDROCHLOROTHIAZIDE, ISOSORBIDE, LISINOPRIL, METFORMIN HYDROCHLORIDE (METFORMIN ER), MONTELUKAST, PREGABALIN, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and TAMSULOSIN for an unknown indication. On 19-May-2022 at 2:09 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2022 at 2:09 PM, the patient experienced EXPIRED DEVICE USED (Vaccine given 21 days after refrigerator shelf live). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf live). At the time of the report, EXPIRED DEVICE USED (Vaccine given 21 days after refrigerator shelf live) and PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf live) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported patient taking inhaler, sildenafil. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Alcohol abuse; Breast tumor malignant; Cerebrovascular accident; Drug allergy (lovastatin); Drug allergy (lisinopril); Food allergy (mold allergy); Heart disease, unspecified; House dust allergy; Hypercholesterolemia; Osteoporosis; Pollen allergy (pollen extracts)
Vorgeschichte: -
Andere Medikamente: ALBUTEROL SULFATE; ALBUTEROL SULFATE HFA; AMITRIPTYLINE; ASPIRIN [ACETYLSALICYLIC ACID]; ATORVASTATIN; BACTRIM DS; FAMOTIDINE; HYDROCHLOROTHIAZIDE; ISOSORBIDE; LISINOPRIL; METFORMIN ER; MONTELUKAST; PREGABALIN; SYMBICORT; TAMSULOSIN
Allergien: -
Vorherige Impfungen: -

VAERS 2317272

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 58,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 19.05.2022
Beginn: 19.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired device used Product storage error

Symptomtext

Vaccine given 21 days after refrigerator shelf live; Vaccine given 21 days after refrigerator shelf live; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED DEVICE USED (Vaccine given 21 days after refrigerator shelf live) and PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf live) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Concurrent medical conditions included House dust allergy, Drug allergy (lisinopril), Drug allergy (lovastatin), Food allergy (mold allergy), Pollen allergy (pollen extracts), Alcohol abuse, Cerebrovascular accident, Heart disease, unspecified, Osteoporosis, Breast tumor malignant and Hypercholesterolemia. Concomitant products included ALBUTEROL SULFATE, SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), AMITRIPTYLINE, ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN, SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM DS), FAMOTIDINE, HYDROCHLOROTHIAZIDE, ISOSORBIDE, LISINOPRIL, METFORMIN HYDROCHLORIDE (METFORMIN ER), MONTELUKAST, PREGABALIN, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) and TAMSULOSIN for an unknown indication. On 19-May-2022 at 2:09 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2022 at 2:09 PM, the patient experienced EXPIRED DEVICE USED (Vaccine given 21 days after refrigerator shelf live). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf live). At the time of the report, EXPIRED DEVICE USED (Vaccine given 21 days after refrigerator shelf live) and PRODUCT STORAGE ERROR (Vaccine given 21 days after refrigerator shelf live) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported patient taking inhaler, sildenafil. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Alcohol abuse; Breast tumor malignant; Cerebrovascular accident; Drug allergy (lovastatin); Drug allergy (lisinopril); Food allergy (mold allergy); Heart disease, unspecified; House dust allergy; Hypercholesterolemia; Osteoporosis; Pollen allergy (pollen extracts)
Vorgeschichte: -
Andere Medikamente: ALBUTEROL SULFATE; ALBUTEROL SULFATE HFA; AMITRIPTYLINE; ASPIRIN [ACETYLSALICYLIC ACID]; ATORVASTATIN; BACTRIM DS; FAMOTIDINE; HYDROCHLOROTHIAZIDE; ISOSORBIDE; LISINOPRIL; METFORMIN ER; MONTELUKAST; PREGABALIN; SYMBICORT; TAMSULOSIN
Allergien: -
Vorherige Impfungen: -

VAERS 2317270

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 22,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 18.05.2022
Beginn: 18.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given 25 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Concurrent medical conditions included Allergy to antibiotic (Azithromycin), Penicillin allergy (penicillins), Drug allergy (Prednisone), Depressive disorder, Thyroid disorder and Diabetes mellitus. Concomitant products included ALBUTEROL SULFATE, BUSPIRONE, METHYLPHENIDATE HYDROCHLORIDE (CONCERTA), DOXYCYCLINE HYCLATE, FLUOXETINE, HYDROCODONE and MELATONIN for an unknown indication. On 18-May-2022 at 12:10 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2022 at 12:10 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The concomitant medication was reported. No treatment medications were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic (Azithromycin); Depressive disorder; Diabetes mellitus; Drug allergy (Prednisone); Penicillin allergy (penicillins); Thyroid disorder
Vorgeschichte: -
Andere Medikamente: ALBUTEROL SULFATE; BUSPIRONE; CONCERTA; DOXYCYCLINE HYCLATE; FLUOXETINE; HYDROCODONE; MELATONIN
Allergien: -
Vorherige Impfungen: -

VAERS 2317270

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 22,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 18.05.2022
Beginn: 18.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given 25 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Concurrent medical conditions included Allergy to antibiotic (Azithromycin), Penicillin allergy (penicillins), Drug allergy (Prednisone), Depressive disorder, Thyroid disorder and Diabetes mellitus. Concomitant products included ALBUTEROL SULFATE, BUSPIRONE, METHYLPHENIDATE HYDROCHLORIDE (CONCERTA), DOXYCYCLINE HYCLATE, FLUOXETINE, HYDROCODONE and MELATONIN for an unknown indication. On 18-May-2022 at 12:10 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2022 at 12:10 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 25 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The concomitant medication was reported. No treatment medications were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic (Azithromycin); Depressive disorder; Diabetes mellitus; Drug allergy (Prednisone); Penicillin allergy (penicillins); Thyroid disorder
Vorgeschichte: -
Andere Medikamente: ALBUTEROL SULFATE; BUSPIRONE; CONCERTA; DOXYCYCLINE HYCLATE; FLUOXETINE; HYDROCODONE; MELATONIN
Allergien: -
Vorherige Impfungen: -

VAERS 2317269

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 41,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine given 8 days after refrigerator shelf life; Vaccine given 8 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 8 days after refrigerator shelf life) in a 41-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. Patient had no known drug allergy. Concurrent medical conditions included Asthma, Depressive disorder, Migraine, Osteoporosis, Diabetes mellitus and Pharynx neoplasm malignant. Concomitant products included ACYCLOVIR [ACICLOVIR], SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), CYCLOBENZAPRINE, FLUTICASONE PROPIONATE, LAMOTRIGINE, MINOCYCLINE, PAROXETINE, RISPERIDONE and SERTRALINE for an unknown indication. On 06-May-2022 at 2:58 PM, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 06-May-2022 at 2:58 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 8 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 8 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Asthma; Depressive disorder; Diabetes mellitus; Migraine; Osteoporosis; Pharynx neoplasm malignant
Vorgeschichte: Comments: Patient had no known drug allergy.
Andere Medikamente: ACYCLOVIR [ACICLOVIR]; ALBUTEROL SULFATE HFA; CYCLOBENZAPRINE; FLUTICASONE PROPIONATE; LAMOTRIGINE; MINOCYCLINE; PAROXETINE; RISPERIDONE; SERTRALINE
Allergien: -
Vorherige Impfungen: -

VAERS 2317269

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 41,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vaccine given 8 days after refrigerator shelf life; Vaccine given 8 days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 8 days after refrigerator shelf life) in a 41-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. Patient had no known drug allergy. Concurrent medical conditions included Asthma, Depressive disorder, Migraine, Osteoporosis, Diabetes mellitus and Pharynx neoplasm malignant. Concomitant products included ACYCLOVIR [ACICLOVIR], SALBUTAMOL SULFATE (ALBUTEROL SULFATE HFA), CYCLOBENZAPRINE, FLUTICASONE PROPIONATE, LAMOTRIGINE, MINOCYCLINE, PAROXETINE, RISPERIDONE and SERTRALINE for an unknown indication. On 06-May-2022 at 2:58 PM, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 06-May-2022 at 2:58 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 8 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 8 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Asthma; Depressive disorder; Diabetes mellitus; Migraine; Osteoporosis; Pharynx neoplasm malignant
Vorgeschichte: Comments: Patient had no known drug allergy.
Andere Medikamente: ACYCLOVIR [ACICLOVIR]; ALBUTEROL SULFATE HFA; CYCLOBENZAPRINE; FLUTICASONE PROPIONATE; LAMOTRIGINE; MINOCYCLINE; PAROXETINE; RISPERIDONE; SERTRALINE
Allergien: -
Vorherige Impfungen: -

VAERS 2317267

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

gering

Staat: IL
Alter: 12,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given 8 days after shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after shelf life) in a 12-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065k21a) for COVID-19 vaccination. Patient had no known drug allergies. Concurrent medical conditions included Anxiety, Eating disorder, ADHD and Depressive disorder. Concomitant products included METHYLPHENIDATE HYDROCHLORIDE (CONCERTA) and FLUOXETINE for an unknown indication. On 06-May-2022 at 1:44 PM, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 06-May-2022 at 1:44 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: ADHD; Anxiety; Depressive disorder; Eating disorder
Vorgeschichte: Comments: Patient had no known drug allergies.
Andere Medikamente: CONCERTA; FLUOXETINE
Allergien: -
Vorherige Impfungen: -

VAERS 2317267

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: IL
Alter: 12,0
Geschlecht: M
Eingang: 22.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given 8 days after shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after shelf life) in a 12-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065k21a) for COVID-19 vaccination. Patient had no known drug allergies. Concurrent medical conditions included Anxiety, Eating disorder, ADHD and Depressive disorder. Concomitant products included METHYLPHENIDATE HYDROCHLORIDE (CONCERTA) and FLUOXETINE for an unknown indication. On 06-May-2022 at 1:44 PM, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 06-May-2022 at 1:44 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 8 days after shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: ADHD; Anxiety; Depressive disorder; Eating disorder
Vorgeschichte: Comments: Patient had no known drug allergies.
Andere Medikamente: CONCERTA; FLUOXETINE
Allergien: -
Vorherige Impfungen: -

VAERS 2317266

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 39,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 02.05.2022
Beginn: 02.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given seven days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given seven days after refrigerator shelf life) in a 39-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. The patient's past medical history included Peripheral nerve decompression. Concurrent medical conditions included Allergy to antibiotic, Diarrhea and Muscle strain. Concomitant products included BIOTIN for Supplementation therapy, NICOTINE for an unknown indication. On 02-May-2022 at 11:04 AM, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-May-2022 at 11:04 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given seven days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given seven days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Patient took biotin for hair, skin, nails as concomitant. It was unknown if patient had adverse event following any previous vaccine. No treatment drugs were reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic; Diarrhea; Muscle strain
Vorgeschichte: Medical History/Concurrent Conditions: Peripheral nerve decompression
Andere Medikamente: BIOTIN; NICOTINE
Allergien: -
Vorherige Impfungen: -

VAERS 2317266

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: 39,0
Geschlecht: F
Eingang: 22.06.2022
Impfdatum: 02.05.2022
Beginn: 02.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Vaccine given seven days after refrigerator shelf life; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given seven days after refrigerator shelf life) in a 39-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis. The patient's past medical history included Peripheral nerve decompression. Concurrent medical conditions included Allergy to antibiotic, Diarrhea and Muscle strain. Concomitant products included BIOTIN for Supplementation therapy, NICOTINE for an unknown indication. On 02-May-2022 at 11:04 AM, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-May-2022 at 11:04 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given seven days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given seven days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Patient took biotin for hair, skin, nails as concomitant. It was unknown if patient had adverse event following any previous vaccine. No treatment drugs were reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Allergy to antibiotic; Diarrhea; Muscle strain
Vorgeschichte: Medical History/Concurrent Conditions: Peripheral nerve decompression
Andere Medikamente: BIOTIN; NICOTINE
Allergien: -
Vorherige Impfungen: -

VAERS 2325142

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 56,0
Geschlecht: F
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion.; Vaccine administered that went under temperature excursion.; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. The patient did not had an allergic reaction to polysorbate polyethylene glycol, or a previous dose of COVID-19 vaccine. The patient never had severe allergic reaction (anaphylaxis) to foods, pets, venom. environmental or oral medications. The patient did have a bleeding disorder, and was on a long-term aspirin therapy or taking other blood thinners. The patient never had Guillain-Barre Syndrome (a type of temporary sever muscle weakness) after receiving a vaccine. The patient never received any dermal fillers (Juvaderm, Restylane, etc) nor had a history of blood clots, nor had myocarditis or pericarditis, nor had heparin-induced thrombocytopenia(HIT), nor had Multisystem inflammatory syndrome known as MIS-C after a COVID-19 infection. Concurrent medical conditions included Bleeding (on long-term aspirin therapy or taking other blood-thinners.). On 15-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient took the booster dose on 15-Jun-2022. No concomitant medications was reported. Patient did not have a fever on 15-Jun-2022 Reporter stated that the data logger was not set with correct parameters and excursion happened for 15 mins at the site +1.9 C. Storage condition at the time of the excursion: Refrigerator Maximum or minimum temperatures reached, as applicable: +1.9 C to +6.4C Excursion duration: 15 min Date vial moved from freezer to refrigerator: 08-Jun-2022 and 1 vial on 15-Jun-2022 Currently the vials kept in fridge (quarantined) Visual inspection noting any vaccine state change: Thawed Proposed desired use by date was reported as afternoon of the day of reporting. Number of doses/vials: 2 (1 punctured and 1 not punctured.) Date and time vial was first punctured: 15-Jun-2022 at 9.15 AM The vial was stored in a portable fridge post puncture. Was the vail exposed to room temperature for greater than 24 hours: All were in fridge. No treatment medications were provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Bleeding (on long-term aspirin therapy or taking other blood-thinners.)
Vorgeschichte: Comments: The patient did not had an allergic reaction to polysorbate polyethylene glycol, or a previous dose of COVID-19 vaccine. The patient never had severe allergic reaction (anaphylaxis) to foods, pets, venom. environmental or oral medications. The patient did have a bleeding disorder, and was on a long-term aspirin therapy or taking other blood thinners. The patient never had Guillain-Barre Syndrome (a type of temporary sever muscle weakness) after receiving a vaccine. The patient never received any dermal fillers (Juvaderm, Restylane, etc) nor had a history of blood clots, nor had myocarditis or pericarditis, nor had heparin-induced thrombocytopenia(HIT), nor had Multisystem inflammatory syndrome known as MIS-C after a COVID-19 infection.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325140

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 55,0
Geschlecht: F
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion.; Vaccine administered that went under temperature excursion.; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. It was reported that patient had no allergies, had not received any dermal filters, did not have a history of myocarditis or pericarditis, blood clots, heparin induced thrombocytopenia or multisystem inflammatory syndrome after a COVID-19 infection and patient was not immunocompromised. Concurrent medical conditions included Haemorrhagic disorder (on long-term aspirin therapy or took other blood thinners). On 15-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the dose was administered 12 hours post puncture. The vial was first punctured on 15-Jun-2022 at 9.15 AM and was stored in portable refrigerator post puncture. Vial underwent a temperature excursion of plus 1.9C to plus 6.4 C for 15 mins. Vial was stored in the refrigerator at the time of the excursion. Vial was moved from freezer to refrigerator on 08-Jun-2022 and 1 vial on 15-Jun-2022. The vial was thawed. Proposed desired use by date was 15-Jun-2022 afternoon. It was confirmed that patient was not sick or did not have fever at the time of reporting. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Haemorrhagic disorder (on long-term aspirin therapy or took other blood thinners)
Vorgeschichte: Comments: It was reported that patient had no allergies, had not received any dermal filters, did not have a history of myocarditis or pericarditis, blood clots, heparin induced thrombocytopenia or multisystem inflammatory syndrome after a COVID-19 infection and patient was not immunocompromised.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325139

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 81,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion.; Vaccine administered that went under temperature excursion.; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pfizer (Dose 1) on 07-Jan-2021, Pfizer (Dose 2) on 28-Jan-2021 and Pfizer (Dose 3) on 05-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 15-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. The expiration date was 05-Jul-2022. Two doses/vials were impacted (1 punctured and 1 not punctured). The vial moved from freezer to refrigerator on 08-Jun-2022 and 1 vial 15-Jun-2022. The vial was first punctured on 15-Jun-2022 at 9.15 AM. The vial was stored in portable fridge post puncture. The vial underwent temperature excursions on plus 1.9C to plus 6.4 C. Excursion duration was 15 min. Vial was stored in the refrigerator at the time of the excursion. The vial was thawed. Proposed desired use by date was 15-Jun-2022 afternoon. All the vials were in the fridge quarantined. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325138

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 80,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion.; Vaccine administered that went under temperature excursion.; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: Pfizer (Dose 1) on 28-Jan-2021, Pfizer (Dose 2) on 18-Feb-2021 and Pfizer (Dose 3) on 05-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 15-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was stated that, the data logger was not set with correct parameter and excursion happened for 15 mins at the site + 1.9 Celsius (C). The storage condition at the time of the excursion was refrigerator and maximum or minimum temperatures reached, as applicable was +1.9 C to +6.4C for 15 minutes. On 15-Jun-2022, the vial moved from freezer to refrigerator. At 09.15 am, the vial was initially punctured. Vial was currently fridge quarantined in portable fridge. The visual inspection noting any vaccine state change stated thawed. The proposed desired Use by Date was stated as afternoon of 15-Jun-2022. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325137

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 75,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental overdose Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion.; Vaccine administered that went under temperature excursion.; Patient had full forth dose; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and ACCIDENTAL OVERDOSE (Patient had full forth dose) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Jun-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and ACCIDENTAL OVERDOSE (Patient had full forth dose). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion.), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion.) and ACCIDENTAL OVERDOSE (Patient had full forth dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications was not provided by the reporter. On 08Jun2022 vial moved from freezer to refrigerator. Excursion duration 15 min. The vials stored in Fridge quarantined and was thawed. The vial first punctured on 15Jun2022 at 9.15 AM. The vial stored in portable fridge. The vial undergone 1.9C to 6.4 C temperature excursions. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental overdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325136

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 94,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion; Vaccine administered that went under temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion) in a 94-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: Pfizer (Dose 1) on 07-Jan-2021, Pfizer (Dose 2) on 28-Jan-2021 and Pfizer (Dose 3) on 05-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 15-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Vial moved from freezer to refrigerator on 08-Jun-2022 and 1 vial on 15-Jun-2022. Proposed desired use by date was 15-Jun-2022 afternoon. Date and time vial was first punctured was on 15-Jun-2022 at 9.15 AM, the vial undergo temperature excursions of plus 1.9 C to plus 6.4 C for 15 mins. Storage condition at the time of the excursion was Refrigerator. Visual inspection noting any vaccine state change was thawed. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: No medical history was reported.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325134

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 80,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion of +1.9C to +6.4 C; Vaccine administered that went under temperature excursion of +1.9C to +6.4 C; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: Pfizer (Dose 1) on 28-Jan-2021, PFIZER BIONTECH COVID-19 VACCINE (Dose 2) on 18-Feb-2021 and Pfizer (Dose 3) on 05-Oct-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, Pfizer and Pfizer. On 15-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was stated that, the data logger was not set with correct parameter and excursion happened for 15 mins at the site + 1.9 Celsius (C). The storage condition at the time of the excursion was refrigerator and maximum or minimum temperatures reached, as applicable was +1.9 C to +6.4C for 15 minutes. On 15-Jun-2022, the vial moved from freezer to refrigerator. At 09:15 am, the vial was initially punctured. Vial was currently fridge quarantined in portal fridge. The visual inspection noting any vaccine state change stated thawed. The proposed desired Use by Date was stated as afternoon. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325131

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 51,0
Geschlecht: F
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion for 15 minutes at the site 1.9 Celsius; Vaccine administered that went under temperature excursion for 15 minutes at the site 1.9 Celsius; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion for 15 minutes at the site 1.9 Celsius) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion for 15 minutes at the site 1.9 Celsius) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. The patient did not have an allergic reaction to polysorbate, polyethylene glycol or a previous dose of COVID-19 vaccine. The patient did not have a serious allergic reaction (anaphylaxis) to another vaccine, injectable medications, food, pets, venom environmental or oral medications. The patient does not have a bleeding disorder or was on a long term aspirin therapy or other blood thinners. The patient has not had Guillain-Barre syndrome after receiving the vaccine. The patient had not received dermal fillers. The patient does not have a history of myocarditis, pericarditis, heparin induced thrombocytopenia (HIT). The patient did not have Multisystem inflammatory syndrome (MUS-A) in adults after a COVID-19 infection. The patient was not immunocompromised. On 15-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion for 15 minutes at the site 1.9 Celsius). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion for 15 minutes at the site 1.9 Celsius). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion for 15 minutes at the site 1.9 Celsius) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion for 15 minutes at the site 1.9 Celsius) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The patient received booster dose on 15-Jun-2022. Concomitant medications were not reported. Number of doses/vials that were administered from that lot was 2 (1 punctured and 1 not punctured). The vial was previously stored in fridge. The vial was moved from freezer to refrigerator on 15-Jun-2022. The vial was first punctured on 15-Jun-2022 at 9.15 AM. The vial was stored in portable fridge post puncture. The vial underwent temperature excursion for about 15 minutes having minimum temperature of 1.9 degree Celsius and maximum temperature of 6.4 degree Celsius. The dose was administered to the patient within less than 12 hours post puncture. Proposed desired use by date and time of the vial was 15-Jun-2022 (afternoon). The vial was returned to fridge and quarantined after administration. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient did not have an allergic reaction to polysorbate, polyethylene glycol or a previous dose of COVID-19 vaccine. The patient did not have a serious allergic reaction (anaphylaxis) to another vaccine, injectable medications, food, pets, venom environmental or oral medications. The patient does not have a bleeding disorder or was on a long term aspirin therapy or other blood thinners. The patient has not had Guillain-Barre syndrome after receiving the vaccine. The patient had not received dermal fillers. The patient does not have a history of myocarditis, pericarditis, heparin induced thrombocytopenia (HIT). The patient did not have Multisystem inflammatory syndrome (MUS-A) in adults after a COVID-19 infection. The patient was not immunocompromised.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325130

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 65,0
Geschlecht: F
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product storage error

Symptomtext

Vaccine administered that went under temperature excursion; Vaccine administered that went under temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered that went under temperature excursion) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. The patient was not sick or had no fever on the day of vaccination. The patient did not have an allergic reaction to polysorbate, polyethylene glycol or a previous dose of COVID-19 vaccine. The patient did not have a serious allergic reaction (anaphylaxis) to another vaccine or any injectable medication, foods, venom, environmental oral medications. The patient had no bleeding disorder and was not on long term aspirin therapy or did not took other blood thinners. The patient did not have Guillian-Barre syndrome (a type of temporary severe weakness) after receiving the vaccine. The patient did not receive any dermal fillers. The patient had no history of blood clots or risk factors for developing blood clots, myocarditis or pericarditis, heparin induced thrombocytopenia (HIT) and multisystem inflammatory syndrome. The patient was not immunocompromised. On 15-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered that went under temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion) and PRODUCT STORAGE ERROR (Vaccine administered that went under temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The patient received booster dose. Date and time vial was first punctured was on 15-Jun-2022 at 9.15 AM, the vial undergo temperature excursions of plus 1.9 degrees C to plus 6.4 degrees C for 15 mins. Storage condition at the time of the excursion was Refrigerator. Vial moved from freezer to refrigerator on 08-Jun-2022 and 1 vial on 15-Jun-2022. The proposed desired use by date provided was on the afternoon of 15-Jun-2022 No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient was not sick or had no fever on the day of vaccination. The patient did not have an allergic reaction to polysorbate, polyethylene glycol or a previous dose of COVID-19 vaccine. The patient did not have a serious allergic reaction (anaphylaxis) to another vaccine or any injectable medication, foods, venom, environmental oral medications. The patient had no bleeding disorder and was not on long term aspirin therapy or did not took other blood thinners. The patient did not have Guillian-Barre syndrome (a type of temporary severe weakness) after receiving the vaccine. The patient did not receive any dermal fillers. The patient had no history of blood clots or risk factors for developing blood clots, myocarditis or pericarditis, heparin induced thrombocytopenia (HIT) and multisystem inflammatory syndrome. The patient was not immunocompromised.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325128

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 78,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion for 15 minutes at the site; Vaccine administered that went under temperature excursion for 15 minutes at the site; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion for 15 minutes at the site) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion for 15 minutes at the site) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for COVID-19 vaccination: Pfizer (Dose 1) on 28-Jan-2021, Pfizer (Dose 2) on 18-Feb-2021 and Pfizer (Dose 3) on 05-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 15-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion for 15 minutes at the site). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion for 15 minutes at the site). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion for 15 minutes at the site) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion for 15 minutes at the site) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. The data logger at the clinic was not set with correct parameters and temperature excursion happened with the vial. Number of doses/vials that were administered from that lot was 2 (1 punctured and 1 not punctured). The vial was previously stored in fridge. The vial was moved from freezer to refrigerator on 15-Jun-2022. The vial was first punctured on 15-Jun-2022 at 9.15 AM. The vial was stored in portable fridge post puncture. The vial underwent temperature excursion for about 15 minutes having minimum temperature of 1.9 degree Celsius and maximum temperature of 6.4 degree Celsius. The dose was administered to the patient within less than 12 hours post puncture. Proposed desired use by date and time of the vial was 15-Jun-2022 (afternoon). The vial was returned to fridge and quarantined after administration. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325127

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 78,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pfizer (Dose 1) on 28-Jan-2021, Pfizer (Dose 2) on 18-Feb-2021 and Pfizer (Dose 3) on 05-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 15-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Date and time vial was first punctured was on 15-Jun-2022 at 9.15 AM, the vial undergo temperature excursions of plus 1.9C to plus 6.4 C for 15 mins. Storage condition at the time of the excursion was Refrigerator. Vial moved from freezer to refrigerator on 08-Jun-2022 and 1 vial on 15-Jun-2022. Visual inspection noting any vaccine state change was thawed. Proposed desired use by date was 15-Jun-2022 afternoon. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325126

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 88,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) in an 88-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: Pfizer (1st dose) on 07-Jan-2021, Pfizer (2nd dose) on 28-Jan-2021 and Pfizer (3rd dose) on 05-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 15-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of +1.9C to +6.4 C) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. 2 doses/vials were impacted (1 punctured and 1 not punctured). The vial moved from freezer to refrigerator on 08-Jun-2022 and 1 vial 15-Jun-2022. The vial was first punctured on 15-Jun-2022 at 9.15 AM. The vial was stored in portable fridge post puncture. The vial undergoes temperature excursions on +1.9C to +6.4 C. Excursion duration was 15 min.. All the vials were in the fridge quarantined. Visual inspection noting any vaccine state change included vial was thawed. No treatment medications were provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325125

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 73,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: Pfizer COVID-19 Vaccine (Dose 1) on 22-Jan-2021, Pfizer COVID-19 Vaccine (Dose 2) on 11-Feb-2021 and Pfizer COVID-19 Vaccine (Dose 3) on 25-Oct-2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 Vaccine, Pfizer COVID-19 Vaccine and Pfizer COVID-19 Vaccine. On 15-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. Date and time vial was first punctured was on 15-Jun-2022 at 9:15 AM. The vial was stored in portable fridge post puncture. The vaccine expiry date was reported as 05-Jul-2022. The vial undergo temperature excursions of plus 1.9C to plus 6.4 C for 15 minutes. Total amount of time the vial was exposed to room temperature range 8? to 25?C that is 46? to 77?F. Storage condition at the time of the excursion was Refrigerator. Vial moved from freezer to refrigerator on 08-Jun-2022 and 1 vial on 15-Jun-2022 Visual inspection noting any vaccine state change was thawed. No treatment medication were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2325124

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 83,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product storage error

Symptomtext

Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C; Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer vaccine on 19-Feb-2021, Pfizer vaccine on 12-Mar-2021 and Pfizer vaccine on 02-Nov-2021. Past adverse reactions to the above products included No adverse reaction with Pfizer vaccine, Pfizer vaccine and Pfizer vaccine. On 15-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. Storage condition of the vaccine at the time of the excursion was reported as stored in the refrigerator. The vial undergo temperature excursions of plus1.9C to plus 6.4 C.\ with excursion duration of 15 min. Number of doses or vials were 2. Date and time vial was first punctured was on 15 Jun 2022 at 9.15 AM. Total amount of time the vial was exposed to room temperature range 8? to 25?C= 46? to 77?F. No treatment medication were reported. This case was linked to MOD-2022-590514, MOD-2022-590536 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2323779

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 89,0
Geschlecht: U
Eingang: 21.06.2022
Impfdatum: 24.09.2021
Beginn: 15.06.2022
Tage bis Beginn: 264,0
Dosis: UNK
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration Poor quality product administered Product temperature excursion issue

Symptomtext

Vaccine administered that went under temperature excursion of plus1.9C to plus 6.4 C; Vaccine administered that went under temperature excursion of Plus1.9C to plus6.4 C; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of plus1.9C to plus 6.4 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of Plus1.9C to plus6.4 C) in an 89-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Patient allergies were none. On 24-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jun-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 15-Jun-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of Plus1.9C to plus6.4 C). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of plus1.9C to plus 6.4 C). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered that went under temperature excursion of plus1.9C to plus 6.4 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion of Plus1.9C to plus6.4 C) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. 2 doses/vials were impacted (1 punctured and 1 not punctured). The vial moved from freezer to refrigerator on 08-Jun-2022 and 1 vial 15-Jun-2022. The vial was first punctured on 15-Jun-2022 at 9.15 AM. The vial was stored in portable fridge post puncture. The vial undergoes temperature excursions on +1.9C to +6.4 C. Excursion duration was 15 min. If unknown, was the vial exposed to room temperature for greater than 24 hours. All were in fridge. The visual inspection noted vaccine state change stated to thawed. The proposed desired use by date was stated as afternoon. No treatment information was reported. This case was linked to MOD-2022-589894 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient allergies were none.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2324067

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 68,0
Geschlecht: U
Eingang: 20.06.2022
Impfdatum: 15.06.2022
Beginn: 15.06.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Poor quality product administered Product storage error

Symptomtext

Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C; Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 prophylaxis. Previously administered products included for COVID-19 vaccination: Pfizer (Dose-1) on 07-Jan-2021, Pfizer (Dose-2) on 28-Jan-2021 and Pfizer (Dose-3) in October 2021. Past adverse reactions to the above products included No adverse reaction with Pfizer, Pfizer and Pfizer. On 15-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Jun-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered that went under temperature excursion happened for 15 mins at the site +1.9 C) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. Date and time vial was first punctured was on 15 Jun 2022 at 9.15 AM, the vial undergo temperature excursions of plus1.9C to plus 6.4 C. Total amount of time the vial was exposed to room temperature range 8? to 25?C= 46? to 77?F. No treatment medication were reported. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2313699

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: NY
Alter: 48,0
Geschlecht: F
Eingang: 09.06.2022
Impfdatum: 05.04.2022
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

Tested positive for Covid / 3 days later had a return of symptoms and have been positive with symptoms for 5 days now; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Jun-2022 and was forwarded to Moderna on 06-Jun-2022. This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive for Covid / 3 days later had a return of symptoms and have been positive with symptoms for 5 days now) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065k21a) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Unknown historical drug). Concomitant products included SERTRALINE for an unknown indication. On 05-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for Covid / 3 days later had a return of symptoms and have been positive with symptoms for 5 days now). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 24-May-2022 to 28-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (Tested positive for Covid / 3 days later had a return of symptoms and have been positive with symptoms for 5 days now) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2022, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, SARS-CoV-2 test: positive (Positive) Positive. Patient had been vaccinated plus received 2 Moderna boosters. Patient tested positive for Covid, took Paxlovid, then 3 days later had a return of symptoms and had been positive with symptoms for 5 days as of 01-Jun-2022. Device date was reported as 01-Jun-2022; Sender's Comments: COMPANY COMMENT: This is an spontaneous case concerning an 48-year-old female patient with medical history of Drug allergy (Unknown historical drug), products included SERTRALINE and PAXLOVID for COVID-19 treatment from 24-May-2022 to 28-May-2022 who experienced the unexpected event of COVID-19 unknown days after 4th dose of mRNA-1273 vaccine. On May-2022, SARS-CoV-2 test: positive The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Name: COVID-19 test; Test Result: Positive ; Result Unstructured Data: Positive; Test Date: 202205; Test Name: COVID-19 test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Drug allergy (Unknown historical drug)
Vorgeschichte: -
Andere Medikamente: SERTRALINE
Allergien: -
Vorherige Impfungen: -

VAERS 2312778

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: -
Geschlecht: U
Eingang: 08.06.2022
Impfdatum: 23.05.2022
Beginn: 23.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Date the vial was initially stored in the refrigerator: 30MAR2021, Date(s) of administration of vaccine : 23-May-2022; Received expired vaccine beyond the 30 day refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator : 30MAR2021, Date(s) of administration of vaccine : 23-May-2022) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 23-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator : 30MAR2021, Date(s) of administration of vaccine : 23-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator : 30MAR2021, Date(s) of administration of vaccine : 23-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant drug was reported. The vial was initially stored in the refrigerator on 30-MAR-2021. The vial did not undergo any temperature excursions. The patient received second booster dose. No treatment drug was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2311487

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: -
Geschlecht: U
Eingang: 07.06.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Received expired vaccine beyond the 30 day refrigerator shelf life; Received expired vaccine beyond the 30 day refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Received expired vaccine beyond the 30 day refrigerator shelf life) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 06-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 06-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received expired vaccine beyond the 30 day refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Received expired vaccine beyond the 30 day refrigerator shelf life) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication reported. It was reported that 6 patients received expired Moderna COVID-19 vaccine, from 05 May 2022 through 23 May 2022. 3 patients received first booster, 1 patient received a second booster, 2 patients received 2nd primary dose. 1 patient received on 05-May-2022, 1 patient on 06-May, 1 patient on 18-May, 2 patients on 19-May, and 1 patient on 23-May-2022. On 30-Mar-2021 the vial was initially stored in the refrigerator and was administered to the patient on 06-May-2022. The vial did not undergo any temperature excursion. No treatment medication reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2311255

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: -
Geschlecht: U
Eingang: 07.06.2022
Impfdatum: 18.05.2022
Beginn: 18.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial was initially stored in the refrigerator on 30 Mar 2022 date of administration of vaccine was on 18 May 2022; Received expired vaccine beyond the 30 day refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 30 Mar 2022 date of administration of vaccine was on 18 May 2022) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 18-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 18-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 30 Mar 2022 date of administration of vaccine was on 18 May 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 30 Mar 2022 date of administration of vaccine was on 18 May 2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant medication were not reported. It was reported that the vials were initially stored in refrigerator on 30-Mar-2021 and was administered to 6 patient on 18-May-2022. The vial did not undergo any temperature excursion. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2311253

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: IL
Alter: -
Geschlecht: U
Eingang: 07.06.2022
Impfdatum: 05.05.2022
Beginn: 05.05.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Received expired vaccine beyond the 30 day refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 05-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine beyond the 30 day refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. It was reported that 6 patients received expired Moderna COVID-19 vaccine beyond the 30 day refrigerator shelf life, from 5 MAY 2022 through 23 MAY 2022. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2310280

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MN
Alter: 94,0
Geschlecht: M
Eingang: 06.06.2022
Impfdatum: 03.11.2021
Beginn: 18.04.2022
Tage bis Beginn: 166,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19

Symptomtext

Patient hospitalized with COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: unknown
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2306220

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

gering

Staat: CA
Alter: 57,0
Geschlecht: M
Eingang: 02.06.2022
Impfdatum: 09.04.2022
Beginn: 12.05.2022
Tage bis Beginn: 33,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

The adverse event is a relapse of Covid infection; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (The adverse event is a relapse of Covid infection) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065k21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer / BioNTech (Dose Number: 1, Batch/Lot No: EP7534, Location of injection: Arm Left) on 16-Mar-2021, Pfizer / BioNTech (Dose Number: 2, Batch/Lot No: ER8729, Location of injection: Arm Left) on 06-Apr-2021, Pfizer / BioNTech (Dose Number: 3, Batch/Lot No: FH8027 and Location of injection: Arm Left) on 16-Nov-2021. Past adverse reactions to the above products included No adverse event with Pfizer / BioNTech, Pfizer / BioNTech and Pfizer / BioNTech. Concurrent medical conditions included Bee sting hypersensitivity (Bee stings) and Allergic to cats (cat hair). Concomitant products included LISDEXAMFETAMINE MESILATE (VYVANSE) from 01-Jan-2022 to an unknown date for an unknown indication. On 09-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2022 at 9:00 PM, the patient experienced COVID-19 (The adverse event is a relapse of Covid infection). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 14-May-2022 to 19-May-2022 for COVID-19 vaccination, at a dose of 1 dosage form. At the time of the report, COVID-19 (The adverse event is a relapse of Covid infection) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-May-2022, SARS-CoV-2 test: positive (Positive) Positive. On 18-May-2022, SARS-CoV-2 test: negative (Negative) Negative. On 21-May-2022, SARS-CoV-2 test: negative (Negative) Negative. On 22-May-2022, SARS-CoV-2 test: positive (Positive) strong positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient's race was reported. Patient was positive for the first time for COVID on 12-May-2022. After taking the prescribed Pfizer Antiviral, on 18-May-2022 patient became negative till 21-May-2022 and positive symptoms reappeared on 22-May-2022 in the evening and patient was strong positive till the time of this report. Patient had same symptoms level than first time, including strong head cold and sinuses congestion, slight cough to none, wake up every 1 hour 30 min in night without reason. Company Comment: This is a spontaneous case concerning a 57-year-old, male patient with no relevant medical history, who experienced the unexpected non-serious AESI event of Covid-19. The events occurred 33 days after the fourth dose of mRNA-1273 COVID 19 Vaccine. Patient tested positive for SARS-CoV-2 test twice ( May 12, 2022 and May 22, 2022). Patient was treated with nirmatrelvir, ritonavir tablet at 1 dosage form. The events were reported as not resolved. Patient was positive for the first time for COVID on 12-May-2022. After taking the prescribed Pfizer Antiviral, on 18-May-2022 patient became negative till 21-May-2022 and positive symptoms reappeared on 22-May-2022 in the evening and patient was strong positive till the time of this report. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.; Sender's Comments: Company Comment: This is a spontaneous case concerning a 57-year-old, male patient with no relevant medical history, who experienced the unexpected non-serious AESI event of Covid-19. The events occurred 33 days after the fourth dose of mRNA-1273 COVID 19 Vaccine. Patient tested positive for SARS-CoV-2 test twice ( May 12, 2022 and May 22, 2022). Patient was treated with nirmatrelvir, ritonavir tablet at 1 dosage form. The events were reported as not resolved. Patient was positive for the first time for COVID on 12-May-2022. After taking the prescribed Pfizer Antiviral, on 18-May-2022 patient became negative till 21-May-2022 and positive symptoms reappeared on 22-May-2022 in the evening and patient was strong positive till the time of this report. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20220512; Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Positive; Test Date: 20220518; Test Name: COVID-19 virus test; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20220521; Test Name: COVID-19 virus test; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20220522; Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: strong positive
Aktuelle Erkrankungen: Allergic to cats (cat hair); Bee sting hypersensitivity (Bee stings)
Vorgeschichte: -
Andere Medikamente: VYVANSE
Allergien: -
Vorherige Impfungen: -

VAERS 2298605

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: MI
Alter: 97,0
Geschlecht: F
Eingang: 27.05.2022
Impfdatum: 09.05.2022
Beginn: 25.05.2022
Tage bis Beginn: 16,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

positive covid test in fully vaccinated and boosteredx2 pt

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2294930

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: WA
Alter: 17,0
Geschlecht: F
Eingang: 25.05.2022
Impfdatum: 05.04.2022
Beginn: 05.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product administered to patient of inappropriate age

Symptomtext

Moderna vaccine was provided to a 17 year old. No adverse outcomes noted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2293160

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CA
Alter: 26,0
Geschlecht: M
Eingang: 24.05.2022
Impfdatum: 27.04.2022
Beginn: 27.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Inappropriate schedule of product administration

Symptomtext

Patient who was vaccinated earlier in the day was on staff's list to offer patient vaccination. Patient accepted and received another dose of Moderna booster shot. provider notified and pt was monitored for any side effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2292782

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: MI
Alter: 66,0
Geschlecht: M
Eingang: 24.05.2022
Impfdatum: 12.05.2022
Beginn: 12.05.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

no symptoms occurred. vaccine was given after use by day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: no
Vorgeschichte: no
Andere Medikamente: no
Allergien: no
Vorherige Impfungen: -

VAERS 2289019

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: PA
Alter: 54,0
Geschlecht: M
Eingang: 21.05.2022
Impfdatum: 14.04.2022
Beginn: 04.05.2022
Tage bis Beginn: 20,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Nasopharyngitis SARS-CoV-2 test

Symptomtext

On 10th day after testing positive, 4 1/2 days after finishing course of paxlovid, cold-like symptoms have returned.; On 10th day after testing positive, 4 1/2 days after finishing course of paxlovid, cold-like symptoms have returned.; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (On 10th day after testing positive, 4 1/2 days after finishing course of paxlovid, cold-like symptoms have returned.) and NASOPHARYNGITIS (On 10th day after testing positive, 4 1/2 days after finishing course of paxlovid, cold-like symptoms have returned.) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. Concurrent medical conditions included Type 1 diabetes mellitus (Type 1 diabetes, well controlled with insulin, pump, and CGM). Concomitant products included METFORMIN and CELECOXIB (CELEBREX) for an unknown indication. On 14-Apr-2022 at 6:00 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (On 10th day after testing positive, 4 1/2 days after finishing course of paxlovid, cold-like symptoms have returned.). On 14-May-2022 at 10:00 PM, the patient experienced NASOPHARYNGITIS (On 10th day after testing positive, 4 1/2 days after finishing course of paxlovid, cold-like symptoms have returned.). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 06-May-2022 to 10-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (On 10th day after testing positive, 4 1/2 days after finishing course of paxlovid, cold-like symptoms have returned.) outcome was unknown and NASOPHARYNGITIS (On 10th day after testing positive, 4 1/2 days after finishing course of paxlovid, cold-like symptoms have returned.) was resolving. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2022, SARS-CoV-2 test: positive (Positive) Positive. Patient's race was reported. CC: This spontaneous case concerns a 54-year-old male patient, with a relevant history of Type I diabetes mellitus, who experienced the unexpected, non-serious Adverse Event of Special Interest of COVID-19, which occurred 20 days after the fourth dose of mRNA-1273 vaccine administration. On 10th day after testing positive, 4 1/2 days after finishing course of Paxlovid, cold-like symptoms (non-serious event Nasopharyngitis) have returned. The diagnosis of COVID-19 was supported by SARS-CoV-2 test which was positive. The ongoing COVID-19 pandemic and underlying history of type I diabetes mellitus could be confounders for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 54-year-old male patient, with a relevant history of Type I diabetes mellitus, who experienced the unexpected, non-serious Adverse Event of Special Interest of COVID-19, which occurred 20 days after the fourth dose of mRNA-1273 vaccine administration. On 10th day after testing positive, 4 1/2 days after finishing course of Paxlovid, cold-like symptoms (non-serious event Nasopharyngitis) have returned. The diagnosis of COVID-19 was supported by SARS-CoV-2 test which was positive. The ongoing COVID-19 pandemic and underlying history of type I diabetes mellitus could be confounders for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20220504; Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Type 1 diabetes mellitus (Type 1 diabetes, well controlled with insulin, pump, and CGM)
Vorgeschichte: -
Andere Medikamente: METFORMIN; CELEBREX
Allergien: -
Vorherige Impfungen: -

VAERS 2286575

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CO
Alter: 95,0
Geschlecht: F
Eingang: 20.05.2022
Impfdatum: 30.03.2022
Beginn: 09.05.2022
Tage bis Beginn: 40,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Inappropriate schedule of product administration Product storage error

Symptomtext

Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 09-May-2022; First dose administered on 30-MAR-2022 and second dose administered on 09-MAY-2022; administered expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered expired dose of the Moderna COVID-19 vaccine), PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 09-May-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 30-MAR-2022 and second dose administered on 09-MAY-2022) in a 95-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 084J21A and 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-May-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 09-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired dose of the Moderna COVID-19 vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 30-MAR-2022 and second dose administered on 09-MAY-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 09-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered expired dose of the Moderna COVID-19 vaccine), PRODUCT STORAGE ERROR (Vaccine was initially stored in the refrigerator on 11-Jan-2022 and was administered to patient on 09-May-2022) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose administered on 30-MAR-2022 and second dose administered on 09-MAY-2022) outcome was unknown. Not Provided For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information provided. On 11-Jan-2022 the vial was initially stored in the fridge. The patient had not reported any adverse reaction. The vaccine in question did not experience any temperature excursions No treatment medication information provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2286460

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CA
Alter: 62,0
Geschlecht: F
Eingang: 20.05.2022
Impfdatum: 02.05.2022
Beginn: 14.05.2022
Tage bis Beginn: 12,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

Have symptoms and test positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Have symptoms and test positive) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment. Concurrent medical conditions included Diabetes. On 02-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 02-May-2022 at 12:00 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2022 at 4:45 AM, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Have symptoms and test positive). At the time of the report, COVID-19 (Have symptoms and test positive) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-May-2022, SARS-CoV-2 test: positive (Positive) Positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. Patient took full dose of Paxlovid and 7 days later had symptoms and tested positive. No treatment medications were provided. Company Comment: This spontaneous case concerns a 62-year-old female patient with no relevant medical history, who experienced the and unexpected non-serious AESI of COVID-19 which occurred 12 days after receiving the fourth dose of mRNA-1273 vaccine. Its reported that patient took a full dose of Paxlovid as a covid-19 treatment and 7 days later she still had symptoms and was tested positive. COVID-19 pandemic could be confounding for the events. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 62-year-old female patient with no relevant medical history, who experienced the and unexpected non-serious AESI of COVID-19 which occurred 12 days after receiving the fourth dose of mRNA-1273 vaccine. Its reported that patient took a full dose of Paxlovid as a covid-19 treatment and 7 days later she still had symptoms and was tested positive. COVID-19 pandemic could be confounding for the events. The benefit-risk relationship of mRNA-1273 is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20220514; Test Name: COVID-19 virus test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: Diabetes
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320257

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 56,0
Geschlecht: M
Eingang: 19.05.2022
Impfdatum: 08.04.2022
Beginn: 09.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320207

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21a

gering

Staat: -
Alter: 56,0
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 08.04.2022
Beginn: 09.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2282710

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: NC
Alter: -
Geschlecht: U
Eingang: 18.05.2022
Impfdatum: 29.04.2022
Beginn: 29.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

vial was out of the fridge for 24 hours post puncture; Dose administered more than 12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture) and PRODUCT STORAGE ERROR (vial was out of the fridge for 24 hours post puncture) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was out of the fridge for 24 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12 hours post puncture) and PRODUCT STORAGE ERROR (vial was out of the fridge for 24 hours post puncture) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided. On 22-Apr-2022, the vial was initially stored in the refrigerator. On 28-Apr-2022 at 7:30 AM, the vial was first punctured. The vial was stored at room temperature post puncture and exposed to room temperature range of 8 to 25 degree Celsius = 46-to-77-degree Fahrenheit for 27-28 Hours. Later on, 29-Apr-2022 at 10:30-11:00 AM, the vaccine was administered. It was reported that, the vial did not undergo any temperature excursions. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2282709

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: PA
Alter: 72,0
Geschlecht: M
Eingang: 18.05.2022
Impfdatum: 12.04.2022
Beginn: 01.04.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

Covid rebound with nasal congestion and fatigue; COVID-19 treated with Paxlovid; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Covid rebound with nasal congestion and fatigue) and COVID-19 (COVID-19 treated with Paxlovid) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065k21a) for COVID-19 vaccination. Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19. The patient's past medical history included Atrial fibrillation. Concomitant products included RIVAROXABAN (XARELTO) for an unknown indication. On 12-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. In April 2022, the patient experienced COVID-19 (COVID-19 treated with Paxlovid). On 09-May-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Covid rebound with nasal congestion and fatigue). At the time of the report, COVID-19 (Covid rebound with nasal congestion and fatigue) had not resolved and COVID-19 (COVID-19 treated with Paxlovid) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-May-2022, SARS-CoV-2 test: positive (Positive) Antigen test positive. On an unknown date, SARS-CoV-2 test: negative (Negative) previous negative test. Patient experienced COVID-19 rebound with nasal congestion and fatigue. Antigen test was positive after previous negative test and disappearance of symptoms. No treatment was taken by the patient. Company Comment: This is a spontaneous case concerning a 73-year-old male patient with no relevant medical history reported, who experienced the unexpected non-serious adverse event of special interest COVID-19 (described as COVID-19 treated with Paxlovid) and COVID-19 recurrent (described as rebound COVID-19 with nasal congestion and fatigue), which occurred after receiving a dose of mRNA-1273 as fourth dose of COVID-19 vaccine (no information disclosed on previous COVID-19 vaccinations). On the same month after mRNA-1273 vaccination, patient had COVID-19 and was treated with Paxlovid for 5 days. However, 7 days after Paxlovid treatment, patient reportedly re-contracted COVID-19 infection associated with nasal congestion and fatigue (28 days post-vaccination), which was supported by a positive SARS-CoV-2 test. Outcome of the event COVID-19 was unknown, while the event COVID-19 recurrent was not yet resolved. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 73-year-old male patient with no relevant medical history reported, who experienced the unexpected non-serious adverse event of special interest COVID-19 (described as COVID-19 treated with Paxlovid) and COVID-19 recurrent (described as rebound COVID-19 with nasal congestion and fatigue), which occurred after receiving a dose of mRNA-1273 as fourth dose of COVID-19 vaccine (no information disclosed on previous COVID-19 vaccinations). On the same month after mRNA-1273 vaccination, patient had COVID-19 and was treated with Paxlovid for 5 days. However, 7 days after Paxlovid treatment, patient reportedly re-contracted COVID-19 infection associated with nasal congestion and fatigue (28 days post-vaccination), which was supported by a positive SARS-CoV-2 test. Outcome of the event COVID-19 was unknown, while the event COVID-19 recurrent was not yet resolved. The benefit-risk relationship of mRNA-1273 is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20220509; Test Name: Antigen test; Test Result: Positive ; Result Unstructured Data: Antigen test positive; Test Name: previous negative test; Test Result: Negative ; Result Unstructured Data: previous negative test
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Atrial fibrillation
Andere Medikamente: XARELTO
Allergien: -
Vorherige Impfungen: -

VAERS 2276194

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CA
Alter: 60,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 7+
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Extra dose administered Product storage error

Symptomtext

The vaccine the patient received was opened May 4th, 2022 at 3:30pm. Patient received the moderna COVID-19 on the left deltoid on May 6th, 2022 at 4:19pm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: Patient is scheduled with a provider to talk options/test May 16th, 2022 at 2:00pm here at the clinic where she received the vaccine.
Aktuelle Erkrankungen: chronic hepatitis C without coma, Hyperlipidema, disorder of eye, left, elevated blood pressure readingmass of left hand, feeling anxious, prediabetes.
Vorgeschichte: Chronic hepatitis C.
Andere Medikamente: acyclovir 400mg , triamcinolone acetonide 0.1% topical ointment, Ketotifen 0.025% (0.035%) eye drops, loratadine 10 mg, fluticasone prop 50 MCG spray.
Allergien: atropine.
Vorherige Impfungen: -

VAERS 2275728

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: CO
Alter: 17,0
Geschlecht: F
Eingang: 13.05.2022
Impfdatum: 15.04.2022
Beginn: 15.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product administered to patient of inappropriate age

Symptomtext

First dose of Moderna Covid-19 vaccine given to 17yr 7 month female. Observed for 15 minutes per protocol and no adverse reactions reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: betametthasone; dulcolax; miralax, ranitidine
Allergien: none
Vorherige Impfungen: -

VAERS 2328562

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 06.04.2022
Beginn: 07.04.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation

Symptomtext

A-Fib Narrative: Employee sort medical attention for heart related issue one day after receiving the 4th dose of Moderna. Was seen in ED and Cardiology. Scheduled for procedure soon

Weitere VAERSDATA-Felder

Praegender Schweregrund: Atrial fibrillation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2328508

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 56,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 08.04.2022
Beginn: 09.04.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2268985

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 065K21A

gering

Staat: NC
Alter: 93,0
Geschlecht: M
Eingang: 10.05.2022
Impfdatum: 02.05.2022
Beginn: 02.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event

Symptomtext

No noted adverses events. Patient received his second booster 26 days early. Pharmacy provided education to staff to prevent error happening again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2328537

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 90,0
Geschlecht: M
Eingang: 09.05.2022
Impfdatum: -
Beginn: 07.04.2022
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Unevaluable event

Symptomtext

Narrative:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2267368

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: NY
Alter: 67,0
Geschlecht: F
Eingang: 09.05.2022
Impfdatum: 22.04.2022
Beginn: 06.05.2022
Tage bis Beginn: 14,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Influenza like illness Vaccine breakthrough infection

Symptomtext

After receiving the fourth dose, I had severe flu like symptoms that lasted about 5 days. Then, two weeks after receiving my 4th dose of the Moderna Vaccine, I had a breakthrough case of COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: I did not have any tests completed.
Aktuelle Erkrankungen: I was not experiencing any illness.
Vorgeschichte: I do not have any chronic health conditions.
Andere Medikamente: Lovastatin 75mcgs Theracurmin 600mg Vitamin D-3 5000K 1 tablet
Allergien: I do not have any allergies.
Vorherige Impfungen: After receiving all 4 doses of my COVID-19 vaccine, I had severe flu like reactions. After the first dose, I was sick for 10 day

VAERS 2266005

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: GA
Alter: 39,0
Geschlecht: F
Eingang: 06.05.2022
Impfdatum: 06.05.2022
Beginn: 06.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration

Symptomtext

Patient was inadvertently given 2nd dose of Moderna vaccine series 6 days earlier than recommended guidelines. Patient notified of event and denied and current adverse effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: ER for chest pain and SOB a few weeks ago but doesn't remember date.
Vorgeschichte: Diabetes type II
Andere Medikamente: Pantorprazol 40 mg bid, Losartan 25 mg qd, jardiance 10 mg qd
Allergien: Cipro and sulfa medications
Vorherige Impfungen: -

VAERS 2263351

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: OH
Alter: 80,0
Geschlecht: F
Eingang: 04.05.2022
Impfdatum: 21.04.2022
Beginn: 26.04.2022
Tage bis Beginn: 5,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

Got COVID-19 - received treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Home test for COVID-19 - Positive.
Aktuelle Erkrankungen: No
Vorgeschichte: Rheumatoid arthritis
Andere Medikamente: Eliquis 5 mg twice a day Atorvastatin 20 once a day Magnesium 400 mg twice a day Calcium 600 mg twice a day Folic acid microgram 800 twice a day Methotrexate injection 20 mg 1 time per week Rituxan infusion 6 times per year Multivitamins da
Allergien: Opium Codeine Morphine Penicillin
Vorherige Impfungen: -

VAERS 2260095

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: NC
Alter: 59,0
Geschlecht: M
Eingang: 02.05.2022
Impfdatum: 02.05.2022
Beginn: 02.05.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Wrong product administered

Symptomtext

Pt requested to receive Pfizer/ Comirnaty 2nd booster. Inadvertently administered Moderna as their second booster. Pt kept in clinic for 15 min, and no reactions were expressed or observed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2258940

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

gering

Staat: CA
Alter: 70,0
Geschlecht: M
Eingang: 29.04.2022
Impfdatum: 14.04.2022
Beginn: 25.04.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

I tested positive for covid antigen on April 25th. I took 2 tests. The rapid tests.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Rapid test April 25. Rapid test April 25.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: diclofenac and low dose bp medication
Allergien: no
Vorherige Impfungen: -

VAERS 2257506

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: TN
Alter: 83,0
Geschlecht: M
Eingang: 28.04.2022
Impfdatum: 03.04.2022
Beginn: 28.04.2022
Tage bis Beginn: 25,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Muscular weakness

Symptomtext

Patient has lost all movement in legs. Unknown when started, wife stated this while pick up prescription

Weitere VAERSDATA-Felder

Praegender Schweregrund: Muscular weakness
Hospital-Tage: -
Labordaten: Unk
Aktuelle Erkrankungen: Unk
Vorgeschichte: Unk
Andere Medikamente: Coreg, Zetia, gabapentin, Lipitor, levothyroxine, Norvasc, Benicar, Plavix
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2254105

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: -
Geschlecht: U
Eingang: 27.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna doses (greater than 12 hours post puncture) were administered to 6 Patients) and PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated/he used vial then be placed back in a cooler with ice packs) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022 at 4:20 PM, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Apr-2022 at 4:20 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna doses (greater than 12 hours post puncture) were administered to 6 Patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated/he used vial then be placed back in a cooler with ice packs). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna doses (greater than 12 hours post puncture) were administered to 6 Patients) and PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated/he used vial then be placed back in a cooler with ice packs) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. Number of doses/vials: 6 doses/1 vial. On 15-Apr-2022, the vial was initially stored in the refrigerator. The vial was first punctured on 19-Apr-2022 at 1 PM central time. HCP reported after the vial was punctured, the vial would then be placed back in a cooler with ice packs and a data temperature logger monitoring the temperature inside the cooler. HCP reported no temperature excursion occurred inside the cooler according to the data logger. HCP stated she could probably send data logger data if needed but would have to get their IT department involved. HCP stated they made home visits to administer the vaccine to individuals. Once a dose was drawn up, the vial was immediately placed back in the cooler. The vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F): 5 minutes. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2254104

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: -
Geschlecht: U
Eingang: 27.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Utilizing cooler to keep punctured vial refrigerated/he vial then be placed back in a cooler with ice packs; Expired Moderna doses (greater than 12 hours post puncture) were administered to 6 Patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna doses (greater than 12 hours post puncture) were administered to 6 Patients) and PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated/he vial then be placed back in a cooler with ice packs) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022 at 8:55 AM, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Apr-2022 at 8:55 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna doses (greater than 12 hours post puncture) were administered to 6 Patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated/he vial then be placed back in a cooler with ice packs). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna doses (greater than 12 hours post puncture) were administered to 6 Patients) and PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated/he vial then be placed back in a cooler with ice packs) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Number of doses/vials: 6 doses/1 vial. On 15-Apr-2022, the vial was initially stored in the refrigerator. The vial was first punctured on 19-Apr-2022 at 1 PM central time. HCP reported after the vial was punctured, the vial would then be placed back in a cooler with ice packs and a data temperature logger monitoring the temperature inside the cooler. HCP reported no temperature excursion occurred inside the cooler according to the data logger. HCP stated she could probably send data logger data. HCP stated they made home visits to administer the vaccine to individuals. Once a dose was drawn up, the vial was immediately placed back in the cooler. The vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F): 5 minutes. No treatment information was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2254103

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: -
Geschlecht: U
Eingang: 27.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

>12 hours post puncture were administered; Expired Moderna doses (>12 hours post puncture) were administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna doses (>12 hours post puncture) were administered) and PRODUCT STORAGE ERROR (>12 hours post puncture were administered) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022 at 7:42 AM, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 20-Apr-2022 at 7:42 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna doses (>12 hours post puncture) were administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (>12 hours post puncture were administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna doses (>12 hours post puncture) were administered) and PRODUCT STORAGE ERROR (>12 hours post puncture were administered) outcome was unknown. Expired Moderna doses (>12 hours post puncture) were administered For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication list was not provided. Dose administered more than 12(US) hours post puncture. The vial was initially stored in the refrigerator on 15-Apr-2022. Date(s) and time(S) vial was first punctured- 19-Apr-2022 at 1 PM Central Time. HCP reported after the vial was punctured, the vial would then be placed back in a cooler with ice packs and a data temperature logger monitoring the temperature inside the cooler. HCP reported no temperature excursion occurred inside the cooler according to the data logger. Once a dose is drawn up, the vial is immediately placed back in the cooler. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F): 5 minutes Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2252784

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: CA
Alter: 40,0
Geschlecht: F
Eingang: 26.04.2022
Impfdatum: 23.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration No adverse event

Symptomtext

Booster #2 given too early. Patient is 40YO and not immunocompromised. Received Janssen as primary dose. Moderna as Booster #1. No adverse effect/event. Reporting procedural error only.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: None disclosed at time of assessment.
Aktuelle Erkrankungen: None disclosed at time of assessment.
Vorgeschichte: None disclosed at time of assessment.
Andere Medikamente: None disclosed at time of assessment.
Allergien: None disclosed at time of assessment.
Vorherige Impfungen: -

VAERS 2251582

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: -
Geschlecht: U
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Utilizing cooler to keep punctured vial refrigerated; Expired doses administered to 6 Patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 6 Patients) and PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022 at 9:39 AM, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 6 Patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 6 Patients) and PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported..

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2251267

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: -
Geschlecht: U
Eingang: 26.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Utilizing cooler to keep punctured vial refrigerated; Expired doses administered to 6 Patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 6 Patients) and PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022 at 3:41 PM, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 20-Apr-2022 at 3:41 PM, after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 6 Patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to 6 Patients) and PRODUCT STORAGE ERROR (Utilizing cooler to keep punctured vial refrigerated) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. Date the vial was initially stored in the refrigerator was 15-Apr-2022. Date and time vial was first punctured was 19-Apr-2022 at 13:00. The vial didn't undergo temperature excursion. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) was 5 minutes. Treatment medication was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2250630

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: -
Alter: 72,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 22.04.2022
Beginn: 01.04.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered No adverse event Wrong product administered

Symptomtext

No adverse events reported. COVID card documentation shows Pfizer was given. Unable to determine definitively which vaccine was given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2250107

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: 74,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered No adverse event

Symptomtext

Patient received COVID vaccine which was considered expired as it exceeded the recommended expiration. The medication was kept at appropriate temp and minimal room temp exposure. There were no obvious side effects as a result of this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD
Andere Medikamente: Senna, Trazadone, Haldol, Hyoscyamine, Lorazepam, Morphine, Bisacodyl.
Allergien: NKA.
Vorherige Impfungen: -

VAERS 2250100

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: PA
Alter: 65,0
Geschlecht: M
Eingang: 25.04.2022
Impfdatum: 22.04.2022
Beginn: 23.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Skin warm

Symptomtext

warm to touch, red, no pain or swelling-not restricting

Weitere VAERSDATA-Felder

Praegender Schweregrund: Erythema
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: nka
Vorherige Impfungen: -

VAERS 2250099

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: 44,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product storage error

Symptomtext

Patient received dose of covid vaccine which had been opened greater than 12 hours but less than 24 hours and contained at temperature less than room temperature. There was no immediate adverse reaction noted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD, Diastolic CHF, Anemia, Bipolar disorder, Seizures, Severe protein calorie malnutrition, tobacco use, O2 dependent.
Andere Medikamente: Buprenorphine, Celexa, Flexeril, Gabapentin, Singulair, Omeprazole, Potassium, Albuterol Sulfate, Senna, Buspar, Albuterol/Atrovent, Haldol, Hyoscyamine, Lamictal, Cipro, Mucines, Bumex, Ativan, Probiotic, Vitamin D, Tylenol, Oxycodone, Pre
Allergien: Vancomycin
Vorherige Impfungen: -

VAERS 2250084

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: 56,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product storage error

Symptomtext

Patient received COVID Booster which had exceeded the recommended 12 hour open time within 24 hours of vial being opened. There was no obvious adverse effect and there still is not. Vaccination had minimal room temperature exposure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Senile degeneration of brain, vascular dementia, Hypertension & chronic kidney disease, Diastolic CHF, Seizures, Hemiplegia, Chronic pain syndrome, abdominal aortic aneurysm, pulmonary hypertension, iron deficiency.
Andere Medikamente: Eliquis, Keppra, Topirimate, Zofran, Ativan, Prednisone, Polytrim, Guaifenesin, Albuterol/Atrovent, Norvasc, Senna, Trazadone, Lortab 10/325 mg, Celexa, Metoprolol Succinate, Topamax, Haldol, Prochlorperazine, Simethicone,
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2250070

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: 69,0
Geschlecht: M
Eingang: 25.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product storage error

Symptomtext

Patient received inital COVID vaccine with serum which had been opened greater than the 12 hour recommended expiration date. However, it had minimal exposure to room air temperature. There were no ill effects as a result of this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, Severe protein calorie malnutrition, nicotine dependence.
Andere Medikamente: Megace, Zoloft, Senna with Docusate, Tylenol, Dexamethasone, Ativan, Pepcid, Remeron, Albuterol/Atrovent.
Allergien: Codeine, Lisinopril
Vorherige Impfungen: -

VAERS 2250061

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: 92,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered No adverse event

Symptomtext

Patient received booster dose which had exceeded the recommended 12 hour open vial recommendation but was at appropriate temperature. There was no signs of adverse event as a result of this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Senile degeneration of brain, dementia, protein calorie malnutrition, mixed incontinence, repeated falls
Andere Medikamente: Tylenol, Levothyroxine
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2250049

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: KY
Alter: 86,0
Geschlecht: F
Eingang: 25.04.2022
Impfdatum: 20.04.2022
Beginn: 20.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Patient received booster dose from vial which had exceed the 12 hour expiration but remained within the recommended temperature setting.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Acute Shingles Infection prior to vaccination.
Vorgeschichte: Alzheimer's Disease, Hx of UTI
Andere Medikamente: Nystatin, Benadryl, Calmoseptine, Senna, Immodium, Guaifenesin, Acetaminophen
Allergien: Cipro, Keflex
Vorherige Impfungen: -

VAERS 2249579

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: ID
Alter: 31,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 18.03.2022
Beginn: 25.03.2022
Tage bis Beginn: 7,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Abortion spontaneous Blood test Factor II mutation Prothrombin level abnormal

Symptomtext

Pregnant at time of vaccine - due date June 8, 2022, baby born still at 3 lbs 1 oz exactly one week after booster vaccine. On March 25th, 2022, I felt decreased fetal movement. I went to the doctor and they confirmed my baby's heart had stopped beating. I delivered my baby stillborn at an estimated gestational age of 29 weeks and 3 days on March 26, 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abortion spontaneous
Hospital-Tage: -
Labordaten: Extensive bloodwork to investigate cause of stillbirth on 3/26/22, 3/27/22, and a thrombophilia panel on 4/4/22. All came back relatively normal aside from thrombophilia panel showing heterozygous for prothrombin G20210A gene mutation.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Citalopram, prenatal vitamin, pantoprazole
Allergien: None
Vorherige Impfungen: -

VAERS 2249347

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MA
Alter: 44,0
Geschlecht: M
Eingang: 23.04.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

At the time of vaccination it was approx 6 to 10 days past the 30 days window; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (At the time of vaccination it was approx 6 to 10 days past the 30 days window) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. It was unknown that the patient was ever been diagnosed positive with COVID-19. Patient had no acute illnesses at the time of vaccination and up to one month before. On 14-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 dosage form. On 14-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (At the time of vaccination it was approx 6 to 10 days past the 30 days window). At the time of the report, EXPIRED PRODUCT ADMINISTERED (At the time of vaccination it was approx 6 to 10 days past the 30 days window) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. A series of patients at a clinic received their second booster dose with a vial of Moderna that went past 30 days at 7-8 degree Celsius. At the time of administration it was approx. 6-10 days past the 30 day window. At the time of report, no patient contacted about any reactions. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: It was unknown that the patient was ever been diagnosed positive with COVID-19. Patient had no acute illnesses at the time of vaccination and up to one month before
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249292

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MA
Alter: 52,0
Geschlecht: M
Eingang: 23.04.2022
Impfdatum: 14.04.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

Covid-19 vaccine that were given beyond the 30 day use by date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date.) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date.) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. A series of patients at a clinic received their second booster dose with a vial of Moderna that went past 30 days at 7-8 degree Celsius. At the time of administration it was approx. 6-10 days past the 30 day window. At the time of report, no patient contacted about any reactions. Treatment information was not provided. This case was linked to MOD-2022-542869 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249291

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MA
Alter: 55,0
Geschlecht: F
Eingang: 23.04.2022
Impfdatum: 09.04.2022
Beginn: 09.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Product storage error; Covid-19 vaccine that were given beyond the 30 day use by date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date.) and PRODUCT STORAGE ERROR (Product storage error) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Apr-2022 at 9:00 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date.) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient Not contacted HCP about any reactions. No concomitant medication information provided. No treatment medication information provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2248358

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: KS
Alter: 73,0
Geschlecht: F
Eingang: 22.04.2022
Impfdatum: 06.04.2022
Beginn: 12.04.2022
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Retinal artery occlusion Visual field tests abnormal

Symptomtext

I had a Branch Retinal Artery Occlusion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Retinal artery occlusion
Hospital-Tage: -
Labordaten: Field of vision test confirmed diagnosis.
Aktuelle Erkrankungen: No
Vorgeschichte: High blood pressure, High cholesterol, Allergies. Osteopenia.
Andere Medikamente: Atorvastatin, Alprazolam, Metoprolol, Spironolactone, Levothyroxine, Zyrtec, Allegra, Vitamin B Complex, Multivitamin, Melatonin, Fish oil, Low dose aspirin, Miralax, Minoxidil, Viviscal, Matriline gel
Allergien: Codeine, Triple antibiotic cream
Vorherige Impfungen: -

VAERS 2248221

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: ID
Alter: 19,0
Geschlecht: F
Eingang: 22.04.2022
Impfdatum: 22.04.2022
Beginn: 22.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product preparation error

Symptomtext

Patient's weight was incorrectly calculated from kilogram to pounds and hence a 1 inch needle was used to give the vaccine in place of a 1.5 inch needle which should have been used. Patient was given standard counseling about the potential for side effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product preparation error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2247896

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: NC
Alter: 60,0
Geschlecht: M
Eingang: 22.04.2022
Impfdatum: 21.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration

Symptomtext

Patient stated that he needed his covid booster. prepared and administered dose. Upon documentation into covid vaccine database the interval between patient's previous dose and this dose was noted to be too short. was informed and she promptly discussed with the provider. telephoned the patient to inform him and address any questions or concerns he had. Patient denied concerns.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: none at this time
Aktuelle Erkrankungen: Dysuria, urinary frequency
Vorgeschichte: Abnormal Weight Loss Alcohol use Atopic Dermatitis Dermatophytosis nails Limb pain left Liver Enlargement Macrocytosis Malnutrition Non-specific Abnormal of Function Studies Liver Tobacco use Urinary frequency
Andere Medikamente: Terbinafine HCL 1% External Cream Vitamin B-12 1000mcg oral tablet Airborne Elderberry oral tablet chewable Centrum Silver oral tablet
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2247671

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MA
Alter: 75,0
Geschlecht: F
Eingang: 22.04.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

At the time of administration the vial was approximately 6-10 days past the 30 days window; Covid-19 vaccine that were given beyond the 30 day use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date) and PRODUCT STORAGE ERROR (At the time of administration the vial was approximately 6-10 days past the 30 days window) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 14-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (At the time of administration the vial was approximately 6-10 days past the 30 days window). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date) and PRODUCT STORAGE ERROR (At the time of administration the vial was approximately 6-10 days past the 30 days window) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. 7 patients received 2nd booster dose of moderna which was approximately 6-10 days past the 30-day expiration window. At the time of this report, no patient has contacted about any reactions. No treatment medications were reported. It was reported that isolated all vaccines with reported lot number and pulled from over inventory rotation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2247670

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MA
Alter: 66,0
Geschlecht: M
Eingang: 22.04.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered Product storage error

Symptomtext

Vial of Moderna went past 30 day at 2-8 degree Celsius; Covid-19 vaccine that were given beyond the 30 day use by date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date.) and PRODUCT STORAGE ERROR (Vial of Moderna went past 30 day at 2-8 degree Celsius) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065K21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial of Moderna went past 30 day at 2-8 degree Celsius). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Covid-19 vaccine that were given beyond the 30 day use by date.) and PRODUCT STORAGE ERROR (Vial of Moderna went past 30 day at 2-8 degree Celsius) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication reported. it was reported that the dose was 0.25 7 patients received 2nd booster dose of moderna which was approximately 6-10 days past the 30-day expiration window. At the time of this report, no patient has contacted about any reactions. No treatment medication reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2247669

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

gering

Staat: MA
Alter: 70,0
Geschlecht: M
Eingang: 22.04.2022
Impfdatum: 14.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

At the time of vaccination it was approx 6 to 10 days past the 30 days window; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (At the time of vaccination it was approx 6 to 10 days past the 30 days window) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065k21A) for COVID-19 vaccination. No Medical History information was reported. On 14-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 14-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (At the time of vaccination it was approx 6 to 10 days past the 30 days window). At the time of the report, EXPIRED PRODUCT ADMINISTERED (At the time of vaccination it was approx 6 to 10 days past the 30 days window) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not provided by the reporter. Patient allergic condition was unknown and patient was diagnosed with COVID-19 condition was unknown. For patient acute illnesses condition at the time of vaccination and up to one month before was unknown. Patient chronic or long lasting health condition was unknown. Also for patient prescription over the counter medications ,dietary supplements or herbal remedies being taken at the time of vaccination or at the time of adverse event was unknown. For patient other vaccines given on the same day as Moderna Covid-19 vaccine as well as vaccines received within one moth prior to any dose of Moderna COVID-19 vaccine was unknown. No patient have contacted to reporter about any reaction. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2246385

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21A

gering

Staat: PA
Alter: 70,0
Geschlecht: M
Eingang: 21.04.2022
Impfdatum: 21.04.2022
Beginn: 21.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Needle issue Skin atrophy

Symptomtext

the needle would not fully go into the patient's muscle due to minimal muscle mass (patient was very thin ) and toughness of the tissue . therefore , I took the needle out without injecting any vaccine component and prepared a new syringe/dose , then I successfully injected the patient with a dose the second time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Needle issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: weakened immune system per form
Vorgeschichte: -
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2244364

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: GA
Alter: 66,0
Geschlecht: M
Eingang: 20.04.2022
Impfdatum: 19.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Seasonal allergy

Symptomtext

Patient reports chest tightness that started shortly after getting the vaccine and continuing the next day. He informed me of this 4/20/22. He spoke with his pulmonologist office, and was told it was most likely seasonal allergies. He has an appointment with his primary care provider 4/21/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest discomfort
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Sarcadosis
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2242011

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MS
Alter: 65,0
Geschlecht: F
Eingang: 19.04.2022
Impfdatum: 19.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Wrong product administered

Symptomtext

Patient was expecting to receive the Pfizer vaccine but was administered the Moderna vaccine instead

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2242008

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: MS
Alter: 61,0
Geschlecht: M
Eingang: 19.04.2022
Impfdatum: 19.04.2022
Beginn: 19.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Wrong product administered

Symptomtext

Patient was given Moderna Vaccine and was expecting to receive the Pfizer vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2241109

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: NJ
Alter: 53,0
Geschlecht: F
Eingang: 19.04.2022
Impfdatum: 15.04.2022
Beginn: 15.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Wrong product administered

Symptomtext

Error: Wrong Vaccine/Product Administered-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2238098

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065K21A

gering

Staat: PA
Alter: 58,0
Geschlecht: M
Eingang: 16.04.2022
Impfdatum: 16.04.2022
Beginn: 16.04.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration No adverse event

Symptomtext

Immunocompromised patient was given 4th dose of Moderna vaccine 11 days early. His vaccine dates are 3/31/21 (0.5ml), 4/28/21 (0.5ml), 12/27/21 (0.25ml) and now 4/16/22 (0.25ml). Because he is immunocompromised, patient should have received 0.5ml as a third dose and then 0.25ml as a 4th dose 4 months later. No other adverse reactions associated with his vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: losartan, hydrochlorothiazide, levothyroxine, sertraline
Allergien: no known drug allergy
Vorherige Impfungen: -

VAERS 2238071

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: PA
Alter: 77,0
Geschlecht: F
Eingang: 16.04.2022
Impfdatum: 13.04.2022
Beginn: 14.04.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cellulitis

Symptomtext

Developed cellulitis. Patient went to med express and doctor prescribed cefuroxime and loratadine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cellulitis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: -
Andere Medikamente: Penlac voltaren gel
Allergien: aloe nsaids
Vorherige Impfungen: -

VAERS 2235906

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: UT
Alter: 24,0
Geschlecht: F
Eingang: 15.04.2022
Impfdatum: 11.04.2022
Beginn: 11.04.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Lymphadenopathy

Symptomtext

Systemic: Lymph Node Swelling-Mild, Additional Details: she felt like her one lymphnode was a bit swollen about 15 min after vaccine. Other patient came in and interrupted and she left.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lymphadenopathy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2235893

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: PA
Alter: 54,0
Geschlecht: F
Eingang: 15.04.2022
Impfdatum: 02.04.2022
Beginn: 08.04.2022
Tage bis Beginn: 6,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Herpes zoster

Symptomtext

Systemic: patient developed shingles 6 days later-Severe, Additional Details: patient diagnosed with shingles 6 days later. unkown if 100% related to vaccine but completing VAERs regardless

Weitere VAERSDATA-Felder

Praegender Schweregrund: Herpes zoster
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2233849

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 065k21a

gering

Staat: KY
Alter: 13,0
Geschlecht: M
Eingang: 14.04.2022
Impfdatum: 13.04.2022
Beginn: 13.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient is not having symptoms at this time. He was given Moderna Vaccine and he is under the age of 18.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: Non
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -